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Discerning the metabolic or enzymatic role of a particular gene product, in the absence of 
information indicating sequence homology to known gene products, is a difficult task.  One 
approach is to compare the levels of metabolites in a wild-type organism to those in an organism 
with a mutation that causes loss of function of the gene. The goal of this project was to develop 
an approach to analyze metabolite data on wild-type and mutant organisms for the purpose of 
identifying the function of a mutated gene.  
To develop and test statistical approaches to analysis of metabolite data for identification 
of gene function, levels of 141 lipid metabolites were measured in leaves of wild-type 
Arabidopsis thaliana plants and in leaves of Arabidopsis thaliana plants with known mutations 
in genes involved in lipid metabolism.  The mutations were primarily in fatty acid desaturases, 
which are enzymes that catalyze reactions in which double bonds are added to fatty acids. When 
these enzymes are mutated, leaf lipid composition is altered, and the altered levels of specific 
lipid metabolites can be detected by a mass spectrometry. 
A randomization P-Value and other metrics were calculated for all potential reactant-
product pairs, which included all lipid metabolite pairs.  An algorithm was developed to combine 
these data and rank the results for each pair as to likelihood of being the actual reactant-product 
pair. This method was designed and tested on data collected on mutants in genes with known 
functions, fad2 (Okuley et al., 1994), fad3 (Arondel et al., 1992), fad4, fad5 (Mekhedov et al., 
2000), fad6 (Falcone et al., 1994), and fad7 (Iba et al., 1993 and Gibson et al., 1994). Application 
of the method to three additional genes produced by random mutagenesis, sfd1, sfd2, and sfd3, 
indicated that the significant pairs for fad6 and sfd3 were similar.  Consistent with this, genetic 
evidence has indicated that sfd3 is a mutation in the FAD6 gene.  
The methods provide a list of putative reactions for an enzyme encoded by an unknown 
mutant gene.  The output lists for unknown genes and known genes can be compared to provide 
evidence for similar biochemical activities.   However, the strength of the current method is that 
the list of candidate chemical reactions for an enzyme encoded by a mutant gene can be 
produced without data other than the metabolite profile of the wild-type and mutant organisms, 
i.e., known gene analysis is not a requirement to obtain the candidate reaction list. 
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“Omics” technologies allow investigators to study the levels of hundreds or thousands of 
compounds in an organism simultaneously. Interest is often in the how the levels of a compound 
vary across tissue type, species type, or in response to a stimulus. Transcriptomics experiments 
evaluate changes in gene expression, proteomics experiments changes in the expression of 
proteins, and metabolomics (including lipidomics) changes in metabolite (or lipid) profiles. The 
latter two involve the study of cellular components downstream from transcription and, thus, 
experiments can be designed to elucidate the function of genes by the study of their effects on 
these downstream components (cf., Trethewey, 2001; Holtorf et al., 2002). Knowledge of gene 
function and downstream components aids in the creation of tools for cataloguing pathways that 
can be updated as more experiments and results are obtained (cf., Mueller, et al., 2003).   
This thesis proposes an exploratory technique to investigate the function of genes 
potentially involved in metabolism or signaling via the study of the lipidome of Arabidopsis 
thaliana. While the method could be applied to other metabolites, here the lipidome from a 
mutant plant is compared with that of wild type to determine the loss of function, as revealed by 
the lipidome associated with the mutated gene. In particular, the levels of lipid pairs were 
analyzed to screen for candidate reactant-product pairs using a method that exploits the loss of 
function associated with a mutant genotype. Figure 1 is a simple illustration of the concept. Two 
lipids are shown, A and B, for two organisms, wild type with lipid concentrations Aw and Bw, 
and a mutant plant with concentrations Am and Bm.  
This figure is a simplification of the biological situation, i.e.,  it does not take into 
account that a reaction may be involved in a complex metabolic network of known and/or 
unknown pathways.  However, this figure illustrates the method and ideas proposed herein, 
which also assume that, to a first approximation, we can obtain information about the function of 
a particular gene product (enzyme) by looking directly at the levels of its substrate (reactant) and 
product. If a reactant A is converted into B in wild-type plants but not in mutant plants, then Am 
concentration should be greater than Aw since the lipid A will build up in the mutant because the 
reaction does not proceed due to the loss of the function of the gene encoding the enzyme that 
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catalyzes the reaction. Similarly, the concentration Bw should be greater than Bm. Alterations in 
metabolite (lipid) concentrations between mutant and wild-type organisms can reveal the role of 
a genotype that might not otherwise be revealed by easily observable phenotypic characteristics 
such as “plant height” (e.g., Raamsdonk et al., 2001). In this thesis, plants of nine different 
mutant genotypes are compared with wild-type plants to identify candidate reactant-product pairs 
in a targeted lipidomic analysis of Arabidopsis thaliana and I/8E/5. Data were collected on 
mutants in genes with known functions, fad2 (Okuley et al., 1994), fad3 (Arondel et al., 1992), 
fad4, fad5 (Mekhedov et al., 2000), fad6 (Falcone et al., 1994), and fad7 (Iba et al., 1993 and 
Gibson et al., 1994) and on mutants with genes produced by random mutagenesis, sfd1, sfd2, and 
sfd3. Of the nine mutants, information regarding the enzymatic function of the mutated gene 
product was available initially for six fad mutants. Thus the proposed method for identifying 
candidate reactant-product lipid pairs can, to some degree, be validated by its ability to detect 
expected reactant-product pairs. The concentrations of 141 lipid species were quantified by mass 
spectrometry, resulting in an exploration of 141*140 = 19,740 lipid pairs (note, no a priori 
knowledge was assumed as to whether a particular lipid would be a product or a reactant) that 
were ranked for likelihood of being a “true” reactant-product pair using the proposed method. 
 
Figure 1-1: Two lipids with concentrations Aw and Bw in a wild-type plant and Am and 
Bm in a mutant. The illustration shows a reactant-product pair when the mutation in a 









The study of functional genomics via the lipidome or metabolome using high throughput 
technologies is relatively recent (Last et al., 2007; Wolf and Quinn, 2008), but some methods for 
analysis and characterization of lipid or metabolite profiles have been proposed. A popular 
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method involves principal components analysis (PCA) and its extensions. Allen et al. (2003), for 
example, used PCA and a machine learning technique to classify mutant strains based on 
metabolomic profiles. The classification is done by clustering strains by the lower dimensional 
principal component scores. Though useful as a classification tool, such linear combinations 
from PCA are not always interpretable and are not pursued here since the focus of the proposed 
screening procedure is on direct detection of candidate reactant-product pairs. Most directly 
relevant to the method proposed here is the functional analysis by co-response in yeast (FANCY) 
technique reported in (Raamsdonk et al., 2001). Their method uses a metric that, using our lipid 
concentration notation above, is of the form, 
                                                   ln( ) ln( )
ln( ) ln( )
Am AwT
Rm Rw
−= −   
where R was a reference metabolite upstream in the metabolic pathway from the metabolites 
involved in the reaction catalyzed by the enzyme being analyzed.  The metric T was 
subsequently transformed by arc-tangent to scale it between -90° and 90°. A co-responding 
metabolite with the reference had a transformed value of T near 45° for a positive co-response 
and -45° for a negative co-response. Though intuitively appealing, this method is not directly 
applicable for the analytical objectives for several reasons. Herein, no assumptions are made 
about an upstream reference. Instead the references are the concentrations of all other lipids. 
Second, for some lipids, the concentration is zero for all samples in a mutant or wild-type plant. 
These zero values cannot be ignored because they might be due to the lack of a reaction in the 
mutant organism (i.e., the product is depleted) or the depletion of a reactant in the wild-type. 
However, the zero values pose problems for logarithm transformations and for metrics involving 
certain ratios. Others have computed the correlation between the concentrations of pairs of 
metabolites and compared these correlation statistics across a control and mutant organism (e.g., 
Weckwerth et al., 2004).   Weckwerth et al., (2004) also used a statistical test comparing the ratio 
of pairs of metabolites between control and mutant conditions. Considering such metrics herein  
poses problems again due to the zero values mentioned earlier and the fact that correlation 
metrics can be misleading as a measure of association in the presence of many tied values, i.e., 
the usual Pearson’s correlation quantifies a linear association between two variables. Wu et al. 
(2005) proposed a conceptual strategy using a quantitative kinetic model relating metabolic 
fluxes to enzymatic activity and metabolic concentrations, and demonstrated the technique with 
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an in silicon case study. Approaches involving such kinetic models of fluxes are beyond the 
scope of the objectives in this thesis.  
The method proposed here uses a multi-step procedure to screen a large number of lipid 
pairs for candidate reactant-product pairs using mutant and wild-type organisms. It can 
accommodate the zero observations and does not rely on distributional assumptions regarding the 
data. It is, thus, heuristic in nature and cut-off values in the screening procedure can be “tuned” 
to produce a larger or smaller number of potential reactant-product pairs for follow-up 
investigation and verification. A larger candidate reactant-product list may include many 
irrelevant findings and a smaller list might miss important pairs. In the next section, the data and 
experimental procedures are discussed. Then the method to screen potential reactant-product 





2  Experimental procedures and the data 
2.1 Experiment procedures 
Electrospray ionization tandem mass spectrometry (ESI-MS/MS) can be used for lipid 
profiling (Briigger et al., 1997). Here, it was used to provide information for 141 lipids, 
including lipids unique to plants as function of plant genotype.  
Plant material and plant growth: The plants were grown and the lipids were extracted 
and analyzed by Ashis Nandi and Christen Buseman, working with Jyoti Shah and Ruth Welti, 
respectively, in the Division of Biology at Kansas State University.  The wild-type plants for the 
first sets of experiments (with the fad mutants) were Arabidopsis thaliana (Columbia ecotype), 
while the wild-type plants in the second set of experiments were 1/8E/5.  Surface-sterilized seeds 
were germinated on agar plates and transferred to soil.  Plants were grown in a chamber with a 
16-h light/8-h dark cycle, at 23/21°C, under cool fluorescent white light (200 μmol m-2 s-1).  
Sample preparation: Lipids were extracted according to the procedure of Devaiah et al. 
(2006) with minor modifications. Briefly, 3 to 5 leaves were quickly immersed in 3 ml 
isopropanol with 0.01% butylated hydroxytoluene at 75ºC to inactivate lipolytic activity. After 
15 minutes, 1.5 ml chloroform and 0.6 ml water were added and the tubes were shaken for 1 h. 
Thereafter, the extract was removed and replaced with chloroform/methanol (2:1) with 0.01% 
butylated hydroxytoluene and the tubes were shaken for 30 min. The latter procedure was 
repeated five times until the leaves of every sample appeared white. The remaining leaf material 
was dried overnight at 105ºC and weighed. The combined extracts were washed once with 1 ml 1 
M KCl and once with 2 ml water, evaporated under nitrogen, and dissolved in 1 ml chloroform. 
ESI-MS/MS: An automated electrospray ionization-tandem mass spectrometry approach 
was used, and data acquisition and analysis and acyl group identification were carried out as 
described previously (Devaiah et al., 2006).    
Unfractionated lipid extracts were introduced by continuous infusion into the ESI source 
on a triple quadrupole MS/MS (API 4000, Applied Biosystems, Foster City, CA).  Samples were 
introduced using an autosampler (LC Mini PAL, CTC Analytics AG, Zwingen, Switzerland) 
fitted with the required injection loop for the acquisition time and presented to the ESI needle at 
30 μl/min. Scans and data processing were as described by Devaiah et al. (2006).  
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Nine experiments were conducted, of which, six were used to derive the method while 
three were used to check its reliability. For each experiment, a control group of 5 samples from 
wild type plants was obtained and, for a treatment group, 5 samples from mutant plants were 
obtained. The samples in the first set of experiments included “treated” groups that had FATTY 
ACID DESATURASE point mutations, fad2, fad3, fad4, fad5, fad6 and fad7.  Other “treated” 
samples, analyzed in a second set of experiments, included initially unmapped point mutations 
produced by random mutagenesis, sfd1, sfd2 and sfd3. (Wild-type genes are designated by capital 
letters, e.g., FAD2, while mutant genes are designated by lower case letters, e.g., fad2.)  The 
control group (i.e., wild type) was the same for all mutations in the same set of experiments. 
Each experiment can be thought as a two group comparison where the “treatment” is wild type 
versus mutant. Levels of 141 different lipids were measured in each sample.  
 
2.2 Description of data 
 
Table 2.2-1 Part of the dataset – fad2 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.249 2.175 2.526 1.956 2.212 3.249 2.553 4.058 2.959 2.785
DGDG34_5 0.141 0.103 0.096 0.166 0.061 0.185 0.193 0.074 0.190 0.236
DGDG34_4 0.258 0.194 0.203 0.177 0.226 0.232 0.291 0.316 0.180 0.270
DGDG34_3 4.694 4.329 4.405 3.858 4.026 3.451 3.398 4.164 3.243 3.026
DGDG34_2 1.012 0.951 1.104 0.807 0.794 1.686 1.020 1.771 1.265 1.506
DGDG34_1 0.414 0.398 0.437 0.354 0.396 0.894 0.977 0.935 0.824 0.845
DGDG36_6 14.954 16.683 14.931 14.079 15.010 8.538 8.896 10.074 8.516 8.990
DGDG36_5 0.000 0.000 0.000 0.000 0.000 0.041 0.000 0.000 0.071 0.000
DGDG36_4 0.455 0.458 0.383 0.462 0.427 0.774 0.871 0.941 0.998 0.811
DGDG36_3 0.221 0.178 0.200 0.129 0.155 0.198 0.050 0.189 0.065 0.044
DGDG36_2 0.007 0.000 0.000 0.000 0.000 0.020 0.049 0.022 0.013 0.048
DGDG36_1 0.000 0.000 0.000 0.000 0.000 0.017 0.000 0.000 0.000 0.000
DGDG38_6 0.179 0.224 0.153 0.217 0.156 0.248 0.274 0.329 0.378 0.378
DGDG38_5 0.000 0.000 0.000 0.000 0.000 0.011 0.000 0.000 0.000 0.000
DGDG38_4 0.082 0.000 0.025 0.025 0.045 0.013 0.008 0.000 0.019 0.000
DGDG38_3 0.000 0.009 0.000 0.000 0.000 0.004 0.007 0.017 0.000 0.000
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Table 2.2-1 shows partial data (i.e., 16 of the 141 lipid levels) for 10 samples from the 
fad2 dataset.  The columns show the lipid levels, where C1 to C5 represent the control group 
(wildtype) and T1 to T5 represent the treated group where the FAD2 gene is mutated. All the 
lipids were measured in the unit of nmol/mg dry weight. As can be seen, many zeros appear 
when lipid levels are either below the detection limit or represent lipids that are not present in the 
sample; this is partially because zero has been substituted for any values for which the measured 
intensity is below the limit of detection. For this analysis, zero values will be assumed to mean 
the lipid is not present in the sample. Imputing values for a lipid, that is present, but below the 
detection limit, is a topic of further investigation. Lipids that are not present in a sample are 
important to include in the analysis because their absence may be due to the loss-of-function of 
the knockout gene. Zero values combined with the relatively small sample sizes create 
challenges when using usual parametric statistical tests. The other datasets and the remainder of 




3 Method to analyze the data 
The analysis of data from lipidomics experiments is relatively new. This paper proposes a 
technique that is exploratory in nature and is aimed at identifying metabolites, quantified by 
mass spectrometry, which are altered when a mutation is present affecting a specific gene.  In 
particular, the goal is to identify compounds that are likely to be substrates (reactants) and 
products of the affected gene. The method can vet a large number of reactant-product pairs to 
determine which pairs might be “important” for follow-up analyses. A set of metrics is used to 
quantify this potential importance and these can be tuned or set by the investigator. Some 
recommended settings are obtained by analyzing data from the six experiments described earlier 
using the proposed method, and checking the results against genes with known function to 
determine if, in fact, the reactant-product pairs identified as “important” are the known reactant-
products pairs of the enzymatic activity of the gene product. If a method is proved to be effective 
on the genes with known functions, it might serve as a method to explore unknown genes’ roles. 
In fact reactions are part of pathways so some lipids not directly associated with a gene product, 
but in the same pathway or network of pathways, may also be changed by mutation of a 
particular gene. Thus it is reasonable to expect to pick up some “false” reactant-product pairs, 
which might provide clues to understand the pathways. Since there are 141 lipid measurements 
in each sample for the experiments analyzed here, and since we do not assume a priori that a 
particular lipid is a product or reactant, there are a total of 141*140 = 19,740 possible lipid pairs 
to be evaluated. 
 
3.1 Overview of screening metrics   
The metrics used to screen candidate reactant-product pairs are described here with 
details to follow in subsequent subsections. Refer to Figure 1 where two lipids, A (for candidate 
reactant) and B (for candidate product), are shown with levels denoted by Aw and Bw for the 
wild-type plant, and Am and Bm for the mutant. First, the levels of Aw and Am (and Bw and 
Bm) should be “statistically” different. However, usual tests such as the t-test are problematic 
because of the zeros present for the level of some lipids across samples. Thus, a randomization 
test is used to assess statistically significant differences between the levels of Aw and Am (and 
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Bw and Bm). The results are two randomization P-values, 1P  and 2P , for testing Aw versus Am 
and Bw versus Bm, respectively. This P-value also has a nice intuitive interpretation as a 
measure of overlap between the values of Aw and Am (and Bw and Bm). The smallest P-values 
occur when the levels of a mutant lipid are greater than (or less than) the corresponding levels of 
a wild-type lipid across all samples.  
The next set of metrics involves the direction of the differences between levels of Aw and 
Am (and Bw and Bm). As mentioned in the introduction, the levels of Aw should be less than the 
levels of Am. We define 1d to be the sample mean of Aw values minus the sample mean of Am 
values. The levels of Bw should be greater than the levels of Bm. Thus we define 2d to be the 
sample mean of Bw values minus the sample mean of Bm values. Moreover, 1d should be 
negative by a distance related to the variability of the sample values of lipid A. So the pooled 
standard deviation for the candidate reactant lipid is computed and denoted 1sp . Similarly, 
2d should be positive by a distance related to the variability of the sample values of lipid B. So 
the pooled standard deviation for the candidate product lipid is computed and denoted 2sp .   
Finally, 2 1d d− should be positive by a sufficient amount to indicate a potential reactant-
product pair. Thus we define a t-score to be the standardized difference of 2 1d d− , that is, 
2 1 2 1( ) / ( )tscore d d SD d d= − − where 2 1( )SD d d− is the estimated standard deviation of the mean 
difference. The calculation flows are diagramed in Figure 3-1. 
 











In the following subsections, details are provided on each of the above metrics that include 
formulas used for computation of the values. Then, a subsection describing the selected cut-off 
values for each metric is provided. 
 
3.2 The randomization p-values 
This type of inference involves permutation of observed responses under a specified null 
hypothesis (Gadbury, 2001). Consider measurements for one lipid, where X denotes lipid levels 
for wild type (lipid Aw and Bw in previous notation) and Y denotes lipid levels for a mutant 
(i.e., lipid Am and Bm in previous notation). The null hypothesis is described as a statement: Ho: 
the mutant knockout had no effect on the expression of this lipid. A test statistic, t, is computed 
to represent a difference in gene expression due to treatment.  
Suppose that jr  is the lipid level of the jth sample, which represents a value of jY  or jX  
depending on whether that sample is a wild-type or mutant sample. The vector ( )1, Nr r…  
represents the lipid levels from the experiment for all N samples. The mutant genotype is 
considered a treatment here with the wild type being a control. A usual randomized experiment 
would select n samples from N items to receive the “treatment”, i.e., mutation. Though this 
controlled assignment was not possible here, the context of a randomized experiment is useful to 
assess the change of a particular lipid from wild type to mutant. The null hypothesis, Ho, 
supposes that a lipid level of a mutant would have been the same if that sample had been wild 
type. Under Ho a randomization distribution of the test statistic is created by randomly choosing 
n values from ( )1, Nr r…  to represent outcomes to mutant with the other m values representing 
outcomes to wild type. Each time this is done, a test statistic *t , is computed yielding 
1*, , *Ct t… , where !( ! !)NC n m=  is the number of unique treatment assignments and each value 
of *t  is equally likely under Ho. The p-value is then computed as the proportion of *t  that is as 
extreme as or more extreme than the test statistic t observed from the data produced from the 
actual treatment assignment. The exactness of this p-value depends on an assumption that is 
sometimes called unit-treatment additivity, meaning, for a sample j, j jY X τ= + , where τ  is a 
constant for all j; 0τ =  under the null hypothesis of no differential lipid expression and has been 
called Fishers “sharp null hypothesis” (Rubin, 1990). Note that unit-treatment additivity 
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necessarily implies that the variances of the two outcome variables Y and X are the same and 
that the two distribution above, YF  and XF , differ only in their location (i.e., their mean).  
In this study, the test statistic was a mean difference in lipid levels, that is, t d x y= = − . 
Moreover, N = 10, n = m = 5, C = 252, and the smallest two-tailed P-value is equal to 2/252 = 
0.007937. This would represent a lipid for which levels for all samples in the mutant group were 
either higher or lower than those in the wild-type group. That is, there is no overlap of lipid 
levels in the two groups. Thus, when selecting potential reactant-product pairs, one might choose 
to consider only those lipids with a small P-value. The actual mean difference, as mentioned 
above, is a second criterion that can be used to assess whether a particular lipid is a candidate 
product or reactant in a pairing. This is discussed next along with the derivation of the t-score for 
ranking pairs.   
 
3.3 Mean differences and the t-score 
Define 1ix to be the lipid level of a candidate reactant in the ith wild-type sample, 1iy to be 
the lipid level of a candidate reactant in the ith mutant sample, 2ix to be the lipid level of a 
candidate product in the ith wild-type sample, and 2iy to be the lipid level of a candidate product 
in the ith mutant sample. In this experiment where are nx wild-type samples and ny mutant 

































= ∑ . Then mean differences shown in figure 3-1 are 111 yxd −= and 
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Where, the estimated m 2 1( )SD d d−  is derived in the following steps.  
First, 
2 1
2 1 1 2
1 1 2 2 1 1 2 2
1 1 2 2
1 2 1 2 2 1 1 2
var( )
var( ) var( ) 2cov( , )
var( ) var( ) 2cov( , )
var( ) var( ) var( ) var( )
2*[cov( , ) cov( , ) cov( , ) cov( , )]
d d
d d d d
x y x y x y x y
x y x y
x x y x y x y y
−
= + −
= − + − − − −
= + + +
− − − +
 
The estimate of the variance is given by 
m m m2 22 21 21 2
2 1 1 2 1 2var( ) 2cov( , ) 2cov( , )y yx x
x y x y
S SS Sd d x x y yn n n n− = + + + − − , 
where, m 1 2 1 1 2 2
1





x x x x x x
n n =
= − −− ∑ , and 
m
1 2 1 1 2 2
1





y y y y y y
n n =
= − −− ∑ . Thus, m m2 1 2 1( ) var( d  - d  )SD d d− = . 
Results for all candidate reactant-product pairs are summarized in Table 3.2, which 
shows criteria used to screen the potential 19,740 possible reactant- product pairs. The 
description of the criteria and what they represent are below. 
 
Table 3.3-1 Example of criteria to evaluate product-reactant pairs 
Reaction-name 1P  2P   1d  2d  1 2d d−  1sp  2sp  t-score 
DGDG34_1_DGDG34_2    
DGDG34_1_DGDG34_3    
……    
PS44_3_PS44_2    
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Reaction-name lists the potential 19740 possible paired reactions (reactant-product). Take 
the first row as an example, DGDG34_1_DGDG34_2 means the possible reaction from 
DGDG34_1 to DGDG34_2. 1P  are the randomization p-values for the reactants. In the first row, 
1P  are the randomization p-values of lipid DGDG34_1. One may be interested in those candidate 
reactants that have the smallest P-values. 2P  are the randomization p-values for the products. In 
the first row, 2P  are the randomization p-values of lipid DGDG34_2. Again one may be 
interested in P-values close to 0 for the products that are significantly different in the wild type 
group and in the mutant group. Again, take the first row as an example. The statistic 1x  
represents the mean for DGDG34_1 (reactant) in the wild type group and 1y  represents the 
mean for DGDG34_1 (reactant) in the mutant group. Since there would be no (or less) reactions 
from DGDG34_1 to DGDG34_2 if the critical gene is not functional, 1x  would be smaller than 
1y . The mean difference 1d  with the value of 1x - 1y  would be negative. In fact, we may wish to 
select those pairs with a value of 1d less than some negative threshold, 1δ . Similarly, 
2x represents the mean for DGDG34_2 (product) in the wild type group and 2y  represents the 
mean for DGDG34_2 (product) in the mutant group. Since there would be no (or less) reactions 
from DGDG34_1 to DGDG34_2 if the critical gene is blocked, 2x would be bigger than 2y . The 
mean difference 2d  with the value of 2x - 2y  would be positive. We may wish to select those 
pairs with a value of 2d larger than some positive threshold, 2δ . The statistic 1sp  is the estimated 
pooled standard deviation across the mutant group and the wild-type group and 2sp  is the 
estimated pooled standard deviation across the mutant group and the wild-type group.  The t-
score combines the information for a candidate reactant and product and is a summary measure 
for a reactant-product pair.  The interest will be in those pairs with the largest t-scores, i.e., those 
where .tscore t cut> . 
 
3.4 The cut-off values for screening candidate pairs 
The rules for the cut-off values are described below. 
1. The t-score was computed for each possible pair. The t-score is expected to be a large 
positive value if the gene mutation prevented the conversion of the candidate reactant to product. 
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Some t-scores were undefined because the lipid levels for a candidate pair (both reactant and 
product) were all zero, i.e. the lipids were not detected in any samples for that pair. This number 
varied by dataset. The top 450 pairs (of 19,740) as ranked by t-score were selected for follow-up 
screening. This selection produced cutoff values (t.cut) for each experiment of 34.05, 9.34, 9.96, 
16.67, 24.65 and 20.30 for fad2, fad3, fad4, fad5, fad6 and fad7 respectively. 
2. Of the 141 lipids that were tested for differential lipid expression across the wild-type 
versus mutant groups with the randomization test, the smallest possible randomization p-value 
was 2/252 = 0.00794. Lipids with the smallest possible P-value (i.e., 1 2,P P  in Table 3.2) were 
chosen as potential candidates for a reactant-product pair.   
3. The mean differences described above, 1d  which is expected to be negative and 
2d which is expected to be positive, are then considered.  A negative cutoff for 1d and a positive 
cutoff for 2d were determined as followed.   Since multiple lipids are involved some threshold 
taking into account the simultaneous estimation was needed. A Bonferroni cutoff was chosen for 
an overall significance level of 0.05, adjusting for the total number of lipids. Since there are 141 
lipids, the cutoff is (in terms of standard errors of a mean) 2 / 5 * (0.05 /141,8)qt±  which gives 
±3.36 for the number of pooled standard deviations computed above (in the above the notation qt 
means the quantile from a t-distribution, the degrees of freedom was 8). The cut-off values for 
1d and 2d  were  1 13* spδ = −  and 2 23* spδ = , respectively. Thus, 1d < 1 13* spδ = −  and 
2d > 2 23* spδ = were considered meeting this criterion. 
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4 Results  
The original lists of reactant-product pairs were decreased from 19,740 to a smaller 
number based on the three selected screening criteria described in section 3. The same cut-off 
rules for screening criteria were used for every experiment.  Application of these rules resulted in 
a varied number of reactant-product pairs meeting these criteria among experiments. 
Results for the experiments of fad2, fad3, fad4, fad5, fad6, and fad7 are listed in the 
following way: the significant reaction pairs detected by this method are presented in Section 4.1 
and the biochemically feasible reaction pairs identified among the significant ones is presented in 
Section 4.2. A comparison of the biochemically feasible pairs with the known substrates and 
products then follows.  
4.1 The significant reactions for fads  
This section lists the significant reaction pairs for fad2, fad3, fad4, fad5, fad6, and fad7, 
respectively.  Only t-scores are listed here. More metrics are provided in appendix A.  
 
Table 4.1-1 The significant reactions for fad2. Biochemically feasible pairs (see section 4.2) 
are shown in blue.  
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
PE34_1_PE40_2 69.05 PC34_1_LysoPE16_0 45.37 PC36_2_PS44_2 40.09 
PE34_1_PS34_2 67.37 PC34_1_LysoPC18_2 45.29 PC36_2_PS36_5 40.09 
PE34_1_PS38_2 66.51 PC34_1_PS38_2 45.05 PC36_2_PA36_5 40.04 
PE34_1_PC38_5 66.38 PC34_1_LysoPC18_3 45.00 PC36_2_PA34_2 40.01 
PE34_1_LysoPE16_0 66.08 PC36_2_PC34_2 44.88 PC36_2_PE34_2 39.93 
PE34_1_PI36_3 66.05 PC36_2_PC36_3 44.53 PC36_2_PC36_6 39.80 
PE34_1_PS38_3 65.94 PC34_1_PS44_2 44.50 PE34_4_PC38_5 39.76 
PE34_1_LysoPE18_2 65.84 PC34_1_PC40_4 44.39 PE36_2_PS34_2 39.04 
PE34_1_LysoPC18_3 65.42 PC34_1_PS36_5 44.22 PE36_2_PC38_5 38.78 
PE34_1_LysoPC18_2 65.42 PE34_4_PS40_2 43.68 PE36_2_PC38_3 38.77 
PE34_1_PC38_3 65.26 PC34_1_PA34_2 42.76 PE36_2_PS42_2 38.55 
PE34_1_PS36_5 64.65 PC36_2_PE36_5 42.62 PE36_2_PS38_3 38.51 
PE34_1_PI36_5 64.56 PC36_2_PI34_2 42.07 PE36_2_LysoPE18_2 38.42 
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PE34_1_PE38_5 64.50 PC36_2_PI36_3 42.04 PE36_2_PS40_2 38.36 
PE34_1_PC40_4 64.44 PE36_2_PI36_3 41.82 PE36_2_LysoPE16_0 38.08 
PE34_1_PS40_2 64.37 PC36_2_PE40_2 41.06 PE36_2_PS38_2 37.99 
PE34_1_PS36_3 64.24 PC36_2_PI36_5 41.03 PE36_2_LysoPC18_2 37.90 
PE34_1_PS44_2 63.91 PC34_1_PA36_5 41.00 PE36_2_PS36_3 37.90 
PE34_1_PS42_2 61.72 PE36_2_PE40_2 40.81 PE36_2_PE38_5 37.89 
PE34_1_PA36_5 55.30 PC36_2_PS34_2 40.76 PE36_2_LysoPC18_3 37.63 
PE34_1_PA34_2 52.07 PC36_2_PC38_3 40.74 PE36_2_PS36_5 37.33 
PC34_1_PI36_3 51.17 PE36_2_PI36_5 40.67 PE36_2_PC40_4 37.32 
PC34_1_PI36_5 49.26 PC36_2_PC38_5 40.53 PC36_2_PC34_3 37.27 
PC34_1_PE40_2 48.69 PC36_2_PS38_3 40.48 PE36_2_PS44_2 37.25 
PC34_1_PS42_2 48.00 PC36_2_PS40_2 40.45 PS42_1_LysoPE16_0 35.67 
PC34_1_PC38_3 47.64 PC36_2_LysoPE18_2 40.38 PE36_2_PA34_2 35.60 
PC34_1_PC36_3 47.58 PC36_2_PS42_2 40.38 PE36_2_PA36_5 35.59 
PC34_1_PS34_2 47.55 PC36_2_LysoPE16_0 40.36 PC36_2_PE34_3 35.48 
PC34_1_PS40_2 46.76 PC36_2_PS36_3 40.30 PC34_1_PC34_2 34.87 
PC34_1_PC38_5 46.55 PC36_2_PS38_2 40.30 PC38_2_PC38_3 34.72 
PC34_1_PS38_3 45.81 PC36_2_PE38_5 40.29 PI34_1_PS34_2 34.34 
PC34_1_LysoPE18_2 45.60 PC36_2_LysoPC18_2 40.28 PS42_1_PC40_4 34.27 
PC34_1_PE38_5 45.58 PC36_2_LysoPC18_3 40.24 PC38_2_PS34_2 34.11 
PC34_1_PS36_3 45.52 PC36_2_PC40_4 40.13   
 
Table 4.1-2 The significant reactions for fad3. Biochemically feasible pairs (see section 4.2) 
are shown in blue. 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
PC36_4_PE34_3 45.37 PC36_4_PE36_6 12.21 PE36_4_PS34_3 9.95 
PE36_4_PE36_5 42.95 PS38_2_LysoPE18_3 12.07 PS38_2_PE34_4 9.93 
PC36_4_PC34_3 39.90 PS36_2_PE38_5 12.02 MGDG36_5_PE34_3 9.82 
PE36_4_PE34_3 33.99 PS36_2_PE40_3 11.82 PE36_4_PS40_3 9.74 
PC36_4_PC36_6 32.60 PS34_2_PS40_3 11.72 PE36_4_PC38_5 9.68 
PC36_4_PE36_5 32.13 PS34_2_PE40_3 11.69 PE36_4_PE40_3 9.66 
PE36_4_PC36_6 31.88 PS38_2_PC38_6 11.68 PE36_4_PC38_4 9.66 
PE36_4_PC34_3 28.32 MGDG36_5_PE36_6 11.63 PE36_4_PE34_4 9.64 
PC36_4_PC36_5 28.02 PS34_2_PC38_4 11.61 PE36_4_PS38_3 9.63 
PE36_4_PE36_6 20.76 PS34_2_PE36_6 11.27 PS36_2_PC38_6 9.62 
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PE36_4_PC36_5 16.03 PS36_2_PS38_3 11.15 PE36_4_PS36_3 9.60 
PS38_2_PC38_5 14.97 PS36_2_PE42_4 10.98 PE36_4_PE38_5 9.60 
PS38_2_PE38_5 14.67 PS36_2_LysoPE16_0 10.90 PS38_2_PS34_3 9.49 
PS38_2_PE40_3 14.20 PS34_2_PE38_5 10.60 PE36_4_PE42_4 9.48 
PS38_2_PE42_4 13.33 PS38_2_PS40_3 10.59 PE36_4_LysoPE16_0 9.47 
PS34_2_PS34_3 13.17 PS38_2_PE36_6 10.57 PE36_4_PC38_6 9.47 
PS38_2_PS38_3 12.67 PS36_2_PE36_6 10.50 PE36_4_LysoPE18_3 9.47 
PS34_2_PC38_5 12.54 PE36_4_PI36_3 10.40 PE36_4_PS42_4 9.44 
PS38_2_PC38_4 12.44 PS36_2_PC38_4 10.39 PE36_4_DGDG36_3 9.38 
PS38_2_LysoPE16_0 12.41 PS36_2_PE34_4 10.20 PS36_2_PS40_3 9.36 
PS34_2_PS36_3 12.28 PS34_2_PS38_3 10.15 PE36_4_PS36_6 9.36 
PS38_2_PS42_4 12.25 PS38_2_PS36_3 10.04 PE36_4_PA36_6 9.35 
PS36_2_PC38_5 12.23 PS36_2_PS42_4 10.03   
 
Table 4.1-3 The significant reactions for fad4. Biochemically feasible pairs (see section 4.2) 
are shown in blue.  
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
PG34_3_PG34_4 35.59 PG34_0_PG34_4 24.35 PG34_3_lysoPG18_3 17.80 
PG34_3_PG34_2 32.90 PG34_3_PG32_1 21.39 PG34_0_PG32_1 14.26 
PG32_0_PG34_4 25.91 PG32_0_PG32_1 19.32 PG32_0_PG34_2 11.62 
 
Table 4.1-4 The significant reactions for fad5. Biochemically feasible pairs (see section 4.2) 
are shown in blue. 
Reaction-name t-score Reaction-name t-score Reaction-name 
t-
score 
DGDG34_3_DGDG36_6 34.41 DGDG36_3_DGDG34_2 23.67 DGDG34_3_MGDG34_4 19.72 
MGDG36_6_DGDG36_6 33.37 MGDG36_6_MGDG34_2 23.60 MGDG38_4_DGDG36_4 19.38 
MGDG36_6_MGDG34_6 30.16 MGDG36_6_DGDG36_4 23.46 MGDG34_3_DGDG34_6 18.56 
DGDG36_3_DGDG34_6 30.14 MGDG36_6_DGDG34_1 23.32 MGDG34_3_MGDG34_4 18.50 
MGDG38_4_DGDG34_6 28.02 MGDG38_4_MGDG34_6 23.07 DGDG34_3_MGDG36_4 18.37 
MGDG34_3_MGDG34_6 27.15 DGDG36_3_MGDG34_6 23.05 DGDG34_3_DGDG34_2 18.07 
DGDG34_3_MGDG34_6 26.50 MGDG36_6_PC34_4 22.91 MGDG34_3_DGDG34_2 17.41 
MGDG36_6_DGDG34_6 25.40 MGDG36_6_DGDG34_5 22.91 MGDG38_4_DGDG36_6 17.25 
DGDG36_3_DGDG34_1 25.07 MGDG36_6_PE34_4 22.88 DGDG34_3_MGDG34_2 17.06 
MGDG36_6_MGDG34_4 24.97 LysoPC16_0_MGDG34_6 22.87 MGDG34_3_MGDG34_2 17.05 
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LysoPC16_0_DGDG34_6 24.50 MGDG38_4_DGDG34_2 20.84 MGDG34_3_MGDG36_4 16.98 
MGDG36_6_DGDG34_2 23.98 MGDG34_3_DGDG36_6 20.43 MGDG34_3_DGDG36_4 16.87 
MGDG36_6_MGDG36_4 23.70 DGDG34_3_DGDG34_6 20.14 DGDG36_3_DGDG36_6 16.67 
 
Table 4.1-5 The significant reactions for fad6. Biochemically feasible pairs (see section 4.2) 
are shown in blue. 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
MGDG36_4_DGDG34_6 52.78 DGDG36_4_PC38_5 33.97 PG34_1_PG34_4 26.75 
PG34_2_PG34_3 49.18 DGDG36_4_PE38_5 33.91 MGDG34_2_DGDG34_3 26.59 
PG34_2_PG34_4 45.41 DGDG36_4_PE40_3 33.79 PC36_3_PG34_4 26.48 
PG34_2_DGDG34_6 41.98 MGDG34_2_DGDG36_3 33.70 PC34_4_PC38_5 26.47 
MGDG34_2_PG34_4 39.74 MGDG34_2_DGDG34_5 33.50 MGDG34_3_DGDG34_6 26.38 
DGDG36_4_DGDG34_6 38.72 MGDG34_2_lysoPG18_3 33.46 PE34_4_PC38_5 26.29 
PG34_2_PC38_5 37.21 MGDG34_2_PC38_5 33.41 PC34_4_DGDG34_6 26.22 
MGDG34_2_DGDG34_6 37.16 MGDG34_2_PE40_3 33.38 PC36_3_PG34_3 25.93 
PG34_2_lysoPG18_3 37.12 MGDG34_2_PE38_5 33.38 MGDG34_3_PG34_4 25.76 
PG34_2_PE38_5 37.09 DGDG34_1_DGDG34_6 32.40 PC34_4_PE40_3 25.72 
PG34_2_DGDG36_3 37.08 DGDG36_4_PG34_3 30.50 PG34_2_MGDG34_6 25.20 
PG34_2_PE40_3 37.08 DGDG36_4_PG34_4 29.78 lysoPG18_1_DGDG34_6 24.94 
PG34_2_DGDG34_5 37.00 PG34_2_DGDG34_3 28.96 PE34_1_DGDG34_6 24.85 
MGDG34_2_PG34_3 35.53 MGDG34_2_MGDG34_6 28.46 DGDG34_1_PG34_4 24.76 
DGDG36_4_DGDG34_5 35.40 MGDG36_2_DGDG34_6 27.90 PE34_4_DGDG34_6 24.75 
DGDG36_4_DGDG36_3 34.66 MGDG36_4_PG34_4 27.22 PC34_1_PG34_4 24.66 
DGDG36_4_lysoPG18_3 34.01 DGDG36_2_DGDG34_6 26.83 PE34_4_PE40_3 24.66 
 
Table 4.1-6 the significant reactions for fad7. Biochemically feasible pairs (see section 4.2) 
are shown in blue. 
Reaction-name t-score Reaction-name t-score Reaction-name 
t-
score 
DGDG36_5_MGDG36_6 47.94 DGDG36_4_MGDG36_6 27.92 DGDG36_4_DGDG34_6 23.41 
DGDG36_5_DGDG34_6 38.12 DGDG34_5_DGDG34_6 26.69 MGDG34_4_MGDG36_6 22.59 
DGDG36_5_DGDG34_3 37.03 DGDG34_2_MGDG36_6 25.95 MGDG34_5_MGDG34_6 22.51 
DGDG36_5_DGDG36_3 36.76 MGDG34_5_DGDG36_3 25.76 MGDG36_3_MGDG36_6 21.82 
DGDG36_5_lysoPG18_3 34.26 MGDG34_5_lysoPG18_3 25.70 PC34_4_MGDG36_6 21.39 
MGDG34_5_MGDG36_6 32.46 DGDG36_5_DGDG36_6 24.77 PE34_4_MGDG36_6 21.35 
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DGDG34_2_DGDG34_6 32.04 DGDG34_5_MGDG36_6 24.42 LysoPC18_2_MGDG36_6 21.35 
MGDG34_5_DGDG36_6 30.99 MGDG36_5_MGDG36_6 24.05 LysoPE18_2_MGDG36_6 21.33 
MGDG34_5_DGDG34_3 30.13 DGDG34_4_MGDG36_6 23.76 lysoPG18_2_MGDG36_6 21.32 
MGDG34_5_DGDG34_6 28.24 PG34_3_MGDG36_6 23.61 LysoPC18_1_MGDG36_6 21.30 
DGDG34_2_DGDG34_3 28.19 DGDG34_5_DGDG34_3 23.51 DGDG36_4_lysoPG18_3 20.76 
MGDG34_5_PG34_4 28.12 DGDG36_4_DGDG34_3 23.46   
 
 
4.2 The biochemically feasible reactions for fad datasets 
Since an enzymatic reaction would only be expected to change only one facet of a 
metabolite’s structure, only a few of the determined significant reactions make biochemical 
sense.  
Before further discussion, explanations are needed for the readers with less biology 
background. For example, lipid PC36_2 (written as PC_36:2 in many cases) has one head group 
and two fatty acids as tails.  “PC” indicates the head group, “36” represents the number of 
carbons and “2” represents the number of double bonds. So, the lipid PC36_2 is the lipid with 
“PC” as a head and 36 carbons, and 2 double bonds in two tails. The lipids with names starting 
with “Lyso” are a little different. LysoPC18_2 has one head and one fatty acid as tail, “PC” 
represents the head group, “18” represents the number of carbons and “2” represents the number 
of double bonds. So, LysoPC18_2 is the lipid with “PC” as a head, and 18 carbons and 2 double 
bonds in one tail. 
The following were rules that were used to determine the biochemical feasibility of a 
particular reactant-product pair, i.e. that the reactant could be converted to the product in a 
reaction catalyzed by a single enzyme:  
1. The change of lipid class. For example, the reaction from PC36_2 to PE36_2 is 
possible. The other lipid class changes, like MGDG to DGDG, PC to PA, etc. are possible. In 
this case, neither the carbon number nor the number of the double bonds can be changed. 
2. Change of fatty acid tail (acyl chain), i.e.  change of the number of double bonds 
and/or the carbon number. Double bond change cannot be greater than 3, because 0-3 is the 
range of double bonds in one acyl chain, so a change of more than 3 would require changes in 
multiple acyl chains.  For example, PC_34:1 cannot be changed to PC_34:5 or the reverse, but 
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PC_34:1 to PC_34:4 is possible, and PC_34:1 to PC_40:4 is also possible. In this case, the head 
group (lipid class) cannot be changed simultaneously. 
3. Addition or subtraction of a fatty acid tail (acyl chain).  If change is from X to lyso X, 
the change can be accomplished by change of one fatty acid. In other words, the double bond 
number can only be decreased by 0-3 double bonds; the double bond number cannot be 
increased.  
All biochemically feasible reactant-product pairs detected by this method are listed in the 
following tables from Table 4.2-1 to Table 4.2-6. The reactions known to be catalyzed by the 
affected gene product are shown in red. 
 
Table 4.2-1 The biochemically feasible reactions for fad2 
Eighteen biochemically feasible reactions were picked up. According to Somerville et al. 
(2000), FAD2 gene product is known to convert an 18:1 chain in PC to 18:2.  The chain in the 
other position may be 16:0, 18:1, 18:2, or 18:3.  If the chain in the other position is 16:0, then the 
“potentially known” reaction would be represented as PC34_1_PC34_2, if both chains are 18:1, 
the reaction would be represented as PC36_2_PC36_3, if the other chain was 18:2, the reaction 
would be PC36_3_PC36_4, and if the other chain was 18:3, the reaction would be 
PC36_4_PC36_5.  PC34_1_PC34_2 and PC36_2_PC36_3 appear in the list of biochemically 
feasible reactions below (red font).  
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
PE34_1_PE40_2 69.05 PC34_1_PC40_4 44.39 PE36_2_LysoPE18_2 38.42 
PE34_1_LysoPE16_0 66.08 PE36_2_PE40_2 40.81 PE36_2_LysoPE16_0 38.08 
PC34_1_PC38_3 47.64 PC36_2_PC38_3 40.74 PE36_2_PE38_5 37.89 
PC34_1_PC36_3 47.58 PC36_2_PC38_5 40.53 PC36_2_PC34_3 37.27 
PC36_2_PC34_2 44.88 PC36_2_LysoPC18_2 40.28 PC34_1_PC34_2 34.87 
PC36_2_PC36_3 44.53 PC36_2_PC40_4 40.13 PC38_2_PC38_3 34.72 
 
Table 4.2-2 The biochemically feasible reactions for fad3 
Twenty-three biochemically feasible pairs were picked up. According to Somerville et al. 
(2000), FAD3 gene product is known to convert an 18:2 chain in PC to 18:3.  The chain in the 
other position may be 16:0, 18:1, 18:2, or 18:3.  If the chain in the other position is 16:0, then the 
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“potentially known” reaction would be represented as PC34_2_PC34_3, if the other chain is 
18:1, the reaction would be represented as PC36_3_PC36_4, if the other chain is 18:2, then the 
reaction would be represented as PC36_4_PC36_5, and if the other chain is 18:3, then the 
reaction would be represented as PC36_5_PC36_6 .  PC36_4_PC36_5 appears on the list of 
biochemically feasible candidate reactions (red font). 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
PE36_4_PE36_5 42.95 PS34_2_PS36_3 12.28 PE36_4_PE40_3 9.66 
PC36_4_PC34_3 39.90 PS38_2_PS42_4 12.25 PE36_4_PE34_4 9.64 
PE36_4_PE34_3 33.99 PS34_2_PS40_3 11.72 PE36_4_PE38_5 9.60 
PC36_4_PC36_6 32.60 PS36_2_PS38_3 11.15 PS38_2_PS34_3 9.49 
PC36_4_PC36_5 28.02 PS38_2_PS40_3 10.59 PE36_4_PE42_4 9.48 
PE36_4_PE36_6 20.76 PS34_2_PS38_3 10.15 PE36_4_LysoPE18_3 9.47 
PS34_2_PS34_3 13.17 PS38_2_PS36_3 10.04 PS36_2_PS40_3 9.36 
PS38_2_PS38_3 12.67 PS36_2_PS42_4 10.03   
 
Table 4.2-3 The biochemically feasible reactions for fad4 
Seven biochemically feasible pairs were identified for FAD4. According to Somerville et 
al. (2000), FAD4 gene product is known to convert an 16:0 chain in PG to 16:1.  The chain in the 
other position may be 16:0, 18:1, 18:2, or 18:3.  If the chain in the other position is 16:0, then the 
“potentially known” reaction would be represented as PG32_0_PG32_1, if the chain in the other 
position is 18:1, then the reaction would be represented as PG34_1_PG34_2, if the chain in the 
other position is 18:2, then the reaction would be represented as PG34_2_PG34_3, while if the 
chain in the other position is 18:3, then the reaction would be represented as PG34_3_PG34_4.  
Both the reactions PG32_0_PG32_1 and PG34_3_PG34_4 appear in the list of biochemically 
feasible reactions below (red font).  
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
PG34_3_PG34_4 35.59 PG32_0_PG32_1 19.32 PG32_0_PG34_2 11.62 
PG34_3_PG34_2 32.90 PG34_3_lysoPG18_3 17.80   
PG34_3_PG32_1 21.39 PG34_0_PG32_1 14.26   
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Table 4.2-4 The biochemically feasible reactions for fad5 
Sixteen biochemically feasible pairs were detected for FAD5. According to Somerville et 
al. (2000), FAD5 gene product is known to convert a 16:0 chain in MGDG (or DGDG) to 16:1.  
The chain in the other position may be 18:1, 18:2, or 18:3.  If the chain in the other position is 
18:1, then the “potentially known” reaction would be represented as MGDG34_1_MGDG34_2, 
if the chain in the other position is 18:2, then the reaction would be represented as 
MGDG34_2_MGDG34_3, while if the chain in the other position is 18:3, then the reaction 
would be represented as MGDG34_3_MGDG34_4.   MGDG34_3_MGDG34_4 appears in the 
list of biochemically feasible reactions below (red font).  
Reaction-name t-score Reaction-name t-score Reaction-name 
t-
score 
DGDG34_3_DGDG36_6 34.41 MGDG36_6_MGDG34_4 24.97 DGDG34_3_DGDG34_2 18.07 
MGDG36_6_DGDG36_6 33.37 MGDG36_6_MGDG36_4 23.70 MGDG34_3_MGDG34_2 17.05 
MGDG36_6_MGDG34_6 30.16 DGDG36_3_DGDG34_2 23.67 MGDG34_3_MGDG36_4 16.98 
DGDG36_3_DGDG34_6 30.14 MGDG38_4_MGDG34_6 23.07 DGDG36_3_DGDG36_6 16.67 
MGDG34_3_MGDG34_6 27.15 DGDG34_3_DGDG34_6 20.14   
DGDG36_3_DGDG34_1 25.07 MGDG34_3_MGDG34_4 18.50   
 
Table 4.2-5 The biochemically feasible reactions for fad6 
Eight biochemically feasible pairs were identified for FAD6. According to Somerville et 
al. (2000), FAD6 gene product is known to convert 16:1 and 18:1 chains in MGDG (or DGDG) 
to 16:2 and 18:2, respectively, and to convert an 18:1 chain in PG to 18:2.  The chain in the other 
position in MGDG could be 16:0, 16:1, 16:2, 18:1, 18:2, or 18:3. In PG, the other chain could be 
16:0 or 16:1.  Thus, the “potentially known” reactions are MGDG34_1_MGDG34_2, 
MGDG34_2_MGDG34_3, MGDG34_3_MGDG34_4, MGDG34_4_MGDG34_5, 
MGDG34_5_MGDG34_6, MGDG36_2_MGDG36_3, MGDG36_3_MGDG36_4, 
MGDG36_4_MGDG36_5, MGDG36_5_MGDG36_6, the corresponding reactions with DGDG, 
PG34_1_PG34_2, and PG34_2_PG34_3.  PG34_2_PG34_3 appears in the list of biochemically 
feasible reactions below with the highest t-score;  DGDG34_4_DGDG34_5 also appears (red 
font). 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
PG34_2_PG34_3 49.18 DGDG36_4_DGDG34_5 35.40 PC34_4_PC38_5 26.47 
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PG34_2_PG34_4 45.41 DGDG36_4_DGDG36_3 34.66 PE34_4_PE40_3 24.66 
DGDG36_4_DGDG34_6 38.72 PG34_1_PG34_4 26.75   
 
 
Table 4.2-6 The biochemically feasible reactions for fad7 
Fourteen biochemically feasible pairs were discovered for FAD7. According to 
Somerville et al. (2000), FAD7 gene product is known to convert 16:2 and 18:2 chains in MGDG 
(or DGDG) to 16:3 and 18:3, respectively, and to convert an 18:2 chain in PG to 18:3.  The chain 
in the other position in MGDG could be 16:0, 16:1, 16:2, 18:1, 18:2, or 18:3. In PG, the other 
chain could be 16:0 or 16:1.  The “potentially known” reactions are MGDG34_2_MGDG34_3,  
MGDG34_3_MGDG34_4, MGDG34_4_MGDG34_5, MGDG34_5_MGDG34_6, 
MGDG36_2_MGDG36_3,  MGDG36_3_MGDG36_4, MGDG36_4_MGDG36_5, 
MGDG36_5_MGDG36_6, the corresponding reactions with DGDG, PG34_2_PG34_3, and 
PG34_3_PG34_4. MGDG34_5_MGDG34_6, DGDG34_5_DGDG34_6,  
MGDG36_5_MGDG36_6 and DGDG36_5_DGDG36_6_appear in the list of biochemically 
feasible reactions below (red font).  
Reaction-name t-score Reaction-name t-score Reaction-name 
t-
score 
DGDG36_5_DGDG34_6 38.12 DGDG34_5_DGDG34_6 26.69 DGDG36_4_DGDG34_6 23.41 
DGDG36_5_DGDG34_3 37.03 DGDG36_5_DGDG36_6 24.77 MGDG34_4_MGDG36_6 22.59 
DGDG36_5_DGDG36_3 36.76 MGDG36_5_MGDG36_6 24.05 MGDG34_5_MGDG34_6 22.51 
MGDG34_5_MGDG36_6 32.46 DGDG34_5_DGDG34_3 23.51 MGDG36_3_MGDG36_6 21.82 
DGDG34_2_DGDG34_3 28.19 DGDG36_4_DGDG34_3 23.46   
 
In the six experiments, each list of significant reactions contained at least one reactant-
product pair considered to be the true substrates and products of the mutant gene. It can be noted 
that not all “potentially known” reactions necessarily occur in vivo.  Next, three more 
experiments, sfd1, sfd2 and sfd3, were used to check the efficiency of this method in Chapter 5.  
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5 Application of data analysis method to sfd1, sfd2, and sfd3 
This method is now applied on sfd1, sfd2 and sfd3. These genes were mutated by random 
mutagenesis and, at the outset of the lipid analysis, the location of the mutations were unknown 
(from Jyoti Shah’s Lab).  Later, it was shown that sfd3 is a mutation in FAD6 (Nandi et al, 
2003).  In other words, sfd3 and fad6 are different mutations in the same gene. 
5.1 The significant reactions for sfds 
Table 5.1-1, Table 5.1-2 and Table5.1-3 list the detected significant pairs for sfd1, sfd2, 
sfd3 respectively. The pairs in blue bold are biochemically feasible. 
 
Table 5.1-1 The significant reactions for sfd1. Biochemically feasible pairs (see section 5.2) 
are shown in blue. 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
MGDG36_6_MGDG34_6 27.10 PE34_1_MGDG34_6 15.58 PI34_1_MGDG34_2 12.14 
DGDG36_6_MGDG34_6 25.98 PI34_1_MGDG34_6 15.43 PC34_1_DGDG34_6 12.06 
PE34_1_MGDG34_2 20.98 PE36_1_MGDG34_6 15.35 MGDG36_6_MGDG34_4 11.94 
PI34_1_DGDG34_2 17.68 PA34_1_MGDG34_6 15.35 MGDG36_6_DGDG34_2 11.78 
PE34_1_DGDG34_2 17.22 PA34_1_DGDG34_2 14.95 MGDG36_6_MGDG34_2 11.68 
PC36_2_MGDG34_6 16.07 PE36_1_DGDG34_2 14.77 PC36_2_DGDG34_6 11.52 
PC34_1_MGDG34_6 16.03 MGDG36_6_DGDG34_6 12.94 MGDG36_6_DGDG34_1 11.49 
 
Table 5.1-2 The significant reactions for sfd2. Biochemically feasible pairs (see section 5.2) 
are shown in blue. 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
MGDG36_6_MGDG34_6 21.02 PG34_1_DGDG34_2 12.16 MGDG36_6_PG32_1 9.71 
MGDG34_3_MGDG34_6 15.44 PE36_3_DGDG34_6 11.55 MGDG36_6_DGDG34_1 9.58 
PG34_1_MGDG34_6 15.03 PE36_2_DGDG34_6 11.26 MGDG34_5_DGDG34_2 9.49 
PE36_3_MGDG34_6 15.02 MGDG34_3_DGDG34_6 10.85 PI36_3_DGDG34_6 9.44 
PE36_2_MGDG34_6 14.98 MGDG36_6_DGDG34_6 10.59 MGDG34_3_DGDG34_2 9.39 
MGDG34_5_MGDG34_6 14.86 PI36_3_DGDG34_1 10.52 PI36_3_DGDG34_2 9.33 
PG34_0_MGDG34_6 14.84 PG34_0_DGDG34_2 10.05 PG34_0_DGDG34_1 9.06 
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PI36_3_MGDG34_6 14.81 MGDG36_6_DGDG34_2 10.05 PE40_3_DGDG34_6 8.96 
PE40_3_MGDG34_6 14.79 PG34_0_DGDG34_6 10.00 PE38_3_DGDG34_6 8.90 
PE38_3_MGDG34_6 14.78 PE36_2_DGDG34_2 9.88 PE40_3_DGDG34_2 8.72 
PE38_5_MGDG34_6 14.77 PE36_3_DGDG34_2 9.87 PE38_5_DGDG34_6 8.70 
PG34_0_PG32_1 13.42 MGDG34_5_DGDG34_6 9.75 PE38_3_DGDG34_2 8.68 
PG34_1_DGDG34_6 12.57 PG34_1_PG32_1 9.74   
 
Table 5.1-3 The significant reactions for sfd3. Biochemically feasible pairs (see section 5.2) 
are shown in blue. 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
MGDG34_2_PA36_6 83.15 PE36_4_PG34_4 39.63 PE36_3_MGDG34_6 33.23 
MGDG34_2_lysoPG18_3 82.92 PG34_2_MGDG34_6 39.58 PC36_2_MGDG34_6 33.16 
MGDG34_2_PG32_1 82.92 DGDG36_4_PG34_3 38.63 PC34_1_MGDG34_6 33.10 
MGDG34_2_PC38_5 82.77 MGDG36_6_MGDG34_6 38.33 MGDG34_3_PG34_4 33.00 
MGDG34_2_LysoPC18_3 82.63 PC34_2_PG34_4 37.16 PG34_1_PG34_4 32.96 
MGDG34_2_PC38_6 82.62 DGDG36_4_PG34_4 36.59 DGDG34_4_MGDG34_6 32.93 
MGDG34_2_PG34_3 82.02 DGDG36_4_PE36_6 35.92 PE36_2_MGDG34_6 32.87 
MGDG34_2_PE36_6 81.86 PE34_2_MGDG34_6 35.25 MGDG36_2_MGDG34_6 32.85 
MGDG34_2_PC36_6 77.14 MGDG36_4_MGDG34_6 34.73 PC34_4_MGDG34_6 32.83 
MGDG34_2_DGDG34_6 73.11 PC36_4_MGDG34_6 34.65 PC36_3_PG34_4 32.78 
MGDG34_2_PG34_4 67.54 DGDG36_4_MGDG34_6 34.62 PI36_4_MGDG34_6 32.77 
PG34_2_PG34_3 65.13 PE36_4_MGDG34_6 34.61 PE42_2_MGDG34_6 32.73 
PG34_2_LysoPC18_3 60.05 DGDG36_4_PA36_6 34.58 PE34_4_MGDG34_6 32.73 
PG34_2_lysoPG18_3 59.99 MGDG34_3_MGDG34_6 34.55 PE38_2_MGDG34_6 32.73 
PG34_2_PC38_5 59.80 MGDG36_4_PG34_4 34.33 PE38_3_MGDG34_6 32.71 
PG34_2_PA36_6 59.74 PE36_4_PC36_6 34.27 PI36_2_MGDG34_6 32.71 
PG34_2_PC38_6 59.72 DGDG36_4_lysoPG18_3 34.16 PE40_2_MGDG34_6 32.71 
PG34_2_PE36_6 59.58 PC34_2_MGDG34_6 34.13 lysoPG18_1_MGDG34_6 32.69 
PG34_2_PG32_1 59.14 PG34_1_MGDG34_6 34.09 PC38_3_MGDG34_6 32.69 
PG34_2_PG34_4 58.13 PC36_3_MGDG34_6 34.00 PE38_4_MGDG34_6 32.68 
PG34_2_PC36_6 56.34 DGDG36_4_LysoPC18_3 33.82 PS42_2_MGDG34_6 32.68 
PE34_2_PG34_4 50.04 DGDG36_4_PC38_5 33.74 PC38_2_MGDG34_6 32.68 
PG34_2_DGDG34_6 49.57 DGDG36_4_PC38_6 33.56 PI34_4_MGDG34_6 32.67 
MGDG34_2_MGDG34_6 42.83 DGDG34_1_MGDG34_6 33.51 PI36_3_MGDG34_6 32.67 
PC36_4_PG34_4 40.44 DGDG34_2_MGDG34_6 33.28 PE42_3_MGDG34_6 32.67 
 26
 
5.2 The biochemically feasible reactions for sfds  
Table 5.2-1, Table 5.2-2 and Table 5.2-3 list the biochemically feasible reactions for sfd1, 
sfd2 and sfd3 respectively.  
Table 5.2-1 The biochemically feasible reactions for sfd1  
Two biochemically feasible pairs were picked up.  SFD1 has been identified as a 
dihydroxyacetone reductase, which converts dihydroxyacteone to glycerol 3-phosphate.  
Glycerol 3-phospate is a precursor for plastidic glycerolipid synthesis.  The true reactant-product 
pair is not among the compounds analyzed; the reactions that were picked up are related to 
indirect effects of the mutation on plastidic glycerolipid synthesis. 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
MGDG36_6_MGDG34_6 27.10 MGDG36_6_MGDG34_4 11.94   
 
Table 5.2-2 The biochemically feasible reactions for sfd2 
Five biochemically feasible pairs were observed.  SFD2 has not been mapped or 
identified as yet.  
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
MGDG36_6_MGDG34_6 21.02 MGDG34_5_MGDG34_6 14.86 PG34_1_PG32_1 9.74 
MGDG34_3_MGDG34_6 15.44 PG34_0_PG32_1 13.42   
 
Table 5.2-3 The biochemically feasible reactions for sfd3 
Seven biochemically feasible pairs were identified.  Similar to the fad6 mutation, 
PG34_2_PG34_3 is has the highest t-score for sfd3.   Comparison of Tables 4.2-5 and 5.2-3 for  
fad6 and sfd3, show additional several similarities. 
Reaction-name t-score Reaction-name t-score Reaction-name t-score 
PG34_2_PG34_3 65.1327 MGDG36_6_MGDG34_6 38.3283 PG34_1_PG34_4 32.9559 
PG34_2_PG32_1 59.1446 MGDG36_4_MGDG34_6 34.7344   





5.3 The number of times a reactant appeared in a list 
In order to assess how similar the data obtained for allelic mutations, sfd3 and fad6 were, 
in comparison to the similarity of their data to that of other mutations, we assessed the number of 
times that each reactant lipid appeared in the lists of significant reactions for each mutant. Table 
5.3-1 shows how many times a lipid, serving as a reactant, appeared in each of fad2, fad3, fad4, 
fad5, fad6, fad7, sfd1, sfd2, and sfd3 lists. For example, in Table 4.1-1, there were 29 pairs with 
PC36_2 as a reactant, so in the table below, PC36_2 for fad2 is 29. The table includes all lipids 
that appeared as a reactant in at least one of the nine data sets, thus there are several zeros.  





















































































fad2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad5 0 0 7 0 0 0 0 0 5 0 0 0 0 0 0 0 2 0 
fad6 2 0 0 0 0 0 0 1 0 9 0 0 0 0 0 0 0 0 
fad7 0 3 0 1 3 0 0 0 0 4 6 0 0 0 0 0 0 0 
sfd1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
sfd2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 













































fad2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 
fad6 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 11 2 0 
fad7 0 1 1 0 0 0 0 1 0 0 0 0 1 0 0 0 0 1 
sfd1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
sfd2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 











































































fad2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad3 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 
fad4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad5 0 0 0 0 0 0 0 12 0 5 0 0 0 0 0 0 0 0 
fad6 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 
fad7 8 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 
sfd1 0 0 0 0 0 0 0 6 0 0 0 0 2 0 0 0 0 0 
sfd2 3 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 0 0 






































fad2 0 0 0 0 0 23 0 0 0 0 29 0 0 0 0 2 0 0 
fad3 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 0 
fad4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad6 0 0 0 0 0 1 0 0 3 0 0 2 0 0 0 0 0 0 
fad7 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
sfd1 0 0 0 0 0 2 0 0 0 0 2 0 0 0 0 0 0 0 
sfd2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 


























fad2 0 0 0 0 0 0 21 0 0 2 0 21 0 0 0 0 0 0 
fad3 0 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 
fad4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad6 0 0 0 0 0 0 1 0 0 3 0 0 0 0 0 0 0 0 
fad7 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
sfd1 0 0 0 0 0 0 3 0 0 0 2 0 0 0 0 0 0 0 
sfd2 0 0 0 0 0 0 0 0 0 0 0 3 3 0 0 0 0 3 



























fad2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
fad3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad4 0 0 0 0 0 0 0 0 3 0 2 0 0 4 0 0 0 0 
fad5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
 29
fad6 0 0 0 0 0 0 0 0 0 0 0 1 11 0 0 0 0 0 
fad7 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
sfd1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 
sfd2 0 2 0 0 3 0 0 0 0 0 5 4 0 0 0 0 0 0 




















fad2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad3 0 0 0 0 0 0 0 0 9 0 0 0 12 0 0 0 0 0 
fad4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
fad7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
sfd1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
sfd2 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
















PS44_3    
fad2 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0    
fad3 15 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
fad4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
fad5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
fad6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
fad7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
sfd1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
sfd2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0    
sfd3 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0    
 
5.4 Fisher’s exact test for similarity  
Fisher’s exact test (cf. Conover, 1998) was used to quantify similarity in the lipids appearing 
as a reactant across two data sets.  A null hypothesis is that the reactant counts are independent 
across two data sets. The alternative hypothesis is that the reactant lists depend on the data set. 
Thus, rejecting the null hypothesis with a small p-value would indicate two data sets that differ 
in their reactant lists. The data are formed into a 2 by 2 contingency table with number of 
columns equal to the total number of lipids in Table 5-3-1 and number of rows equal to 2, one for 
each of two data sets. Since there are 9 data sets, there are 36 pairs of data sets so 36 hypotheses 
 30
are tested. A small P-value indicates evidence for dependence. A large P-value is a metric by 
which to quantify a similarity of the reactant profiles for two data sets. Fisher’s exact test 
presupposes that row and column totals for the contingency table are fixed, which may be 
questionable here. However, when this assumption is not met, the test is likely conservative with 
Type I errors below nominal values. As can be seen in Table 5.4-1 P-values are very small for all 
pairs except the fad6-sdf3 pairs which show a marked similarity of the reactant profiles 
indentified in the two data sets. A strength of Fisher’s exact test is that it can accommodate the 
very small counts, and even zero counts appearing in the contingency table (i.e., where a 
particular lipid did not appear at all as a reactant in a pair of data sets).  
With a P-value of 0.957861, the alternative hypothesis that the reactant lists in the fad6 
and sfd3 datasets are different is not rejected. Thus, the large p-value indicates similarity in the 
reactant lists.  The P-values for the other pairs were as small as 0, which suggests that the feature 
of the metabolite profiles that is represented by the significant reactants is not similar; this is 
consistent with the mutations affecting the metabolite profiles being in different genes. 
 
Table 5.4-1 Fisher’s exact test for similarity 
 fad2 fad3 fad4 fad5 fad6 fad7 sfd1 sfd2_2 sfd3 
fad2 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000
fad3 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000
fad4 0.000000 0.000000 0.000000 0.000000 0.000000 0.000071 0.000006 0.000040 0.000022
fad5 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000001 0.000000 0.000000
fad6 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.957861
fad7 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000
sfd1 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000002 0.000000
sfd2_2 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000 0.000000





6 Summary and future work 
 This report proposed a multi-step exploratory technique to discover reactant-product 
lipid pairs in mutant/wild-type lipidomics experiments. A numerical screening procedure 
narrowed a large number of candidate pairs to a much smaller list. This list can then be narrowed 
further using biochemical knowledge of the genes involved in catalyzing certain reactions. The 
technique is exploratory and does not discover all pairs that are biochemically feasible nor does 
it rule out all those that are not. The intent of the method is a screening procedure to simplify 
follow-on confirmatory work.  
Sample sizes were small in these experiments. The role of sample size, as well as sample 
size requirements for such experiments, is a worthy topic of further research. A larger sample 
size might improve the detection of likely reactants and possibly allow for other measures of 
certainty to be computed for each reactant that is discovered. Any method should be vetted by 
discovering its performance properties. These require analytical investigation or, as is likely the 
case here, investigation via simulation experiments. How to simulate realistic data from a 
lipidomics experiment for which some truth is known is another area of future investigation.  
Data from lipidomics experiments are relatively new and statistical techniques for such 
data still evolving. It is hoped that the methods described here are one step forward in the 
development of statistical technique to deal with the metabolome (lipidome) emerging from 
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Appendix A – The original dataset for each experiment 
Table A-1 The original dataset for fad2 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.25 2.18 2.53 1.96 2.21 3.25 2.55 4.06 2.96 2.79 
DGDG34_5 0.14 0.10 0.10 0.17 0.06 0.19 0.19 0.07 0.19 0.24 
DGDG34_4 0.26 0.19 0.20 0.18 0.23 0.23 0.29 0.32 0.18 0.27 
DGDG34_3 4.69 4.33 4.41 3.86 4.03 3.45 3.40 4.16 3.24 3.03 
DGDG34_2 1.01 0.95 1.10 0.81 0.79 1.69 1.02 1.77 1.27 1.51 
DGDG34_1 0.41 0.40 0.44 0.35 0.40 0.89 0.98 0.94 0.82 0.85 
DGDG36_6 14.95 16.68 14.93 14.08 15.01 8.54 8.90 10.07 8.52 8.99 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 0.07 0.00 
DGDG36_4 0.46 0.46 0.38 0.46 0.43 0.77 0.87 0.94 1.00 0.81 
DGDG36_3 0.22 0.18 0.20 0.13 0.16 0.20 0.05 0.19 0.07 0.04 
DGDG36_2 0.01 0.00 0.00 0.00 0.00 0.02 0.05 0.02 0.01 0.05 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 
DGDG38_6 0.18 0.22 0.15 0.22 0.16 0.25 0.27 0.33 0.38 0.38 
DGDG38_5 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 
DGDG38_4 0.08 0.00 0.03 0.03 0.05 0.01 0.01 0.00 0.02 0.00 
DGDG38_3 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.02 0.00 0.00 
MGDG34_6 67.36 73.73 71.54 61.98 58.12 72.07 73.54 70.04 61.64 82.23 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG34_4 2.04 2.69 2.02 2.32 1.86 3.42 3.89 2.81 2.60 3.51 
MGDG34_3 0.94 0.72 0.74 0.83 0.70 0.98 0.63 0.83 0.99 1.23 
MGDG34_2 0.44 0.80 0.60 0.61 0.49 0.74 1.06 0.92 0.78 1.20 
MGDG34_1 0.37 0.00 0.00 1.24 0.00 0.38 1.12 0.00 1.98 0.41 
MGDG36_6 11.56 12.24 11.68 10.73 11.68 4.80 5.81 5.59 4.47 5.68 
MGDG36_5 0.01 0.04 0.09 0.26 0.03 0.07 0.00 0.05 0.31 0.00 
MGDG36_4 1.28 1.18 1.35 0.87 1.17 1.97 1.73 1.76 1.81 1.69 
MGDG36_3 0.04 0.11 0.00 0.11 0.00 0.00 0.00 0.04 0.00 0.00 
MGDG36_2 0.05 0.00 0.03 0.00 0.01 0.20 0.08 0.14 0.29 0.15 
MGDG36_1 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_4 0.04 0.06 0.06 0.00 0.00 0.00 0.00 0.02 0.02 0.02 
MGDG38_3 0.00 0.05 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.17 
PC32_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC34_4 0.12 0.12 0.12 0.14 0.16 0.13 0.13 0.14 0.15 0.14 
PC34_3 2.45 2.47 2.33 2.81 3.40 1.08 1.07 1.06 1.10 1.00 
PC34_2 3.24 3.21 3.12 3.53 4.13 0.44 0.42 0.44 0.45 0.39 
PC34_1 0.53 0.50 0.47 0.57 0.67 2.94 2.94 2.93 3.07 2.80 
PC36_6 1.71 1.81 1.78 2.18 2.61 0.47 0.53 0.53 0.53 0.48 
PC36_5 4.31 4.46 4.35 5.20 6.01 0.31 0.30 0.34 0.33 0.29 
PC36_4 3.42 3.33 3.35 3.87 4.52 3.01 3.07 3.30 3.34 3.14 
PC36_3 1.43 1.43 1.32 1.57 1.81 0.90 0.94 0.96 0.95 0.91 
PC36_2 0.58 0.56 0.51 0.65 0.74 6.98 7.08 7.40 7.90 7.49 
PC36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
PC38_5 0.05 0.04 0.04 0.05 0.06 0.01 0.00 0.01 0.01 0.01 
PC38_4 0.08 0.07 0.07 0.08 0.09 0.06 0.05 0.06 0.07 0.06 
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PC38_3 0.09 0.08 0.08 0.09 0.09 0.03 0.04 0.04 0.04 0.03 
PC38_2 0.05 0.05 0.05 0.05 0.05 0.13 0.12 0.14 0.15 0.13 
PC40_5 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_4 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PC40_3 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC40_2 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_3 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
LysoPC18_2 0.02 0.02 0.02 0.02 0.03 0.00 0.00 0.00 0.00 0.00 
LysoPC18_1 0.00 0.00 0.00 0.00 0.01 0.03 0.04 0.03 0.04 0.03 
LysoPC18_0 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.01 0.01 0.01 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_0 0.04 0.04 0.04 0.04 0.04 0.02 0.02 0.02 0.02 0.02 
LysoPE18_3 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.02 
LysoPE18_2 0.04 0.03 0.03 0.04 0.04 0.01 0.01 0.00 0.01 0.01 
LysoPE18_1 0.00 0.00 0.00 0.00 0.00 0.04 0.04 0.04 0.04 0.03 
PE34_4 0.05 0.05 0.05 0.06 0.06 0.11 0.11 0.11 0.12 0.11 
PE34_3 2.74 2.87 2.76 3.33 3.79 1.83 1.80 1.80 1.88 1.80 
PE34_2 4.12 4.02 3.89 4.67 5.26 0.53 0.47 0.50 0.54 0.49 
PE34_1 0.00 0.00 0.00 0.00 0.00 1.49 1.42 1.52 1.55 1.55 
PE36_6 0.75 0.74 0.72 0.92 1.05 0.57 0.56 0.61 0.61 0.57 
PE36_5 2.19 2.14 2.13 2.67 2.97 0.36 0.34 0.37 0.38 0.37 
PE36_4 2.31 2.28 2.19 2.70 2.95 2.60 2.54 2.67 2.76 2.69 
PE36_3 0.59 0.56 0.52 0.66 0.72 0.66 0.64 0.70 0.69 0.71 
PE36_2 0.29 0.28 0.26 0.34 0.35 2.28 2.18 2.29 2.46 2.43 
PE36_1 0.01 0.01 0.01 0.00 0.01 0.06 0.06 0.05 0.04 0.05 
PE38_6 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
PE38_5 0.03 0.03 0.03 0.04 0.04 0.01 0.01 0.01 0.01 0.01 
PE38_4 0.05 0.04 0.04 0.05 0.05 0.06 0.06 0.06 0.07 0.06 
PE38_3 0.06 0.07 0.06 0.08 0.09 0.07 0.06 0.06 0.06 0.07 
PE38_2 0.08 0.09 0.09 0.10 0.11 0.10 0.10 0.10 0.11 0.10 
PE40_3 0.05 0.05 0.04 0.05 0.06 0.05 0.05 0.05 0.06 0.05 
PE40_2 0.10 0.09 0.09 0.11 0.12 0.03 0.02 0.03 0.03 0.03 
PE42_4 0.02 0.02 0.02 0.02 0.03 0.04 0.03 0.03 0.04 0.03 
PE42_3 0.09 0.08 0.08 0.09 0.11 0.07 0.07 0.07 0.07 0.07 
PE42_2 0.09 0.08 0.08 0.11 0.12 0.12 0.11 0.11 0.12 0.12 
PG32_1 0.53 0.60 0.79 0.69 0.81 1.62 1.67 1.51 1.86 1.44 
PG32_0 0.23 0.26 0.25 0.41 0.38 0.59 0.62 0.42 0.46 0.56 
PG34_4 8.69 9.14 10.46 10.02 10.91 7.87 8.34 8.86 8.17 7.76 
PG34_3 2.40 2.58 2.39 2.61 3.16 2.18 2.42 2.37 2.57 2.13 
PG34_2 2.03 1.93 2.03 2.16 2.47 1.85 1.96 2.18 1.96 2.16 
PG34_1 1.18 1.31 1.22 1.31 1.48 2.74 2.78 3.14 2.84 2.57 
PG34_0 0.02 0.00 0.03 0.00 0.04 0.08 0.09 0.07 0.08 0.01 
lysoPG16_1 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.02 
lysoPG16_0 0.01 0.01 0.01 0.00 0.01 0.01 0.02 0.01 0.01 0.00 
lysoPG18_3 0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.04 
lysoPG18_2 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
lysoPG18_1 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.00 
PA34_6 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 
PA34_4 0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_3 0.15 0.16 0.28 0.16 0.17 0.08 0.06 0.08 0.09 0.05 
PA34_2 0.16 0.18 0.26 0.14 0.21 0.04 0.02 0.02 0.03 0.02 
PA34_1 0.11 0.10 0.10 0.06 0.06 0.21 0.16 0.20 0.18 0.16 
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PA36_6 0.05 0.05 0.08 0.04 0.05 0.02 0.02 0.03 0.03 0.02 
PA36_5 0.10 0.09 0.18 0.07 0.11 0.02 0.01 0.01 0.02 0.01 
PA36_4 0.11 0.08 0.18 0.09 0.12 0.06 0.05 0.08 0.08 0.05 
PA36_3 0.03 0.03 0.06 0.04 0.02 0.03 0.02 0.02 0.03 0.03 
PA36_2 0.01 0.01 0.01 0.01 0.01 0.07 0.07 0.09 0.11 0.06 
PI34_4 0.02 0.02 0.01 0.02 0.03 0.03 0.02 0.03 0.03 0.02 
PI34_3 1.28 1.48 1.45 1.68 2.15 1.19 1.18 1.24 1.15 1.12 
PI34_2 1.52 1.64 1.68 1.88 2.35 0.25 0.22 0.27 0.25 0.21 
PI34_1 0.00 0.00 0.00 0.00 0.00 1.43 1.26 1.52 1.36 1.35 
PI36_6 0.07 0.06 0.08 0.10 0.11 0.04 0.04 0.06 0.05 0.05 
PI36_5 0.12 0.11 0.11 0.12 0.15 0.01 0.01 0.00 0.01 0.02 
PI36_4 0.14 0.11 0.11 0.16 0.15 0.21 0.17 0.19 0.17 0.17 
PI36_3 0.16 0.13 0.15 0.16 0.21 0.08 0.09 0.11 0.10 0.10 
PI36_2 0.11 0.11 0.08 0.12 0.13 0.35 0.32 0.34 0.38 0.33 
PI36_1 0.01 0.01 0.01 0.01 0.00 0.08 0.08 0.07 0.09 0.07 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS34_3 0.07 0.07 0.08 0.08 0.10 0.06 0.06 0.06 0.06 0.06 
PS34_2 0.08 0.08 0.08 0.08 0.10 0.01 0.01 0.02 0.01 0.01 
PS34_1 0.00 0.00 0.00 0.00 0.00 0.05 0.05 0.05 0.06 0.05 
PS36_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 
PS36_4 0.01 0.01 0.01 0.01 0.02 0.04 0.03 0.04 0.04 0.05 
PS36_3 0.04 0.05 0.04 0.04 0.05 0.02 0.02 0.02 0.02 0.02 
PS36_2 0.03 0.03 0.04 0.03 0.03 0.06 0.05 0.06 0.06 0.06 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.01 0.03 0.02 0.02 0.02 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.02 0.01 
PS38_3 0.04 0.04 0.03 0.04 0.05 0.02 0.02 0.02 0.02 0.02 
PS38_2 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.02 0.02 0.01 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_3 0.04 0.04 0.04 0.06 0.06 0.04 0.04 0.05 0.05 0.04 
PS40_2 0.06 0.05 0.06 0.06 0.07 0.01 0.01 0.01 0.01 0.01 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.03 0.03 
PS42_4 0.01 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 
PS42_3 0.08 0.07 0.08 0.08 0.11 0.07 0.06 0.08 0.08 0.07 
PS42_2 0.07 0.07 0.06 0.08 0.09 0.03 0.03 0.03 0.03 0.03 
PS42_1 0.00 0.00 0.00 0.00 0.00 0.04 0.05 0.05 0.05 0.05 
PS44_3 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00 
PS44_2 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
 
Table A-2 The original dataset for fad3 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.25 2.18 2.53 1.96 2.21 1.71 2.53 2.29 2.07 1.84 
DGDG34_5 0.14 0.10 0.10 0.17 0.06 0.14 0.00 0.21 0.04 0.14 
DGDG34_4 0.26 0.19 0.20 0.18 0.23 0.12 0.18 0.17 0.22 0.14 
DGDG34_3 4.69 4.33 4.41 3.86 4.03 2.86 3.59 3.31 3.27 2.57 
DGDG34_2 1.01 0.95 1.10 0.81 0.79 0.63 0.73 0.64 0.66 0.84 
DGDG34_1 0.41 0.40 0.44 0.35 0.40 0.27 0.43 0.35 0.28 0.32 
DGDG36_6 14.95 16.68 14.93 14.08 15.01 12.22 13.87 14.07 13.17 11.37 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
 38
DGDG36_4 0.46 0.46 0.38 0.46 0.43 0.56 0.51 0.52 0.55 0.43 
DGDG36_3 0.22 0.18 0.20 0.13 0.16 0.10 0.06 0.08 0.08 0.03 
DGDG36_2 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.04 0.04 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG38_6 0.18 0.22 0.15 0.22 0.16 0.19 0.12 0.20 0.14 0.09 
DGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 
DGDG38_4 0.08 0.00 0.03 0.03 0.05 0.00 0.00 0.00 0.00 0.01 
DGDG38_3 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG34_6 67.36 73.73 71.54 61.98 58.12 56.92 58.94 79.13 53.16 57.69 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG34_4 2.04 2.69 2.02 2.32 1.86 2.10 1.84 2.58 1.63 1.86 
MGDG34_3 0.94 0.72 0.74 0.83 0.70 0.61 0.69 1.16 0.60 0.80 
MGDG34_2 0.44 0.80 0.60 0.61 0.49 0.42 0.41 0.40 0.34 0.41 
MGDG34_1 0.37 0.00 0.00 1.24 0.00 0.08 0.00 1.27 0.68 0.00 
MGDG36_6 11.56 12.24 11.68 10.73 11.68 11.45 11.17 11.03 8.77 9.19 
MGDG36_5 0.01 0.04 0.09 0.26 0.03 0.58 0.31 0.37 0.46 0.39 
MGDG36_4 1.28 1.18 1.35 0.87 1.17 0.79 0.76 0.71 0.55 0.72 
MGDG36_3 0.04 0.11 0.00 0.11 0.00 0.00 0.08 0.16 0.08 0.08 
MGDG36_2 0.05 0.00 0.03 0.00 0.01 0.07 0.00 0.00 0.00 0.00 
MGDG36_1 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_4 0.04 0.06 0.06 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
MGDG38_3 0.00 0.05 0.00 0.02 0.00 0.00 0.00 0.00 0.03 0.14 
PC32_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC34_4 0.12 0.12 0.12 0.14 0.16 0.08 0.10 0.10 0.10 0.10 
PC34_3 2.45 2.47 2.33 2.81 3.40 1.24 1.41 1.50 1.42 1.46 
PC34_2 3.24 3.21 3.12 3.53 4.13 3.72 4.01 4.04 3.96 3.83 
PC34_1 0.53 0.50 0.47 0.57 0.67 0.41 0.50 0.47 0.46 0.53 
PC36_6 1.71 1.81 1.78 2.18 2.61 0.59 0.77 0.84 0.77 0.80 
PC36_5 4.31 4.46 4.35 5.20 6.01 2.75 3.09 3.16 3.09 3.04 
PC36_4 3.42 3.33 3.35 3.87 4.52 5.00 5.36 5.31 5.20 5.07 
PC36_3 1.43 1.43 1.32 1.57 1.81 1.61 1.78 1.79 1.75 1.78 
PC36_2 0.58 0.56 0.51 0.65 0.74 0.58 0.59 0.59 0.57 0.57 
PC36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.01 0.01 0.01 0.02 0.02 0.00 0.00 0.01 0.01 0.00 
PC38_5 0.05 0.04 0.04 0.05 0.06 0.02 0.02 0.02 0.02 0.02 
PC38_4 0.08 0.07 0.07 0.08 0.09 0.06 0.06 0.06 0.05 0.05 
PC38_3 0.09 0.08 0.08 0.09 0.09 0.07 0.07 0.07 0.07 0.07 
PC38_2 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.04 0.04 
PC40_5 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_4 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PC40_3 0.01 0.00 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 
PC40_2 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_3 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
LysoPC18_2 0.02 0.02 0.02 0.02 0.03 0.02 0.03 0.03 0.03 0.03 
LysoPC18_1 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.01 0.01 
LysoPC18_0 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_0 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.03 0.03 0.03 
LysoPE18_3 0.02 0.02 0.02 0.02 0.03 0.01 0.01 0.01 0.01 0.01 
LysoPE18_2 0.04 0.03 0.03 0.04 0.04 0.04 0.05 0.05 0.04 0.05 
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LysoPE18_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PE34_4 0.05 0.05 0.05 0.06 0.06 0.03 0.03 0.04 0.03 0.03 
PE34_3 2.74 2.87 2.76 3.33 3.79 1.22 1.34 1.43 1.34 1.37 
PE34_2 4.12 4.02 3.89 4.67 5.26 4.86 5.17 5.15 4.82 4.85 
PE34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PE36_6 0.75 0.74 0.72 0.92 1.05 0.15 0.16 0.20 0.17 0.18 
PE36_5 2.19 2.14 2.13 2.67 2.97 1.12 1.23 1.29 1.16 1.21 
PE36_4 2.31 2.28 2.19 2.70 2.95 3.96 4.14 4.06 3.87 3.80 
PE36_3 0.59 0.56 0.52 0.66 0.72 0.58 0.62 0.65 0.61 0.61 
PE36_2 0.29 0.28 0.26 0.34 0.35 0.29 0.26 0.26 0.27 0.26 
PE36_1 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 
PE38_6 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
PE38_5 0.03 0.03 0.03 0.04 0.04 0.01 0.01 0.02 0.01 0.01 
PE38_4 0.05 0.04 0.04 0.05 0.05 0.04 0.04 0.03 0.04 0.03 
PE38_3 0.06 0.07 0.06 0.08 0.09 0.06 0.05 0.06 0.06 0.05 
PE38_2 0.08 0.09 0.09 0.10 0.11 0.10 0.11 0.12 0.10 0.10 
PE40_3 0.05 0.05 0.04 0.05 0.06 0.02 0.02 0.02 0.02 0.02 
PE40_2 0.10 0.09 0.09 0.11 0.12 0.10 0.10 0.10 0.10 0.10 
PE42_4 0.02 0.02 0.02 0.02 0.03 0.01 0.01 0.01 0.01 0.01 
PE42_3 0.09 0.08 0.08 0.09 0.11 0.09 0.09 0.09 0.10 0.09 
PE42_2 0.09 0.08 0.08 0.11 0.12 0.10 0.10 0.11 0.11 0.10 
PG32_1 0.53 0.60 0.79 0.69 0.81 0.47 0.51 0.57 0.46 0.52 
PG32_0 0.23 0.26 0.25 0.41 0.38 0.29 0.26 0.25 0.27 0.23 
PG34_4 8.69 9.14 10.46 10.02 10.91 8.19 8.20 8.02 7.86 7.27 
PG34_3 2.40 2.58 2.39 2.61 3.16 2.60 2.37 2.22 2.34 2.05 
PG34_2 2.03 1.93 2.03 2.16 2.47 2.27 2.04 1.94 1.97 1.78 
PG34_1 1.18 1.31 1.22 1.31 1.48 1.27 1.18 1.16 1.23 1.08 
PG34_0 0.02 0.00 0.03 0.00 0.04 0.04 0.02 0.01 0.01 0.01 
lysoPG16_1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
lysoPG16_0 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.00 0.01 
lysoPG18_3 0.05 0.04 0.04 0.04 0.04 0.03 0.04 0.04 0.03 0.03 
lysoPG18_2 0.01 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.00 
lysoPG18_1 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.01 0.00 0.00 
PA34_6 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_4 0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_3 0.15 0.16 0.28 0.16 0.17 0.05 0.06 0.08 0.12 0.08 
PA34_2 0.16 0.18 0.26 0.14 0.21 0.14 0.17 0.25 0.33 0.25 
PA34_1 0.11 0.10 0.10 0.06 0.06 0.08 0.08 0.08 0.07 0.07 
PA36_6 0.05 0.05 0.08 0.04 0.05 0.01 0.01 0.02 0.02 0.02 
PA36_5 0.10 0.09 0.18 0.07 0.11 0.03 0.04 0.06 0.08 0.08 
PA36_4 0.11 0.08 0.18 0.09 0.12 0.09 0.14 0.18 0.27 0.22 
PA36_3 0.03 0.03 0.06 0.04 0.02 0.02 0.03 0.05 0.06 0.03 
PA36_2 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 
PI34_4 0.02 0.02 0.01 0.02 0.03 0.01 0.02 0.01 0.01 0.01 
PI34_3 1.28 1.48 1.45 1.68 2.15 0.73 0.94 0.98 0.87 0.83 
PI34_2 1.52 1.64 1.68 1.88 2.35 1.99 2.37 2.50 2.24 2.07 
PI34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PI36_6 0.07 0.06 0.08 0.10 0.11 0.03 0.05 0.05 0.03 0.04 
PI36_5 0.12 0.11 0.11 0.12 0.15 0.06 0.09 0.09 0.08 0.07 
PI36_4 0.14 0.11 0.11 0.16 0.15 0.14 0.16 0.18 0.15 0.14 
PI36_3 0.16 0.13 0.15 0.16 0.21 0.10 0.11 0.11 0.10 0.10 
PI36_2 0.11 0.11 0.08 0.12 0.13 0.11 0.12 0.12 0.10 0.11 
PI36_1 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.01 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
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PS34_3 0.07 0.07 0.08 0.08 0.10 0.03 0.04 0.04 0.03 0.03 
PS34_2 0.08 0.08 0.08 0.08 0.10 0.13 0.12 0.12 0.12 0.10 
PS34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.01 
PS36_4 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.01 
PS36_3 0.04 0.05 0.04 0.04 0.05 0.02 0.02 0.03 0.02 0.02 
PS36_2 0.03 0.03 0.04 0.03 0.03 0.05 0.04 0.05 0.04 0.04 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 
PS38_3 0.04 0.04 0.03 0.04 0.05 0.01 0.01 0.02 0.02 0.02 
PS38_2 0.04 0.04 0.04 0.04 0.04 0.06 0.05 0.05 0.05 0.05 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_3 0.04 0.04 0.04 0.06 0.06 0.02 0.02 0.02 0.02 0.02 
PS40_2 0.06 0.05 0.06 0.06 0.07 0.08 0.08 0.09 0.07 0.09 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS42_4 0.01 0.02 0.02 0.02 0.02 0.01 0.00 0.01 0.01 0.01 
PS42_3 0.08 0.07 0.08 0.08 0.11 0.06 0.06 0.06 0.06 0.06 
PS42_2 0.07 0.07 0.06 0.08 0.09 0.09 0.10 0.10 0.09 0.10 
PS42_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_3 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PS44_2 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.00 
 
Table A-3 The original dataset for fad4 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.25 2.18 2.53 1.96 2.21 2.35 2.67 2.15 2.21 2.85 
DGDG34_5 0.14 0.10 0.10 0.17 0.06 0.24 0.11 0.02 0.11 0.21 
DGDG34_4 0.26 0.19 0.20 0.18 0.23 0.22 0.34 0.05 0.22 0.32 
DGDG34_3 4.69 4.33 4.41 3.86 4.03 4.40 4.37 3.99 4.03 5.29 
DGDG34_2 1.01 0.95 1.10 0.81 0.79 0.71 0.80 0.65 0.75 0.65 
DGDG34_1 0.41 0.40 0.44 0.35 0.40 0.52 0.55 0.38 0.45 0.47 
DGDG36_6 14.95 16.68 14.93 14.08 15.01 16.82 16.58 16.23 14.62 15.37 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG36_4 0.46 0.46 0.38 0.46 0.43 0.43 0.41 0.47 0.28 0.38 
DGDG36_3 0.22 0.18 0.20 0.13 0.16 0.14 0.14 0.12 0.18 0.12 
DGDG36_2 0.01 0.00 0.00 0.00 0.00 0.01 0.02 0.04 0.01 0.04 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG38_6 0.18 0.22 0.15 0.22 0.16 0.12 0.15 0.13 0.17 0.22 
DGDG38_5 0.00 0.00 0.00 0.00 0.00 0.05 0.00 0.00 0.00 0.00 
DGDG38_4 0.08 0.00 0.03 0.03 0.05 0.01 0.00 0.01 0.01 0.00 
DGDG38_3 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG34_6 67.36 73.73 71.54 61.98 58.12 57.81 64.12 58.41 58.08 58.71 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG34_4 2.04 2.69 2.02 2.32 1.86 1.95 2.19 1.89 1.80 2.12 
MGDG34_3 0.94 0.72 0.74 0.83 0.70 0.59 0.71 0.72 0.56 0.66 
MGDG34_2 0.44 0.80 0.60 0.61 0.49 0.43 0.52 0.48 0.62 0.44 
MGDG34_1 0.37 0.00 0.00 1.24 0.00 0.00 1.09 1.11 0.00 0.00 
MGDG36_6 11.56 12.24 11.68 10.73 11.68 13.41 10.71 13.54 10.32 10.84 
MGDG36_5 0.01 0.04 0.09 0.26 0.03 0.00 0.00 0.00 0.00 0.00 
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MGDG36_4 1.28 1.18 1.35 0.87 1.17 1.09 0.87 1.13 0.95 1.58 
MGDG36_3 0.04 0.11 0.00 0.11 0.00 0.09 0.07 0.12 0.08 0.00 
MGDG36_2 0.05 0.00 0.03 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
MGDG36_1 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_4 0.04 0.06 0.06 0.00 0.00 0.05 0.03 0.11 0.01 0.08 
MGDG38_3 0.00 0.05 0.00 0.02 0.00 0.04 0.12 0.00 0.00 0.00 
PC32_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC34_4 0.12 0.12 0.12 0.14 0.16 0.12 0.11 0.11 0.12 0.11 
PC34_3 2.45 2.47 2.33 2.81 3.40 2.29 2.28 2.30 2.47 2.33 
PC34_2 3.24 3.21 3.12 3.53 4.13 2.88 3.08 2.89 3.40 3.22 
PC34_1 0.53 0.50 0.47 0.57 0.67 0.52 0.53 0.54 0.59 0.57 
PC36_6 1.71 1.81 1.78 2.18 2.61 1.95 1.90 1.88 1.95 1.97 
PC36_5 4.31 4.46 4.35 5.20 6.01 4.29 4.42 4.25 4.85 4.62 
PC36_4 3.42 3.33 3.35 3.87 4.52 3.32 3.46 3.31 3.84 3.63 
PC36_3 1.43 1.43 1.32 1.57 1.81 1.39 1.49 1.38 1.70 1.51 
PC36_2 0.58 0.56 0.51 0.65 0.74 0.49 0.54 0.54 0.64 0.59 
PC36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
PC38_5 0.05 0.04 0.04 0.05 0.06 0.04 0.04 0.04 0.04 0.05 
PC38_4 0.08 0.07 0.07 0.08 0.09 0.07 0.06 0.06 0.08 0.09 
PC38_3 0.09 0.08 0.08 0.09 0.09 0.07 0.07 0.07 0.09 0.10 
PC38_2 0.05 0.05 0.05 0.05 0.05 0.04 0.04 0.04 0.05 0.05 
PC40_5 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_4 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PC40_3 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.01 
PC40_2 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_3 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
LysoPC18_2 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.02 0.03 0.03 
LysoPC18_1 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_0 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_0 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.04 0.04 0.04 
LysoPE18_3 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.02 0.02 0.02 
LysoPE18_2 0.04 0.03 0.03 0.04 0.04 0.03 0.03 0.04 0.04 0.03 
LysoPE18_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PE34_4 0.05 0.05 0.05 0.06 0.06 0.05 0.05 0.05 0.05 0.05 
PE34_3 2.74 2.87 2.76 3.33 3.79 2.72 2.76 2.73 2.98 2.85 
PE34_2 4.12 4.02 3.89 4.67 5.26 3.72 4.02 3.77 4.21 4.17 
PE34_1 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.02 0.02 0.00 
PE36_6 0.75 0.74 0.72 0.92 1.05 0.76 0.78 0.76 0.82 0.79 
PE36_5 2.19 2.14 2.13 2.67 2.97 2.17 2.19 2.17 2.46 2.36 
PE36_4 2.31 2.28 2.19 2.70 2.95 2.19 2.33 2.24 2.60 2.42 
PE36_3 0.59 0.56 0.52 0.66 0.72 0.55 0.59 0.55 0.64 0.59 
PE36_2 0.29 0.28 0.26 0.34 0.35 0.23 0.26 0.25 0.30 0.29 
PE36_1 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.01 
PE38_6 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
PE38_5 0.03 0.03 0.03 0.04 0.04 0.03 0.03 0.03 0.04 0.03 
PE38_4 0.05 0.04 0.04 0.05 0.05 0.04 0.04 0.04 0.04 0.05 
PE38_3 0.06 0.07 0.06 0.08 0.09 0.05 0.06 0.06 0.07 0.07 
PE38_2 0.08 0.09 0.09 0.10 0.11 0.07 0.07 0.07 0.09 0.09 
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PE40_3 0.05 0.05 0.04 0.05 0.06 0.04 0.04 0.04 0.05 0.05 
PE40_2 0.10 0.09 0.09 0.11 0.12 0.08 0.09 0.08 0.10 0.09 
PE42_4 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.02 
PE42_3 0.09 0.08 0.08 0.09 0.11 0.07 0.08 0.07 0.09 0.08 
PE42_2 0.09 0.08 0.08 0.11 0.12 0.07 0.08 0.07 0.09 0.09 
PG32_1 0.53 0.60 0.79 0.69 0.81 0.05 0.04 0.02 0.03 0.01 
PG32_0 0.23 0.26 0.25 0.41 0.38 0.64 0.66 0.59 0.62 0.56 
PG34_4 8.69 9.14 10.46 10.02 10.91 0.07 0.04 0.05 0.05 0.04 
PG34_3 2.40 2.58 2.39 2.61 3.16 6.60 6.71 6.24 7.39 6.85 
PG34_2 2.03 1.93 2.03 2.16 2.47 1.24 1.21 1.15 1.47 1.39 
PG34_1 1.18 1.31 1.22 1.31 1.48 1.55 1.35 1.42 1.64 1.41 
PG34_0 0.02 0.00 0.03 0.00 0.04 0.07 0.10 0.11 0.14 0.15 
lysoPG16_1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
lysoPG16_0 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.01 0.01 
lysoPG18_3 0.05 0.04 0.04 0.04 0.04 0.00 0.00 0.00 0.00 0.00 
lysoPG18_2 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
lysoPG18_1 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_6 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_4 0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_3 0.15 0.16 0.28 0.16 0.17 0.13 0.16 0.11 0.13 0.11 
PA34_2 0.16 0.18 0.26 0.14 0.21 0.15 0.16 0.15 0.10 0.11 
PA34_1 0.11 0.10 0.10 0.06 0.06 0.09 0.05 0.06 0.07 0.09 
PA36_6 0.05 0.05 0.08 0.04 0.05 0.05 0.05 0.04 0.04 0.03 
PA36_5 0.10 0.09 0.18 0.07 0.11 0.09 0.09 0.07 0.08 0.07 
PA36_4 0.11 0.08 0.18 0.09 0.12 0.11 0.09 0.06 0.09 0.08 
PA36_3 0.03 0.03 0.06 0.04 0.02 0.03 0.03 0.03 0.03 0.02 
PA36_2 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.00 0.01 0.02 
PI34_4 0.02 0.02 0.01 0.02 0.03 0.02 0.02 0.02 0.02 0.02 
PI34_3 1.28 1.48 1.45 1.68 2.15 1.34 1.45 1.34 1.43 1.51 
PI34_2 1.52 1.64 1.68 1.88 2.35 1.40 1.65 1.49 1.61 1.74 
PI34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PI36_6 0.07 0.06 0.08 0.10 0.11 0.09 0.07 0.08 0.07 0.08 
PI36_5 0.12 0.11 0.11 0.12 0.15 0.11 0.11 0.12 0.12 0.11 
PI36_4 0.14 0.11 0.11 0.16 0.15 0.11 0.12 0.11 0.17 0.14 
PI36_3 0.16 0.13 0.15 0.16 0.21 0.12 0.17 0.12 0.15 0.14 
PI36_2 0.11 0.11 0.08 0.12 0.13 0.08 0.09 0.07 0.10 0.11 
PI36_1 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.01 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS34_3 0.07 0.07 0.08 0.08 0.10 0.08 0.06 0.08 0.08 0.07 
PS34_2 0.08 0.08 0.08 0.08 0.10 0.08 0.07 0.08 0.09 0.08 
PS34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_6 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PS36_4 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 
PS36_3 0.04 0.05 0.04 0.04 0.05 0.04 0.04 0.04 0.04 0.04 
PS36_2 0.03 0.03 0.04 0.03 0.03 0.03 0.03 0.03 0.04 0.04 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.01 
PS38_3 0.04 0.04 0.03 0.04 0.05 0.04 0.03 0.03 0.03 0.04 
PS38_2 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.03 0.04 0.04 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
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PS40_3 0.04 0.04 0.04 0.06 0.06 0.04 0.04 0.05 0.05 0.05 
PS40_2 0.06 0.05 0.06 0.06 0.07 0.06 0.06 0.06 0.06 0.06 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS42_4 0.01 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.02 0.01 
PS42_3 0.08 0.07 0.08 0.08 0.11 0.08 0.07 0.07 0.08 0.08 
PS42_2 0.07 0.07 0.06 0.08 0.09 0.07 0.07 0.07 0.08 0.07 
PS42_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_3 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PS44_2 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.00 
 
Table A-4 The original dataset for fad5 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.25 2.18 2.53 1.96 2.21 0.00 0.00 0.01 0.00 0.00 
DGDG34_5 0.14 0.10 0.10 0.17 0.06 0.00 0.00 0.00 0.00 0.00 
DGDG34_4 0.26 0.19 0.20 0.18 0.23 0.07 0.19 0.11 0.17 0.10 
DGDG34_3 4.69 4.33 4.41 3.86 4.03 13.31 13.83 13.53 16.35 13.24 
DGDG34_2 1.01 0.95 1.10 0.81 0.79 0.00 0.00 0.00 0.00 0.00 
DGDG34_1 0.41 0.40 0.44 0.35 0.40 0.09 0.09 0.07 0.00 0.17 
DGDG36_6 14.95 16.68 14.93 14.08 15.01 6.42 6.51 6.58 7.92 6.87 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG36_4 0.46 0.46 0.38 0.46 0.43 0.26 0.03 0.19 0.12 0.16 
DGDG36_3 0.22 0.18 0.20 0.13 0.16 0.55 0.53 0.49 0.40 0.49 
DGDG36_2 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG38_6 0.18 0.22 0.15 0.22 0.16 0.17 0.24 0.29 0.17 0.30 
DGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 
DGDG38_4 0.08 0.00 0.03 0.03 0.05 0.00 0.00 0.01 0.00 0.00 
DGDG38_3 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG34_6 67.36 73.73 71.54 61.98 58.12 0.02 0.11 0.02 0.02 0.04 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 0.00 0.09 0.00 0.00 0.00 
MGDG34_4 2.04 2.69 2.02 2.32 1.86 0.31 0.27 0.27 0.41 0.16 
MGDG34_3 0.94 0.72 0.74 0.83 0.70 21.06 19.73 18.05 17.96 14.75 
MGDG34_2 0.44 0.80 0.60 0.61 0.49 0.00 0.00 0.00 0.00 0.00 
MGDG34_1 0.37 0.00 0.00 1.24 0.00 0.44 0.00 0.00 0.43 0.60 
MGDG36_6 11.56 12.24 11.68 10.73 11.68 35.13 31.82 30.26 34.22 34.34 
MGDG36_5 0.01 0.04 0.09 0.26 0.03 0.00 0.00 0.00 0.00 0.00 
MGDG36_4 1.28 1.18 1.35 0.87 1.17 0.38 0.43 0.49 0.53 0.44 
MGDG36_3 0.04 0.11 0.00 0.11 0.00 0.40 0.46 0.12 0.27 0.25 
MGDG36_2 0.05 0.00 0.03 0.00 0.01 0.00 0.00 0.02 0.00 0.00 
MGDG36_1 0.02 0.00 0.00 0.00 0.00 0.04 0.00 0.06 0.10 0.00 
MGDG38_6 0.00 0.00 0.00 0.00 0.00 0.02 0.05 0.00 0.00 0.00 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_4 0.04 0.06 0.06 0.00 0.00 0.43 0.22 0.30 0.36 0.33 
MGDG38_3 0.00 0.05 0.00 0.02 0.00 0.00 0.00 0.00 0.09 0.00 
PC32_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC34_4 0.12 0.12 0.12 0.14 0.16 0.05 0.05 0.05 0.05 0.04 
PC34_3 2.45 2.47 2.33 2.81 3.40 2.26 2.36 2.44 2.18 1.77 
PC34_2 3.24 3.21 3.12 3.53 4.13 4.01 3.67 3.96 3.85 2.79 
PC34_1 0.53 0.50 0.47 0.57 0.67 0.68 0.65 0.62 0.66 0.51 
PC36_6 1.71 1.81 1.78 2.18 2.61 1.61 1.62 1.78 1.56 1.31 
PC36_5 4.31 4.46 4.35 5.20 6.01 4.24 3.98 4.30 4.15 3.29 
PC36_4 3.42 3.33 3.35 3.87 4.52 4.40 4.08 4.37 4.42 3.29 
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PC36_3 1.43 1.43 1.32 1.57 1.81 2.03 1.92 1.96 2.06 1.65 
PC36_2 0.58 0.56 0.51 0.65 0.74 0.81 0.74 0.75 0.74 0.61 
PC36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
PC38_5 0.05 0.04 0.04 0.05 0.06 0.06 0.05 0.05 0.05 0.04 
PC38_4 0.08 0.07 0.07 0.08 0.09 0.11 0.09 0.10 0.11 0.07 
PC38_3 0.09 0.08 0.08 0.09 0.09 0.11 0.09 0.10 0.10 0.08 
PC38_2 0.05 0.05 0.05 0.05 0.05 0.07 0.06 0.06 0.07 0.05 
PC40_5 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_4 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 
PC40_3 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 
PC40_2 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01 0.00 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_3 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 
LysoPC18_2 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.02 
LysoPC18_1 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_0 0.00 0.00 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.01 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_0 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.04 0.03 
LysoPE18_3 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.03 0.02 0.02 
LysoPE18_2 0.04 0.03 0.03 0.04 0.04 0.05 0.05 0.05 0.05 0.04 
LysoPE18_1 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 
PE34_4 0.05 0.05 0.05 0.06 0.06 0.03 0.03 0.03 0.03 0.02 
PE34_3 2.74 2.87 2.76 3.33 3.79 2.78 2.87 2.99 2.75 2.18 
PE34_2 4.12 4.02 3.89 4.67 5.26 5.32 5.06 5.13 5.22 3.79 
PE34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PE36_6 0.75 0.74 0.72 0.92 1.05 0.63 0.63 0.67 0.58 0.53 
PE36_5 2.19 2.14 2.13 2.67 2.97 2.28 2.15 2.36 2.17 1.74 
PE36_4 2.31 2.28 2.19 2.70 2.95 3.04 2.84 3.06 3.00 2.25 
PE36_3 0.59 0.56 0.52 0.66 0.72 0.85 0.80 0.82 0.75 0.61 
PE36_2 0.29 0.28 0.26 0.34 0.35 0.35 0.34 0.34 0.35 0.29 
PE36_1 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 
PE38_6 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
PE38_5 0.03 0.03 0.03 0.04 0.04 0.05 0.04 0.04 0.04 0.03 
PE38_4 0.05 0.04 0.04 0.05 0.05 0.08 0.06 0.07 0.07 0.05 
PE38_3 0.06 0.07 0.06 0.08 0.09 0.07 0.07 0.07 0.08 0.05 
PE38_2 0.08 0.09 0.09 0.10 0.11 0.11 0.11 0.10 0.11 0.09 
PE40_3 0.05 0.05 0.04 0.05 0.06 0.05 0.05 0.04 0.04 0.04 
PE40_2 0.10 0.09 0.09 0.11 0.12 0.11 0.12 0.11 0.11 0.08 
PE42_4 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.01 
PE42_3 0.09 0.08 0.08 0.09 0.11 0.10 0.09 0.10 0.10 0.07 
PE42_2 0.09 0.08 0.08 0.11 0.12 0.12 0.11 0.11 0.11 0.08 
PG32_1 0.53 0.60 0.79 0.69 0.81 0.52 0.59 0.54 0.53 0.42 
PG32_0 0.23 0.26 0.25 0.41 0.38 0.25 0.37 0.27 0.26 0.18 
PG34_4 8.69 9.14 10.46 10.02 10.91 13.18 11.52 12.40 12.88 8.67 
PG34_3 2.40 2.58 2.39 2.61 3.16 2.71 2.94 2.87 2.46 2.18 
PG34_2 2.03 1.93 2.03 2.16 2.47 2.04 1.92 1.96 1.91 1.56 
PG34_1 1.18 1.31 1.22 1.31 1.48 1.12 1.11 1.12 1.08 0.73 
PG34_0 0.02 0.00 0.03 0.00 0.04 0.05 0.03 0.00 0.04 0.00 
lysoPG16_1 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.02 
lysoPG16_0 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.02 0.01 0.01 
lysoPG18_3 0.05 0.04 0.04 0.04 0.04 0.05 0.04 0.03 0.06 0.04 
lysoPG18_2 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
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lysoPG18_1 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.01 
PA34_6 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_4 0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_3 0.15 0.16 0.28 0.16 0.17 0.13 0.10 0.12 0.11 0.08 
PA34_2 0.16 0.18 0.26 0.14 0.21 0.15 0.10 0.13 0.18 0.08 
PA34_1 0.11 0.10 0.10 0.06 0.06 0.15 0.26 0.19 0.10 0.14 
PA36_6 0.05 0.05 0.08 0.04 0.05 0.02 0.01 0.03 0.02 0.02 
PA36_5 0.10 0.09 0.18 0.07 0.11 0.05 0.04 0.06 0.06 0.04 
PA36_4 0.11 0.08 0.18 0.09 0.12 0.06 0.06 0.06 0.08 0.05 
PA36_3 0.03 0.03 0.06 0.04 0.02 0.02 0.01 0.03 0.01 0.03 
PA36_2 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 
PI34_4 0.02 0.02 0.01 0.02 0.03 0.00 0.00 0.01 0.01 0.01 
PI34_3 1.28 1.48 1.45 1.68 2.15 1.45 1.50 1.34 1.56 1.19 
PI34_2 1.52 1.64 1.68 1.88 2.35 1.98 2.15 1.89 2.21 1.56 
PI34_1 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 
PI36_6 0.07 0.06 0.08 0.10 0.11 0.07 0.12 0.08 0.11 0.07 
PI36_5 0.12 0.11 0.11 0.12 0.15 0.10 0.11 0.11 0.11 0.09 
PI36_4 0.14 0.11 0.11 0.16 0.15 0.16 0.13 0.14 0.15 0.12 
PI36_3 0.16 0.13 0.15 0.16 0.21 0.18 0.19 0.16 0.16 0.14 
PI36_2 0.11 0.11 0.08 0.12 0.13 0.13 0.12 0.11 0.12 0.09 
PI36_1 0.01 0.01 0.01 0.01 0.00 0.02 0.02 0.01 0.01 0.01 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS34_3 0.07 0.07 0.08 0.08 0.10 0.08 0.08 0.09 0.08 0.06 
PS34_2 0.08 0.08 0.08 0.08 0.10 0.11 0.10 0.11 0.12 0.07 
PS34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_6 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PS36_4 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.01 0.01 0.01 
PS36_3 0.04 0.05 0.04 0.04 0.05 0.04 0.04 0.04 0.05 0.04 
PS36_2 0.03 0.03 0.04 0.03 0.03 0.04 0.04 0.03 0.04 0.03 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.00 
PS38_3 0.04 0.04 0.03 0.04 0.05 0.04 0.03 0.03 0.04 0.03 
PS38_2 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.03 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_3 0.04 0.04 0.04 0.06 0.06 0.05 0.04 0.05 0.05 0.04 
PS40_2 0.06 0.05 0.06 0.06 0.07 0.06 0.07 0.07 0.07 0.06 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS42_4 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.01 
PS42_3 0.08 0.07 0.08 0.08 0.11 0.08 0.07 0.10 0.08 0.08 
PS42_2 0.07 0.07 0.06 0.08 0.09 0.07 0.10 0.09 0.10 0.07 
PS42_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_3 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PS44_2 0.00 0.01 0.01 0.00 0.01 0.00 0.01 0.00 0.00 0.00 
 
Table A-5 The original dataset for fad6 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.25 2.18 2.53 1.96 2.21 0.01 0.00 0.00 0.00 0.00 
DGDG34_5 0.14 0.10 0.10 0.17 0.06 0.01 0.00 0.00 0.01 0.00 
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DGDG34_4 0.26 0.19 0.20 0.18 0.23 0.52 0.49 0.47 0.43 0.26 
DGDG34_3 4.69 4.33 4.41 3.86 4.03 3.35 2.82 3.42 3.14 2.44 
DGDG34_2 1.01 0.95 1.10 0.81 0.79 1.24 1.18 1.32 1.18 0.89 
DGDG34_1 0.41 0.40 0.44 0.35 0.40 1.29 1.16 1.33 1.11 1.06 
DGDG36_6 14.95 16.68 14.93 14.08 15.01 12.61 12.62 12.83 12.07 11.13 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG36_4 0.46 0.46 0.38 0.46 0.43 3.74 3.54 3.53 4.07 3.69 
DGDG36_3 0.22 0.18 0.20 0.13 0.16 0.00 0.00 0.00 0.00 0.00 
DGDG36_2 0.01 0.00 0.00 0.00 0.00 0.25 0.21 0.26 0.23 0.30 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
DGDG38_6 0.18 0.22 0.15 0.22 0.16 0.12 0.14 0.10 0.11 0.11 
DGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG38_4 0.08 0.00 0.03 0.03 0.05 0.04 0.07 0.02 0.03 0.06 
DGDG38_3 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG34_6 67.36 73.73 71.54 61.98 58.12 0.00 0.00 0.00 0.00 0.00 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 0.05 0.06 0.03 0.00 0.04 
MGDG34_4 2.04 2.69 2.02 2.32 1.86 1.66 1.30 1.69 1.13 1.48 
MGDG34_3 0.94 0.72 0.74 0.83 0.70 3.07 3.18 3.14 3.12 3.82 
MGDG34_2 0.44 0.80 0.60 0.61 0.49 16.53 16.55 16.62 16.12 18.84 
MGDG34_1 0.37 0.00 0.00 1.24 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG36_6 11.56 12.24 11.68 10.73 11.68 14.51 13.60 12.15 12.23 13.63 
MGDG36_5 0.01 0.04 0.09 0.26 0.03 0.00 0.00 0.00 0.00 0.00 
MGDG36_4 1.28 1.18 1.35 0.87 1.17 3.77 3.66 3.30 3.60 3.50 
MGDG36_3 0.04 0.11 0.00 0.11 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG36_2 0.05 0.00 0.03 0.00 0.01 0.27 0.25 0.21 0.21 0.19 
MGDG36_1 0.02 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 
MGDG38_6 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.00 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_4 0.04 0.06 0.06 0.00 0.00 0.12 0.07 0.07 0.13 0.09 
MGDG38_3 0.00 0.05 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 
PC32_0 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 
PC34_4 0.12 0.12 0.12 0.14 0.16 0.36 0.40 0.38 0.37 0.36 
PC34_3 2.45 2.47 2.33 2.81 3.40 2.30 2.43 2.24 2.27 2.24 
PC34_2 3.24 3.21 3.12 3.53 4.13 3.48 3.74 3.26 3.51 3.40 
PC34_1 0.53 0.50 0.47 0.57 0.67 0.78 0.79 0.79 0.84 0.80 
PC36_6 1.71 1.81 1.78 2.18 2.61 1.45 1.49 1.52 1.44 1.39 
PC36_5 4.31 4.46 4.35 5.20 6.01 3.83 4.02 3.91 3.89 3.85 
PC36_4 3.42 3.33 3.35 3.87 4.52 4.11 4.37 3.87 4.16 4.08 
PC36_3 1.43 1.43 1.32 1.57 1.81 1.92 1.98 1.85 2.00 2.08 
PC36_2 0.58 0.56 0.51 0.65 0.74 0.68 0.72 0.61 0.67 0.64 
PC36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01 
PC38_5 0.05 0.04 0.04 0.05 0.06 0.02 0.03 0.02 0.03 0.02 
PC38_4 0.08 0.07 0.07 0.08 0.09 0.06 0.06 0.06 0.06 0.07 
PC38_3 0.09 0.08 0.08 0.09 0.09 0.08 0.08 0.07 0.09 0.09 
PC38_2 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.06 
PC40_5 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_4 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PC40_3 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01 
PC40_2 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_3 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 
LysoPC18_2 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.04 0.03 
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LysoPC18_1 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_0 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
LysoPE16_0 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.03 0.04 0.03 
LysoPE18_3 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.03 0.02 
LysoPE18_2 0.04 0.03 0.03 0.04 0.04 0.04 0.05 0.04 0.05 0.04 
LysoPE18_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 
PE34_4 0.05 0.05 0.05 0.06 0.06 0.12 0.13 0.11 0.13 0.12 
PE34_3 2.74 2.87 2.76 3.33 3.79 2.60 2.80 2.43 2.66 2.51 
PE34_2 4.12 4.02 3.89 4.67 5.26 4.43 4.61 4.01 4.54 4.30 
PE34_1 0.00 0.00 0.00 0.00 0.00 0.04 0.04 0.06 0.06 0.05 
PE36_6 0.75 0.74 0.72 0.92 1.05 0.61 0.62 0.62 0.62 0.59 
PE36_5 2.19 2.14 2.13 2.67 2.97 2.21 2.30 2.06 2.17 2.09 
PE36_4 2.31 2.28 2.19 2.70 2.95 2.94 3.01 2.57 2.85 2.79 
PE36_3 0.59 0.56 0.52 0.66 0.72 0.74 0.77 0.67 0.74 0.69 
PE36_2 0.29 0.28 0.26 0.34 0.35 0.26 0.27 0.20 0.26 0.24 
PE36_1 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.02 0.01 0.01 
PE38_6 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
PE38_5 0.03 0.03 0.03 0.04 0.04 0.02 0.02 0.02 0.02 0.02 
PE38_4 0.05 0.04 0.04 0.05 0.05 0.03 0.04 0.03 0.04 0.04 
PE38_3 0.06 0.07 0.06 0.08 0.09 0.07 0.07 0.06 0.07 0.06 
PE38_2 0.08 0.09 0.09 0.10 0.11 0.09 0.08 0.08 0.08 0.08 
PE40_3 0.05 0.05 0.04 0.05 0.06 0.03 0.04 0.03 0.03 0.03 
PE40_2 0.10 0.09 0.09 0.11 0.12 0.08 0.08 0.07 0.08 0.08 
PE42_4 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.02 
PE42_3 0.09 0.08 0.08 0.09 0.11 0.09 0.09 0.07 0.09 0.09 
PE42_2 0.09 0.08 0.08 0.11 0.12 0.09 0.10 0.07 0.10 0.09 
PG32_1 0.53 0.60 0.79 0.69 0.81 0.45 0.34 0.47 0.44 0.50 
PG32_0 0.23 0.26 0.25 0.41 0.38 0.29 0.31 0.27 0.24 0.21 
PG34_4 8.69 9.14 10.46 10.02 10.91 0.33 0.36 0.38 0.42 0.35 
PG34_3 2.40 2.58 2.39 2.61 3.16 0.90 0.70 0.87 0.86 0.85 
PG34_2 2.03 1.93 2.03 2.16 2.47 11.07 10.63 11.20 12.03 11.42 
PG34_1 1.18 1.31 1.22 1.31 1.48 2.55 3.17 2.34 2.77 2.48 
PG34_0 0.02 0.00 0.03 0.00 0.04 0.03 0.00 0.00 0.00 0.01 
lysoPG16_1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
lysoPG16_0 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.01 0.00 
lysoPG18_3 0.05 0.04 0.04 0.04 0.04 0.00 0.00 0.00 0.00 0.00 
lysoPG18_2 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
lysoPG18_1 0.00 0.01 0.01 0.01 0.00 0.05 0.05 0.05 0.05 0.05 
PA34_6 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_4 0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_3 0.15 0.16 0.28 0.16 0.17 0.16 0.12 0.11 0.19 0.13 
PA34_2 0.16 0.18 0.26 0.14 0.21 0.23 0.15 0.18 0.29 0.18 
PA34_1 0.11 0.10 0.10 0.06 0.06 0.08 0.10 0.06 0.08 0.06 
PA36_6 0.05 0.05 0.08 0.04 0.05 0.04 0.03 0.03 0.04 0.04 
PA36_5 0.10 0.09 0.18 0.07 0.11 0.09 0.07 0.10 0.13 0.08 
PA36_4 0.11 0.08 0.18 0.09 0.12 0.13 0.09 0.10 0.12 0.12 
PA36_3 0.03 0.03 0.06 0.04 0.02 0.04 0.02 0.04 0.05 0.03 
PA36_2 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PI34_4 0.02 0.02 0.01 0.02 0.03 0.06 0.06 0.05 0.06 0.06 
PI34_3 1.28 1.48 1.45 1.68 2.15 1.46 1.53 1.29 1.51 1.35 
PI34_2 1.52 1.64 1.68 1.88 2.35 1.91 2.06 1.72 2.07 2.02 
PI34_1 0.00 0.00 0.00 0.00 0.00 0.04 0.00 0.00 0.02 0.00 
PI36_6 0.07 0.06 0.08 0.10 0.11 0.07 0.06 0.07 0.08 0.06 
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PI36_5 0.12 0.11 0.11 0.12 0.15 0.09 0.10 0.08 0.13 0.08 
PI36_4 0.14 0.11 0.11 0.16 0.15 0.18 0.13 0.15 0.16 0.15 
PI36_3 0.16 0.13 0.15 0.16 0.21 0.16 0.15 0.16 0.20 0.20 
PI36_2 0.11 0.11 0.08 0.12 0.13 0.08 0.10 0.08 0.11 0.08 
PI36_1 0.01 0.01 0.01 0.01 0.00 0.02 0.01 0.01 0.01 0.01 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS34_3 0.07 0.07 0.08 0.08 0.10 0.07 0.08 0.07 0.07 0.07 
PS34_2 0.08 0.08 0.08 0.08 0.10 0.09 0.08 0.08 0.10 0.09 
PS34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PS36_4 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.02 0.02 
PS36_3 0.04 0.05 0.04 0.04 0.05 0.04 0.04 0.03 0.04 0.04 
PS36_2 0.03 0.03 0.04 0.03 0.03 0.03 0.03 0.03 0.04 0.03 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.01 0.01 
PS38_3 0.04 0.04 0.03 0.04 0.05 0.04 0.04 0.04 0.04 0.03 
PS38_2 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_3 0.04 0.04 0.04 0.06 0.06 0.05 0.05 0.04 0.05 0.05 
PS40_2 0.06 0.05 0.06 0.06 0.07 0.06 0.07 0.06 0.06 0.06 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS42_4 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 
PS42_3 0.08 0.07 0.08 0.08 0.11 0.09 0.09 0.08 0.10 0.08 
PS42_2 0.07 0.07 0.06 0.08 0.09 0.09 0.09 0.08 0.09 0.08 
PS42_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_3 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PS44_2 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 
 
Table A-6 The original dataset for fad7 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.25 2.17 2.53 1.96 2.21 0.72 0.69 0.96 0.45 0.81 
DGDG34_5 0.14 0.10 0.10 0.17 0.06 1.88 1.58 2.04 1.38 1.70 
DGDG34_4 0.26 0.19 0.20 0.18 0.23 0.99 0.65 0.89 0.81 1.00 
DGDG34_3 4.69 4.33 4.40 3.86 4.03 2.37 2.06 2.32 1.77 2.30 
DGDG34_2 1.01 0.95 1.10 0.81 0.79 2.42 2.25 2.48 1.82 2.14 
DGDG34_1 0.41 0.40 0.44 0.35 0.40 0.37 0.16 0.29 0.30 0.38 
DGDG36_6 14.95 16.68 14.93 14.08 15.01 9.39 9.46 9.57 8.30 9.89 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 5.90 5.81 5.64 5.62 6.57 
DGDG36_4 0.45 0.46 0.38 0.46 0.43 2.45 2.01 2.20 2.06 2.38 
DGDG36_3 0.22 0.18 0.20 0.13 0.15 0.00 0.09 0.00 0.00 0.06 
DGDG36_2 0.01 0.00 0.00 0.00 0.00 0.10 0.02 0.12 0.12 0.08 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 
DGDG38_6 0.18 0.22 0.15 0.22 0.16 0.09 0.09 0.02 0.12 0.10 
DGDG38_5 0.00 0.00 0.00 0.00 0.00 0.03 0.03 0.01 0.01 0.04 
DGDG38_4 0.08 0.00 0.02 0.02 0.05 0.01 0.00 0.02 0.05 0.00 
DGDG38_3 0.00 0.01 0.00 0.00 0.00 0.00 0.04 0.00 0.00 0.00 
MGDG34_6 67.36 73.73 71.54 61.98 58.12 21.02 23.09 20.25 16.03 18.93 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 23.51 21.63 21.32 18.85 19.61 
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MGDG34_4 2.04 2.69 2.02 2.32 1.86 13.08 12.59 9.44 9.49 11.65 
MGDG34_3 0.94 0.72 0.74 0.83 0.70 0.66 0.88 0.97 0.90 0.99 
MGDG34_2 0.44 0.80 0.60 0.61 0.49 0.85 0.81 0.57 0.64 0.63 
MGDG34_1 0.37 0.00 0.00 1.24 0.00 0.00 0.00 0.34 0.17 0.00 
MGDG36_6 11.56 12.24 11.68 10.73 11.67 5.16 5.31 4.75 4.63 5.63 
MGDG36_5 0.01 0.04 0.09 0.26 0.03 3.98 2.92 3.10 3.68 3.29 
MGDG36_4 1.28 1.18 1.35 0.87 1.17 1.35 2.03 1.33 1.57 1.84 
MGDG36_3 0.04 0.11 0.00 0.11 0.00 0.24 0.24 0.18 0.39 0.37 
MGDG36_2 0.05 0.00 0.03 0.00 0.01 0.05 0.11 0.10 0.03 0.18 
MGDG36_1 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 
MGDG38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_4 0.04 0.06 0.06 0.00 0.00 0.02 0.04 0.00 0.05 0.00 
MGDG38_3 0.00 0.05 0.00 0.02 0.00 0.17 0.02 0.12 0.05 0.03 
PC32_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC34_4 0.11 0.11 0.12 0.13 0.16 0.20 0.20 0.21 0.20 0.20 
PC34_3 2.45 2.47 2.33 2.81 3.40 1.87 2.02 2.04 1.83 1.94 
PC34_2 3.24 3.21 3.12 3.53 4.13 3.80 3.82 3.83 3.63 3.75 
PC34_1 0.53 0.50 0.47 0.57 0.66 0.56 0.50 0.48 0.50 0.50 
PC36_6 1.71 1.81 1.78 2.18 2.61 1.11 1.34 1.27 1.05 1.17 
PC36_5 4.31 4.46 4.35 5.19 6.01 4.34 4.78 4.40 4.18 4.39 
PC36_4 3.42 3.33 3.35 3.87 4.52 4.62 4.68 4.44 4.42 4.51 
PC36_3 1.43 1.43 1.32 1.57 1.81 1.78 1.70 1.52 1.68 1.67 
PC36_2 0.58 0.56 0.51 0.65 0.74 0.61 0.64 0.61 0.63 0.63 
PC36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 
PC38_5 0.05 0.04 0.04 0.05 0.06 0.04 0.04 0.04 0.04 0.04 
PC38_4 0.08 0.07 0.07 0.08 0.09 0.07 0.08 0.07 0.07 0.08 
PC38_3 0.09 0.08 0.08 0.09 0.09 0.08 0.09 0.08 0.08 0.09 
PC38_2 0.05 0.05 0.04 0.05 0.05 0.05 0.05 0.05 0.06 0.06 
PC40_5 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_4 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 
PC40_3 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.00 
PC40_2 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.01 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_3 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
LysoPC18_2 0.02 0.02 0.02 0.02 0.03 0.03 0.04 0.04 0.04 0.04 
LysoPC18_1 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_0 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_0 0.04 0.03 0.04 0.04 0.04 0.04 0.04 0.05 0.04 0.04 
LysoPE18_3 0.02 0.02 0.02 0.02 0.03 0.02 0.03 0.03 0.02 0.02 
LysoPE18_2 0.04 0.03 0.03 0.03 0.04 0.05 0.05 0.05 0.05 0.05 
LysoPE18_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
PE34_4 0.05 0.05 0.05 0.06 0.06 0.08 0.09 0.08 0.08 0.09 
PE34_3 2.74 2.87 2.76 3.33 3.79 2.20 2.57 2.30 2.21 2.28 
PE34_2 4.12 4.02 3.89 4.67 5.26 4.87 5.17 4.71 4.76 4.85 
PE34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PE36_6 0.75 0.74 0.72 0.92 1.05 0.48 0.62 0.56 0.50 0.52 
PE36_5 2.19 2.14 2.13 2.67 2.97 2.14 2.30 2.13 2.02 2.09 
PE36_4 2.31 2.28 2.18 2.70 2.95 3.06 3.10 2.91 3.01 2.94 
PE36_3 0.59 0.56 0.52 0.66 0.72 0.70 0.69 0.61 0.64 0.64 
PE36_2 0.29 0.28 0.26 0.34 0.35 0.31 0.31 0.29 0.31 0.30 
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PE36_1 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.01 
PE38_6 0.02 0.02 0.01 0.02 0.02 0.01 0.02 0.01 0.01 0.01 
PE38_5 0.03 0.03 0.03 0.04 0.04 0.03 0.03 0.03 0.03 0.03 
PE38_4 0.05 0.03 0.04 0.05 0.05 0.04 0.05 0.05 0.04 0.04 
PE38_3 0.06 0.07 0.06 0.08 0.09 0.05 0.06 0.05 0.06 0.06 
PE38_2 0.08 0.09 0.09 0.10 0.11 0.08 0.09 0.10 0.09 0.09 
PE40_3 0.05 0.05 0.04 0.05 0.06 0.04 0.05 0.05 0.04 0.04 
PE40_2 0.10 0.09 0.09 0.11 0.12 0.11 0.12 0.12 0.12 0.12 
PE42_4 0.02 0.02 0.02 0.02 0.03 0.02 0.03 0.02 0.02 0.03 
PE42_3 0.09 0.08 0.08 0.09 0.11 0.09 0.11 0.11 0.10 0.10 
PE42_2 0.09 0.08 0.07 0.11 0.12 0.13 0.12 0.11 0.12 0.13 
PG32_1 0.53 0.60 0.79 0.69 0.80 0.47 0.51 0.51 0.44 0.45 
PG32_0 0.23 0.26 0.25 0.41 0.38 0.17 0.21 0.25 0.27 0.22 
PG34_4 8.69 9.14 10.46 10.02 10.91 6.83 7.15 6.60 6.37 6.77 
PG34_3 2.40 2.58 2.39 2.61 3.16 3.89 4.01 3.45 3.86 3.81 
PG34_2 2.02 1.93 2.03 2.16 2.47 2.63 2.39 2.33 2.57 2.54 
PG34_1 1.18 1.31 1.22 1.31 1.48 1.34 1.24 1.19 1.32 1.37 
PG34_0 0.02 0.00 0.03 0.00 0.04 0.00 0.00 0.00 0.01 0.00 
lysoPG16_1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
lysoPG16_0 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.01 0.01 
lysoPG18_3 0.05 0.04 0.03 0.04 0.04 0.03 0.02 0.03 0.02 0.03 
lysoPG18_2 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 
lysoPG18_1 0.00 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 
PA34_6 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_4 0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_3 0.15 0.16 0.28 0.16 0.17 0.12 0.17 0.19 0.13 0.14 
PA34_2 0.16 0.18 0.26 0.14 0.21 0.20 0.28 0.26 0.24 0.20 
PA34_1 0.11 0.10 0.10 0.06 0.06 0.07 0.07 0.05 0.05 0.07 
PA36_6 0.05 0.04 0.08 0.04 0.05 0.03 0.06 0.04 0.03 0.04 
PA36_5 0.10 0.09 0.18 0.07 0.11 0.09 0.14 0.12 0.11 0.10 
PA36_4 0.10 0.08 0.18 0.09 0.12 0.12 0.18 0.17 0.16 0.15 
PA36_3 0.03 0.03 0.06 0.04 0.02 0.03 0.05 0.04 0.03 0.03 
PA36_2 0.01 0.01 0.01 0.01 0.01 0.02 0.00 0.02 0.01 0.01 
PI34_4 0.02 0.02 0.01 0.02 0.03 0.03 0.03 0.03 0.03 0.03 
PI34_3 1.28 1.48 1.45 1.68 2.15 1.15 1.30 1.11 1.25 1.04 
PI34_2 1.52 1.64 1.68 1.88 2.35 2.17 2.12 1.84 2.24 2.17 
PI34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PI36_6 0.07 0.06 0.08 0.09 0.11 0.06 0.06 0.05 0.05 0.04 
PI36_5 0.12 0.11 0.11 0.12 0.15 0.11 0.13 0.13 0.11 0.13 
PI36_4 0.14 0.11 0.11 0.16 0.15 0.17 0.16 0.16 0.17 0.15 
PI36_3 0.16 0.13 0.15 0.16 0.21 0.14 0.16 0.14 0.13 0.14 
PI36_2 0.11 0.11 0.08 0.12 0.13 0.12 0.12 0.11 0.11 0.11 
PI36_1 0.01 0.00 0.01 0.01 0.00 0.01 0.02 0.00 0.00 0.03 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS34_3 0.07 0.07 0.08 0.08 0.10 0.05 0.07 0.06 0.07 0.06 
PS34_2 0.08 0.08 0.08 0.07 0.10 0.09 0.10 0.10 0.10 0.11 
PS34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PS36_4 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.01 0.02 0.01 
PS36_3 0.04 0.05 0.04 0.04 0.05 0.03 0.05 0.04 0.04 0.04 
PS36_2 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.03 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
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PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.01 
PS38_3 0.04 0.04 0.03 0.04 0.05 0.03 0.04 0.04 0.03 0.04 
PS38_2 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.04 0.05 0.04 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_3 0.04 0.04 0.04 0.06 0.06 0.04 0.04 0.04 0.04 0.03 
PS40_2 0.06 0.05 0.06 0.06 0.07 0.06 0.07 0.06 0.08 0.07 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS42_4 0.01 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.01 0.01 
PS42_3 0.08 0.07 0.08 0.08 0.11 0.08 0.09 0.08 0.08 0.08 
PS42_2 0.07 0.07 0.06 0.08 0.09 0.08 0.09 0.07 0.09 0.10 
PS42_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_3 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PS44_2 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
 
Table A-7 The original dataset for sfd1 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.21 2.71 3.29 2.67 2.32 0.62 0.93 0.84 0.77 0.56 
DGDG34_5 0.05 0.00 0.09 0.05 0.05 0.08 0.09 0.12 0.19 0.08 
DGDG34_4 0.14 0.17 0.21 0.19 0.15 0.10 0.21 0.14 0.10 0.10 
DGDG34_3 3.46 4.28 4.65 4.59 3.59 2.81 3.11 3.04 3.42 2.28 
DGDG34_2 0.61 0.66 0.75 0.78 0.57 0.00 0.08 0.00 0.00 0.08 
DGDG34_1 0.21 0.35 0.31 0.30 0.25 0.09 0.08 0.09 0.13 0.05 
DGDG36_6 11.21 12.35 13.46 14.73 12.38 17.89 22.29 22.04 22.26 16.90 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG36_4 0.31 0.32 0.30 0.37 0.48 0.36 0.51 0.43 0.51 0.41 
DGDG36_3 0.10 0.21 0.16 0.17 0.12 0.02 0.11 0.07 0.08 0.10 
DGDG36_2 0.05 0.00 0.00 0.00 0.03 0.00 0.01 0.00 0.00 0.00 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG38_6 0.17 0.12 0.12 0.14 0.16 0.24 0.24 0.28 0.16 0.26 
DGDG38_5 0.00 0.00 0.00 0.01 0.00 0.00 0.02 0.00 0.09 0.00 
DGDG38_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.01 
DGDG38_3 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG34_6 51.35 54.56 58.91 60.60 59.56 24.28 29.29 27.36 25.47 23.88 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 
MGDG34_4 1.50 1.65 1.50 1.96 1.64 0.54 0.54 0.91 0.74 0.69 
MGDG34_3 0.49 0.48 0.74 0.60 0.65 0.48 0.60 0.43 0.42 0.20 
MGDG34_2 0.34 0.36 0.34 0.40 0.30 0.02 0.18 0.11 0.02 0.03 
MGDG34_1 0.64 0.19 0.34 0.00 0.00 0.00 0.74 0.06 0.00 0.00 
MGDG36_6 9.11 9.41 9.93 10.51 9.21 24.94 34.51 29.40 31.41 26.42 
MGDG36_5 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG36_4 0.39 0.43 0.56 0.40 0.56 0.40 0.90 0.74 0.88 0.86 
MGDG36_3 0.00 0.04 0.03 0.04 0.00 0.02 0.09 0.03 0.13 0.01 
MGDG36_2 0.00 0.00 0.00 0.06 0.00 0.00 0.01 0.00 0.00 0.00 
MGDG36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_6 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.06 0.00 0.00 0.00 0.00 
MGDG38_4 0.00 0.00 0.03 0.00 0.00 0.03 0.13 0.16 0.00 0.03 
MGDG38_3 0.07 0.05 0.00 0.00 0.00 0.00 0.04 0.00 0.07 0.04 
PC32_0 0.01 0.01 0.02 0.01 0.01 0.02 0.02 0.01 0.01 0.01 
PC34_4 0.11 0.10 0.13 0.12 0.13 0.10 0.16 0.11 0.09 0.09 
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PC34_3 2.40 2.15 2.71 2.42 2.76 2.06 3.15 2.15 1.90 1.69 
PC34_2 2.61 2.44 2.71 2.74 3.02 2.34 3.72 2.67 2.34 2.14 
PC34_1 0.55 0.58 0.62 0.61 0.65 1.04 1.47 1.15 0.90 0.96 
PC36_6 2.13 1.92 2.54 2.11 2.47 1.85 3.01 1.92 1.73 1.61 
PC36_5 4.16 3.82 4.52 4.18 4.90 3.80 6.11 4.24 3.71 3.49 
PC36_4 2.96 2.84 3.12 3.15 3.47 3.57 5.57 4.04 3.43 3.46 
PC36_3 1.36 1.36 1.46 1.58 1.61 2.45 3.81 2.66 2.33 2.54 
PC36_2 0.49 0.52 0.50 0.58 0.59 1.02 1.53 1.13 0.86 1.04 
PC36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC38_5 0.03 0.03 0.03 0.03 0.04 0.03 0.05 0.03 0.03 0.03 
PC38_4 0.05 0.05 0.05 0.05 0.05 0.06 0.09 0.06 0.06 0.06 
PC38_3 0.05 0.05 0.05 0.06 0.06 0.07 0.10 0.07 0.06 0.07 
PC38_2 0.02 0.03 0.03 0.03 0.03 0.04 0.06 0.04 0.03 0.03 
PC40_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 
PC40_3 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 
PC40_2 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 
LysoPC18_3 0.03 0.03 0.04 0.03 0.04 0.03 0.05 0.03 0.03 0.02 
LysoPC18_2 0.03 0.03 0.03 0.03 0.03 0.03 0.05 0.03 0.04 0.03 
LysoPC18_1 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.01 0.02 
LysoPC18_0 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_0 0.04 0.04 0.05 0.04 0.04 0.04 0.07 0.04 0.04 0.04 
LysoPE18_3 0.04 0.03 0.04 0.03 0.04 0.03 0.06 0.03 0.03 0.03 
LysoPE18_2 0.04 0.04 0.04 0.05 0.05 0.05 0.09 0.05 0.04 0.05 
LysoPE18_1 0.01 0.01 0.00 0.01 0.01 0.01 0.02 0.01 0.01 0.01 
PE34_4 0.05 0.04 0.07 0.06 0.06 0.05 0.08 0.05 0.05 0.04 
PE34_3 3.18 2.77 3.75 3.22 3.61 2.92 4.40 2.91 2.70 2.53 
PE34_2 3.63 3.31 4.03 3.84 4.21 4.02 5.86 4.10 3.81 3.71 
PE34_1 0.07 0.05 0.07 0.04 0.05 0.32 0.47 0.34 0.25 0.29 
PE36_6 0.96 0.83 1.19 0.97 1.07 0.83 1.31 0.88 0.75 0.76 
PE36_5 2.21 2.01 2.61 2.36 2.57 2.34 3.61 2.53 2.19 2.20 
PE36_4 2.04 1.86 2.30 2.20 2.37 2.73 4.17 2.93 2.53 2.56 
PE36_3 0.65 0.60 0.76 0.70 0.76 1.16 1.74 1.31 1.02 1.12 
PE36_2 0.26 0.23 0.26 0.28 0.30 0.35 0.54 0.35 0.31 0.34 
PE36_1 0.01 0.01 0.01 0.01 0.01 0.03 0.03 0.02 0.02 0.02 
PE38_6 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
PE38_5 0.02 0.02 0.03 0.03 0.03 0.03 0.04 0.03 0.03 0.03 
PE38_4 0.03 0.03 0.03 0.04 0.04 0.05 0.07 0.04 0.04 0.04 
PE38_3 0.05 0.06 0.07 0.07 0.07 0.07 0.10 0.07 0.06 0.06 
PE38_2 0.07 0.08 0.09 0.09 0.09 0.08 0.13 0.09 0.08 0.08 
PE40_3 0.05 0.04 0.05 0.05 0.05 0.04 0.06 0.04 0.03 0.03 
PE40_2 0.08 0.07 0.08 0.09 0.09 0.08 0.12 0.08 0.08 0.08 
PE42_4 0.02 0.02 0.03 0.02 0.03 0.02 0.03 0.02 0.02 0.02 
PE42_3 0.10 0.08 0.09 0.09 0.10 0.08 0.13 0.08 0.09 0.08 
PE42_2 0.09 0.08 0.10 0.10 0.11 0.10 0.16 0.11 0.09 0.10 
PG32_1 0.61 0.53 0.70 0.69 0.64 0.94 1.30 0.99 0.77 0.88 
PG32_0 0.25 0.25 0.34 0.24 0.31 0.28 0.51 0.20 0.25 0.26 
PG34_4 7.87 7.53 8.61 8.68 9.31 8.46 11.31 8.03 7.75 7.75 
PG34_3 1.74 1.48 1.79 1.76 1.77 1.44 2.14 1.57 1.33 1.40 
PG34_2 1.36 1.28 1.33 1.59 1.51 1.36 1.72 1.24 1.15 1.19 
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PG34_1 0.80 0.74 0.86 0.95 0.97 0.61 0.71 0.49 0.46 0.59 
PG34_0 0.03 0.01 0.02 0.00 0.02 0.00 0.00 0.00 0.01 0.02 
lysoPG16_1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
lysoPG16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
lysoPG18_3 0.04 0.06 0.05 0.05 0.05 0.07 0.07 0.04 0.04 0.04 
lysoPG18_2 0.00 0.01 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 
lysoPG18_1 0.00 0.01 0.01 0.00 0.01 0.00 0.01 0.00 0.00 0.00 
PA34_6 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_4 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PA34_3 0.17 0.14 0.23 0.20 0.24 0.12 0.36 0.21 0.18 0.18 
PA34_2 0.18 0.14 0.20 0.21 0.21 0.12 0.37 0.24 0.17 0.16 
PA34_1 0.04 0.06 0.05 0.05 0.04 0.10 0.08 0.08 0.07 0.08 
PA36_6 0.05 0.07 0.07 0.07 0.07 0.05 0.15 0.08 0.06 0.05 
PA36_5 0.12 0.10 0.14 0.13 0.14 0.08 0.25 0.18 0.12 0.13 
PA36_4 0.13 0.10 0.12 0.12 0.14 0.10 0.29 0.19 0.15 0.11 
PA36_3 0.04 0.04 0.05 0.05 0.06 0.05 0.11 0.08 0.06 0.07 
PA36_2 0.01 0.01 0.02 0.01 0.02 0.01 0.04 0.03 0.02 0.02 
PI34_4 0.01 0.02 0.02 0.02 0.01 0.01 0.04 0.02 0.01 0.01 
PI34_3 1.47 1.36 1.78 1.54 1.66 1.50 2.51 1.55 1.48 1.35 
PI34_2 1.33 1.24 1.42 1.47 1.47 1.63 2.76 1.65 1.67 1.52 
PI34_1 0.00 0.00 0.02 0.01 0.01 0.11 0.14 0.10 0.08 0.11 
PI36_6 0.09 0.09 0.10 0.08 0.09 0.11 0.14 0.09 0.07 0.08 
PI36_5 0.09 0.12 0.10 0.10 0.12 0.11 0.20 0.12 0.12 0.11 
PI36_4 0.10 0.09 0.12 0.12 0.12 0.17 0.25 0.16 0.13 0.15 
PI36_3 0.15 0.15 0.14 0.15 0.15 0.18 0.41 0.19 0.17 0.18 
PI36_2 0.08 0.09 0.06 0.09 0.11 0.10 0.15 0.09 0.08 0.11 
PI36_1 0.01 0.00 0.00 0.00 0.00 0.02 0.01 0.02 0.01 0.01 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS34_3 0.08 0.07 0.10 0.09 0.10 0.07 0.13 0.07 0.06 0.06 
PS34_2 0.07 0.07 0.07 0.07 0.08 0.08 0.12 0.08 0.08 0.06 
PS34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 
PS36_6 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PS36_4 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.02 0.01 
PS36_3 0.03 0.04 0.04 0.04 0.04 0.03 0.05 0.04 0.03 0.03 
PS36_2 0.02 0.02 0.03 0.03 0.03 0.03 0.04 0.03 0.02 0.02 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.01 
PS38_3 0.03 0.03 0.04 0.03 0.04 0.02 0.05 0.03 0.03 0.02 
PS38_2 0.03 0.03 0.03 0.03 0.03 0.03 0.05 0.03 0.02 0.03 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_3 0.05 0.04 0.06 0.05 0.05 0.04 0.08 0.05 0.04 0.04 
PS40_2 0.05 0.04 0.05 0.05 0.05 0.05 0.09 0.06 0.05 0.05 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS42_4 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.01 0.02 0.01 
PS42_3 0.08 0.08 0.10 0.08 0.10 0.09 0.15 0.10 0.08 0.09 
PS42_2 0.06 0.06 0.07 0.06 0.07 0.08 0.14 0.08 0.08 0.08 
PS42_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_3 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_2 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
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Table A-8 The original dataset for sfd2 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.72 2.37 3.22 3.62 2.35 0.53 0.73 0.81 0.79 0.64 
DGDG34_5 0.25 0.18 0.32 0.52 0.28 0.30 0.36 0.57 0.34 0.57 
DGDG34_4 0.18 0.17 0.19 0.23 0.17 0.22 0.21 0.27 0.26 0.26 
DGDG34_3 6.26 4.10 5.69 7.68 4.31 5.21 7.39 9.30 8.83 9.10 
DGDG34_2 1.45 0.92 1.11 1.60 0.86 0.00 0.00 0.00 0.00 0.00 
DGDG34_1 0.22 0.26 0.31 0.38 0.24 0.08 0.10 0.15 0.12 0.09 
DGDG36_6 21.92 17.10 19.53 23.71 16.36 16.37 20.05 24.80 18.95 18.18 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG36_4 0.51 0.31 0.40 0.47 0.34 0.39 0.49 0.69 0.65 0.47 
DGDG36_3 0.35 0.23 0.24 0.40 0.19 0.43 0.53 0.62 1.38 0.76 
DGDG36_2 0.00 0.00 0.01 0.00 0.02 0.02 0.01 0.05 0.00 0.12 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.03 0.02 0.05 
DGDG38_6 0.18 0.04 0.11 0.07 0.06 0.18 0.36 0.29 0.29 0.29 
DGDG38_5 0.00 0.00 0.00 0.00 0.03 0.01 0.00 0.00 0.00 0.00 
DGDG38_4 0.04 0.01 0.00 0.04 0.01 0.12 0.04 0.05 0.00 0.14 
DGDG38_3 0.00 0.00 0.00 0.00 0.01 0.00 0.04 0.00 0.03 0.00 
MGDG34_6 93.22 84.88 98.40 105.88 74.46 9.85 10.22 11.72 12.22 9.07 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 0.52 0.44 0.68 0.42 1.09 
MGDG34_4 0.58 0.39 0.64 0.83 0.32 0.55 0.50 0.62 0.76 0.39 
MGDG34_3 0.62 0.48 0.55 0.54 0.52 3.10 3.34 3.82 5.71 4.94 
MGDG34_2 0.09 0.09 0.13 0.10 0.04 0.04 0.00 0.00 0.00 0.00 
MGDG34_1 0.45 0.00 0.00 0.00 0.21 0.00 0.00 0.00 0.00 0.18 
MGDG36_6 20.26 15.46 18.83 20.41 15.42 35.60 50.50 47.15 50.38 46.60 
MGDG36_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG36_4 1.15 0.88 0.79 0.96 1.07 0.91 1.27 1.43 1.86 1.45 
MGDG36_3 0.00 0.00 0.00 0.02 0.00 0.20 0.25 0.41 0.99 0.00 
MGDG36_2 0.00 0.00 0.00 0.00 0.00 0.01 0.05 0.07 0.12 0.17 
MGDG36_1 0.02 0.00 0.01 0.00 0.00 0.00 0.00 0.02 0.00 0.00 
MGDG38_6 0.09 0.01 0.02 0.03 0.00 0.04 0.09 0.10 0.11 0.30 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.03 
MGDG38_4 0.08 0.05 0.02 0.07 0.14 0.32 0.44 0.40 0.66 0.86 
MGDG38_3 0.00 0.26 0.06 0.48 0.11 0.00 0.01 0.00 0.00 0.00 
PC32_0 0.02 0.02 0.02 0.03 0.02 0.02 0.03 0.04 0.03 0.03 
PC34_4 0.17 0.15 0.15 0.17 0.13 0.07 0.11 0.13 0.09 0.11 
PC34_3 3.84 3.25 3.58 3.97 2.94 2.60 4.89 6.11 5.75 4.86 
PC34_2 3.57 2.89 3.15 3.52 2.64 1.75 3.30 3.64 2.92 3.32 
PC34_1 0.18 0.13 0.14 0.22 0.11 0.11 0.14 0.15 0.07 0.17 
PC36_6 3.03 2.93 2.89 3.39 2.36 1.87 3.29 3.84 2.77 2.96 
PC36_5 5.70 4.80 5.00 5.94 4.16 2.14 4.01 4.54 2.63 3.93 
PC36_4 3.52 2.82 2.94 3.58 2.56 1.23 2.31 2.24 1.27 2.28 
PC36_3 0.84 0.69 0.74 0.94 0.61 1.25 2.13 2.30 2.86 1.58 
PC36_2 0.44 0.35 0.37 0.47 0.32 0.78 1.39 1.43 1.64 0.83 
PC36_1 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.02 0.01 0.02 0.02 0.01 0.01 0.02 0.03 0.02 0.02 
PC38_5 0.04 0.04 0.04 0.04 0.03 0.03 0.06 0.05 0.04 0.05 
PC38_4 0.07 0.06 0.05 0.07 0.05 0.05 0.10 0.08 0.09 0.07 
PC38_3 0.06 0.05 0.05 0.06 0.05 0.05 0.09 0.08 0.08 0.07 
PC38_2 0.03 0.02 0.02 0.03 0.02 0.02 0.04 0.04 0.04 0.03 
PC40_5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 
PC40_4 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC40_3 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 
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PC40_2 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.03 0.03 
LysoPC18_3 0.01 0.02 0.01 0.02 0.01 0.03 0.02 0.02 0.02 0.02 
LysoPC18_2 0.01 0.02 0.01 0.02 0.01 0.02 0.01 0.02 0.01 0.03 
LysoPC18_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC18_0 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.01 0.03 0.01 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPE16_0 0.04 0.03 0.04 0.04 0.02 0.03 0.04 0.05 0.06 0.07 
LysoPE18_3 0.01 0.02 0.02 0.02 0.02 0.03 0.02 0.03 0.03 0.03 
LysoPE18_2 0.03 0.02 0.03 0.03 0.02 0.03 0.03 0.03 0.04 0.04 
LysoPE18_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PE34_4 0.06 0.06 0.06 0.07 0.05 0.04 0.06 0.07 0.06 0.05 
PE34_3 3.57 3.24 3.30 3.79 2.71 3.13 4.99 6.42 6.24 5.08 
PE34_2 4.69 3.85 4.11 4.58 3.51 3.09 4.95 5.35 4.45 4.65 
PE34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PE36_6 0.69 0.72 0.67 0.82 0.54 0.56 1.01 1.25 1.21 0.96 
PE36_5 2.28 2.03 2.04 2.44 1.69 1.43 2.47 2.80 2.49 2.35 
PE36_4 2.25 1.89 1.98 2.33 1.67 1.26 2.20 2.37 1.96 2.03 
PE36_3 0.51 0.41 0.45 0.49 0.36 0.86 1.31 1.53 1.71 0.95 
PE36_2 0.37 0.31 0.33 0.38 0.28 0.76 1.19 1.23 1.45 0.68 
PE36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PE38_6 0.02 0.02 0.02 0.02 0.02 0.01 0.03 0.03 0.03 0.03 
PE38_5 0.03 0.02 0.02 0.03 0.02 0.03 0.05 0.05 0.04 0.04 
PE38_4 0.04 0.04 0.04 0.04 0.03 0.04 0.08 0.06 0.06 0.05 
PE38_3 0.04 0.04 0.04 0.06 0.04 0.07 0.10 0.09 0.12 0.08 
PE38_2 0.06 0.06 0.05 0.06 0.05 0.10 0.13 0.14 0.16 0.07 
PE40_3 0.05 0.05 0.05 0.06 0.04 0.08 0.12 0.12 0.14 0.09 
PE40_2 0.15 0.12 0.13 0.16 0.12 0.16 0.24 0.24 0.24 0.19 
PE42_4 0.04 0.03 0.03 0.04 0.03 0.02 0.04 0.03 0.02 0.03 
PE42_3 0.08 0.07 0.08 0.09 0.06 0.05 0.09 0.08 0.09 0.09 
PE42_2 0.12 0.11 0.14 0.13 0.11 0.09 0.18 0.13 0.17 0.16 
PG32_1 1.03 0.94 0.83 1.02 0.85 0.47 0.57 0.65 0.65 0.68 
PG32_0 0.38 0.40 0.38 0.35 0.27 0.48 0.41 0.76 0.63 0.61 
PG34_4 17.98 13.78 15.32 15.42 13.36 8.99 12.59 14.22 9.86 10.83 
PG34_3 4.09 2.91 3.19 3.31 2.41 3.75 5.36 5.92 4.14 5.77 
PG34_2 1.95 1.26 1.44 1.61 1.26 1.83 2.67 2.80 2.62 2.80 
PG34_1 0.63 0.31 0.43 0.71 0.44 0.77 1.14 1.42 1.42 1.50 
PG34_0 0.02 0.02 0.00 0.00 0.00 0.26 0.27 0.43 0.56 0.45 
lysoPG16_1 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.02 
lysoPG16_0 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 
lysoPG18_3 0.02 0.02 0.02 0.03 0.01 0.03 0.02 0.02 0.00 0.02 
lysoPG18_2 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
lysoPG18_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_4 0.02 0.00 0.02 0.00 0.01 0.24 0.02 0.00 0.02 0.21 
PA34_3 0.18 0.23 0.19 0.46 0.30 2.49 0.25 0.30 0.33 1.34 
PA34_2 0.23 0.21 0.19 0.40 0.25 1.99 0.15 0.19 0.16 1.00 
PA34_1 0.00 0.00 0.00 0.00 0.01 0.02 0.04 0.00 0.03 0.06 
PA36_6 0.05 0.08 0.06 0.11 0.09 0.80 0.08 0.07 0.08 0.26 
PA36_5 0.14 0.13 0.08 0.22 0.18 1.33 0.10 0.09 0.09 0.44 
PA36_4 0.09 0.07 0.06 0.17 0.15 0.90 0.08 0.05 0.08 0.29 
PA36_3 0.04 0.02 0.02 0.04 0.04 0.52 0.06 0.05 0.08 0.43 
PA36_2 0.01 0.00 0.00 0.01 0.02 0.23 0.03 0.03 0.08 0.27 
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PI34_4 0.00 0.01 0.02 0.02 0.02 0.00 0.01 0.01 0.01 0.01 
PI34_3 2.44 2.14 2.17 2.40 2.11 1.99 2.51 2.92 2.56 2.59 
PI34_2 2.44 2.02 2.06 2.26 1.95 1.65 2.12 2.17 1.74 2.06 
PI34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PI36_6 0.09 0.11 0.14 0.14 0.12 0.09 0.09 0.10 0.06 0.08 
PI36_5 0.11 0.11 0.09 0.13 0.09 0.06 0.08 0.07 0.04 0.10 
PI36_4 0.09 0.08 0.05 0.08 0.07 0.06 0.04 0.04 0.02 0.07 
PI36_3 0.11 0.15 0.11 0.17 0.12 0.25 0.33 0.31 0.36 0.22 
PI36_2 0.09 0.09 0.09 0.10 0.10 0.15 0.28 0.23 0.32 0.17 
PI36_1 0.01 0.00 0.01 0.04 0.00 0.02 0.00 0.05 0.00 0.06 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS34_3 0.16 0.14 0.15 0.18 0.13 0.11 0.16 0.21 0.17 0.16 
PS34_2 0.16 0.14 0.17 0.19 0.13 0.10 0.15 0.17 0.12 0.14 
PS34_1 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PS36_6 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.01 
PS36_4 0.01 0.01 0.02 0.02 0.01 0.01 0.02 0.02 0.01 0.01 
PS36_3 0.07 0.06 0.07 0.08 0.05 0.07 0.11 0.11 0.13 0.09 
PS36_2 0.06 0.04 0.05 0.06 0.04 0.04 0.07 0.06 0.06 0.06 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_3 0.05 0.04 0.04 0.05 0.04 0.04 0.07 0.07 0.06 0.06 
PS38_2 0.05 0.03 0.04 0.05 0.04 0.04 0.05 0.06 0.04 0.05 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 
PS40_3 0.06 0.05 0.05 0.06 0.04 0.06 0.10 0.11 0.10 0.11 
PS40_2 0.08 0.06 0.06 0.07 0.05 0.06 0.10 0.11 0.10 0.08 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS42_4 0.03 0.02 0.03 0.03 0.02 0.01 0.03 0.03 0.02 0.03 
PS42_3 0.16 0.13 0.14 0.15 0.12 0.09 0.15 0.17 0.17 0.19 
PS42_2 0.11 0.10 0.12 0.13 0.09 0.08 0.11 0.11 0.14 0.14 
PS42_1 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_3 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 
PS44_2 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.01 0.01 0.01 
 
Table A-9 The original dataset for sfd3 
lipid C1 C2 C3 C4 C5 T1 T2 T3 T4 T5 
DGDG34_6 2.21 2.71 3.29 2.67 2.32 0.00 0.00 0.02 0.00 0.00 
DGDG34_5 0.05 0.00 0.09 0.05 0.05 0.00 0.00 0.00 0.00 0.00 
DGDG34_4 0.14 0.17 0.21 0.19 0.15 0.59 0.45 0.39 0.32 0.41 
DGDG34_3 3.46 4.28 4.65 4.59 3.59 3.31 3.05 2.52 2.66 3.05 
DGDG34_2 0.61 0.66 0.75 0.78 0.57 1.37 1.34 1.04 1.06 1.24 
DGDG34_1 0.21 0.35 0.31 0.30 0.25 1.96 2.00 1.37 1.44 1.76 
DGDG36_6 11.21 12.35 13.46 14.73 12.38 11.60 11.65 11.62 10.69 11.87 
DGDG36_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG36_4 0.31 0.32 0.30 0.37 0.48 3.09 3.05 3.28 3.19 3.49 
DGDG36_3 0.10 0.21 0.16 0.17 0.12 0.13 0.00 0.01 0.09 0.00 
DGDG36_2 0.05 0.00 0.00 0.00 0.03 0.15 0.26 0.18 0.23 0.31 
DGDG36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 
DGDG38_6 0.17 0.12 0.12 0.14 0.16 0.16 0.19 0.26 0.18 0.10 
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DGDG38_5 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
DGDG38_4 0.00 0.00 0.00 0.00 0.00 0.03 0.05 0.03 0.04 0.04 
DGDG38_3 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 
MGDG34_6 51.35 54.56 58.91 60.60 59.56 0.00 0.00 0.00 0.00 0.02 
MGDG34_5 0.00 0.00 0.00 0.00 0.00 0.10 0.14 0.00 0.02 0.03 
MGDG34_4 1.50 1.65 1.50 1.96 1.64 1.80 1.70 1.49 1.73 1.72 
MGDG34_3 0.49 0.48 0.74 0.60 0.65 2.83 2.64 3.25 2.48 3.10 
MGDG34_2 0.34 0.36 0.34 0.40 0.30 18.41 18.43 19.41 18.13 18.82 
MGDG34_1 0.64 0.19 0.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG36_6 9.11 9.41 9.93 10.51 9.21 14.52 13.39 13.56 13.48 13.97 
MGDG36_5 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 0.04 
MGDG36_4 0.39 0.43 0.56 0.40 0.56 3.91 3.49 3.36 3.40 4.14 
MGDG36_3 0.00 0.04 0.03 0.04 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG36_2 0.00 0.00 0.00 0.06 0.00 0.24 0.32 0.13 0.19 0.14 
MGDG36_1 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 
MGDG38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.02 0.00 0.02 
MGDG38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
MGDG38_4 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.16 
MGDG38_3 0.07 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC32_0 0.01 0.01 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 
PC34_4 0.11 0.10 0.13 0.12 0.13 0.37 0.31 0.34 0.33 0.37 
PC34_3 2.40 2.15 2.71 2.42 2.76 2.04 1.86 1.97 1.93 2.07 
PC34_2 2.61 2.44 2.71 2.74 3.02 3.45 3.09 3.45 3.31 3.36 
PC34_1 0.55 0.58 0.62 0.61 0.65 0.95 0.83 0.86 0.85 0.89 
PC36_6 2.13 1.92 2.54 2.11 2.47 1.22 1.15 1.22 1.21 1.29 
PC36_5 4.16 3.82 4.52 4.18 4.90 3.64 3.45 3.54 3.57 3.72 
PC36_4 2.96 2.84 3.12 3.15 3.47 4.31 3.87 4.22 4.23 4.23 
PC36_3 1.36 1.36 1.46 1.58 1.61 2.45 2.15 2.29 2.33 2.38 
PC36_2 0.49 0.52 0.50 0.58 0.59 1.04 0.90 0.92 0.93 0.97 
PC36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC38_6 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PC38_5 0.03 0.03 0.03 0.03 0.04 0.02 0.02 0.03 0.03 0.03 
PC38_4 0.05 0.05 0.05 0.05 0.05 0.07 0.07 0.07 0.07 0.07 
PC38_3 0.05 0.05 0.05 0.06 0.06 0.11 0.10 0.10 0.10 0.11 
PC38_2 0.02 0.03 0.03 0.03 0.03 0.05 0.04 0.05 0.05 0.05 
PC40_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PC40_3 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 
PC40_2 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.01 0.01 
LysoPC16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
LysoPC16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_3 0.03 0.03 0.04 0.03 0.04 0.02 0.02 0.02 0.03 0.02 
LysoPC18_2 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.04 
LysoPC18_1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
LysoPC18_0 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.01 0.01 0.01 
LysoPE16_1 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 
LysoPE16_0 0.04 0.04 0.05 0.04 0.04 0.05 0.05 0.05 0.04 0.05 
LysoPE18_3 0.04 0.03 0.04 0.03 0.04 0.03 0.02 0.03 0.03 0.03 
LysoPE18_2 0.04 0.04 0.04 0.05 0.05 0.06 0.06 0.06 0.06 0.08 
LysoPE18_1 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
PE34_4 0.05 0.04 0.07 0.06 0.06 0.14 0.13 0.14 0.13 0.15 
PE34_3 3.18 2.77 3.75 3.22 3.61 2.75 2.59 2.59 2.58 2.79 
PE34_2 3.63 3.31 4.03 3.84 4.21 4.82 4.58 4.59 4.75 4.86 
PE34_1 0.07 0.05 0.07 0.04 0.05 0.08 0.04 0.07 0.04 0.06 
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PE36_6 0.96 0.83 1.19 0.97 1.07 0.63 0.60 0.63 0.64 0.70 
PE36_5 2.21 2.01 2.61 2.36 2.57 2.40 2.22 2.34 2.29 2.42 
PE36_4 2.04 1.86 2.30 2.20 2.37 3.46 3.21 3.33 3.26 3.39 
PE36_3 0.65 0.60 0.76 0.70 0.76 1.05 0.94 0.95 0.98 0.99 
PE36_2 0.26 0.23 0.26 0.28 0.30 0.48 0.45 0.43 0.45 0.44 
PE36_1 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 
PE38_6 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 
PE38_5 0.02 0.02 0.03 0.03 0.03 0.02 0.02 0.03 0.02 0.03 
PE38_4 0.03 0.03 0.03 0.04 0.04 0.05 0.05 0.05 0.06 0.05 
PE38_3 0.05 0.06 0.07 0.07 0.07 0.09 0.08 0.09 0.09 0.08 
PE38_2 0.07 0.08 0.09 0.09 0.09 0.12 0.11 0.11 0.10 0.11 
PE40_3 0.05 0.04 0.05 0.05 0.05 0.06 0.05 0.05 0.05 0.05 
PE40_2 0.08 0.07 0.08 0.09 0.09 0.14 0.12 0.13 0.13 0.13 
PE42_4 0.02 0.02 0.03 0.02 0.03 0.02 0.02 0.03 0.02 0.03 
PE42_3 0.10 0.08 0.09 0.09 0.10 0.13 0.12 0.12 0.14 0.13 
PE42_2 0.09 0.08 0.10 0.10 0.11 0.18 0.17 0.17 0.17 0.16 
PG32_1 0.61 0.53 0.70 0.69 0.64 0.50 0.47 0.45 0.41 0.42 
PG32_0 0.25 0.25 0.34 0.24 0.31 0.19 0.24 0.26 0.21 0.20 
PG34_4 7.87 7.53 8.61 8.68 9.31 0.35 0.33 0.35 0.36 0.39 
PG34_3 1.74 1.48 1.79 1.76 1.77 0.63 0.75 0.69 0.73 0.70 
PG34_2 1.36 1.28 1.33 1.59 1.51 12.20 11.99 12.86 12.77 12.17 
PG34_1 0.80 0.74 0.86 0.95 0.97 2.50 2.13 2.27 2.27 2.06 
PG34_0 0.03 0.01 0.02 0.00 0.02 0.00 0.02 0.07 0.00 0.05 
lysoPG16_1 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.02 0.02 
lysoPG16_0 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
lysoPG18_3 0.04 0.06 0.05 0.05 0.05 0.00 0.00 0.00 0.00 0.00 
lysoPG18_2 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
lysoPG18_1 0.00 0.01 0.01 0.00 0.01 0.08 0.07 0.08 0.09 0.08 
PA34_6 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 
PA34_4 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 
PA34_3 0.17 0.14 0.23 0.20 0.24 0.18 0.09 0.11 0.17 0.13 
PA34_2 0.18 0.14 0.20 0.21 0.21 0.22 0.17 0.16 0.23 0.24 
PA34_1 0.04 0.06 0.05 0.05 0.04 0.09 0.06 0.14 0.12 0.07 
PA36_6 0.05 0.07 0.07 0.07 0.07 0.04 0.02 0.03 0.02 0.04 
PA36_5 0.12 0.10 0.14 0.13 0.14 0.11 0.07 0.07 0.09 0.10 
PA36_4 0.13 0.10 0.12 0.12 0.14 0.16 0.09 0.10 0.11 0.15 
PA36_3 0.04 0.04 0.05 0.05 0.06 0.06 0.04 0.04 0.05 0.05 
PA36_2 0.01 0.01 0.02 0.01 0.02 0.02 0.02 0.00 0.01 0.01 
PI34_4 0.01 0.02 0.02 0.02 0.01 0.05 0.04 0.05 0.04 0.05 
PI34_3 1.47 1.36 1.78 1.54 1.66 1.28 1.01 1.16 1.16 1.28 
PI34_2 1.33 1.24 1.42 1.47 1.47 2.02 1.63 1.79 1.60 1.86 
PI34_1 0.00 0.00 0.02 0.01 0.01 0.01 0.00 0.02 0.00 0.01 
PI36_6 0.09 0.09 0.10 0.08 0.09 0.07 0.06 0.09 0.07 0.06 
PI36_5 0.09 0.12 0.10 0.10 0.12 0.10 0.08 0.09 0.08 0.10 
PI36_4 0.10 0.09 0.12 0.12 0.12 0.19 0.14 0.16 0.18 0.17 
PI36_3 0.15 0.15 0.14 0.15 0.15 0.21 0.18 0.18 0.19 0.21 
PI36_2 0.08 0.09 0.06 0.09 0.11 0.17 0.14 0.14 0.15 0.13 
PI36_1 0.01 0.00 0.00 0.00 0.00 0.01 0.03 0.02 0.01 0.00 
PS34_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS34_3 0.08 0.07 0.10 0.09 0.10 0.07 0.06 0.06 0.07 0.06 
PS34_2 0.07 0.07 0.07 0.07 0.08 0.08 0.07 0.09 0.09 0.08 
PS34_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_6 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS36_5 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 
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PS36_4 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.01 
PS36_3 0.03 0.04 0.04 0.04 0.04 0.05 0.04 0.03 0.04 0.04 
PS36_2 0.02 0.02 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 
PS36_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_5 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS38_4 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.01 
PS38_3 0.03 0.03 0.04 0.03 0.04 0.04 0.04 0.04 0.04 0.04 
PS38_2 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.04 
PS38_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_4 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS40_3 0.05 0.04 0.06 0.05 0.05 0.05 0.04 0.05 0.04 0.05 
PS40_2 0.05 0.04 0.05 0.05 0.05 0.07 0.06 0.06 0.05 0.06 
PS40_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS42_4 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.02 0.02 
PS42_3 0.08 0.08 0.10 0.08 0.10 0.10 0.10 0.09 0.09 0.10 
PS42_2 0.06 0.06 0.07 0.06 0.07 0.11 0.09 0.10 0.10 0.09 
PS42_1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_3 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
PS44_2 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 
 
 60
Appendix B – The significant reactions for each experiment 













PE34_1_PE40_2 -1.50 0.07 -1.58 0.037 0.010 69.05 
PE34_1_PS34_2 -1.50 0.07 -1.57 0.037 0.006 67.37 
PE34_1_PS38_2 -1.50 0.01 -1.51 0.037 0.002 66.51 
PE34_1_PC38_5 -1.50 0.04 -1.55 0.037 0.005 66.38 
PE34_1_LysoPE16_0 -1.50 0.02 -1.52 0.037 0.002 66.08 
PE34_1_PI36_3 -1.50 0.07 -1.57 0.037 0.021 66.05 
PE34_1_PS38_3 -1.50 0.02 -1.52 0.037 0.004 65.94 
PE34_1_LysoPE18_2 -1.50 0.03 -1.53 0.037 0.004 65.84 
PE34_1_LysoPC18_3 -1.50 0.01 -1.51 0.037 0.002 65.42 
PE34_1_LysoPC18_2 -1.50 0.02 -1.52 0.037 0.002 65.42 
PE34_1_PC38_3 -1.50 0.05 -1.55 0.037 0.006 65.26 
PE34_1_PS36_5 -1.50 0.01 -1.51 0.037 0.001 64.65 
PE34_1_PI36_5 -1.50 0.11 -1.62 0.037 0.013 64.56 
PE34_1_PE38_5 -1.50 0.02 -1.53 0.037 0.004 64.50 
PE34_1_PC40_4 -1.50 0.00 -1.51 0.037 0.000 64.44 
PE34_1_PS40_2 -1.50 0.05 -1.56 0.037 0.005 64.37 
PE34_1_PS36_3 -1.50 0.02 -1.53 0.037 0.005 64.24 
PE34_1_PS44_2 -1.50 0.00 -1.51 0.037 0.001 63.91 
PE34_1_PS42_2 -1.50 0.05 -1.55 0.037 0.009 61.72 
PE34_1_PA36_5 -1.50 0.10 -1.60 0.037 0.028 55.30 
PE34_1_PA34_2 -1.50 0.16 -1.67 0.037 0.034 52.07 
PC34_1_PI36_3 -2.39 0.07 -2.46 0.085 0.021 51.17 
PC34_1_PI36_5 -2.39 0.11 -2.50 0.085 0.013 49.26 
PC34_1_PE40_2 -2.39 0.07 -2.46 0.085 0.010 48.69 
PC34_1_PS42_2 -2.39 0.05 -2.43 0.085 0.009 48.00 
PC34_1_PC38_3 -2.39 0.05 -2.44 0.085 0.006 47.64 
PC34_1_PC36_3 -2.39 0.58 -2.97 0.085 0.134 47.58 
PC34_1_PS34_2 -2.39 0.07 -2.46 0.085 0.006 47.55 
PC34_1_PS40_2 -2.39 0.05 -2.44 0.085 0.005 46.76 
PC34_1_PC38_5 -2.39 0.04 -2.43 0.085 0.005 46.55 
1d 2d 1 2d d− 1sp 2sp
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PC34_1_PS38_3 -2.39 0.02 -2.41 0.085 0.004 45.81 
PC34_1_LysoPE18_2 -2.39 0.03 -2.42 0.085 0.004 45.60 
PC34_1_PE38_5 -2.39 0.02 -2.41 0.085 0.004 45.58 
PC34_1_PS36_3 -2.39 0.02 -2.41 0.085 0.005 45.52 
PC34_1_LysoPE16_0 -2.39 0.02 -2.41 0.085 0.002 45.37 
PC34_1_LysoPC18_2 -2.39 0.02 -2.41 0.085 0.002 45.29 
PC34_1_PS38_2 -2.39 0.01 -2.40 0.085 0.002 45.05 
PC34_1_LysoPC18_3 -2.39 0.01 -2.40 0.085 0.002 45.00 
PC36_2_PC34_2 -6.76 3.02 -9.78 0.267 0.292 44.88 
PC36_2_PC36_3 -6.76 0.58 -7.34 0.267 0.134 44.53 
PC34_1_PS44_2 -2.39 0.00 -2.39 0.085 0.001 44.50 
PC34_1_PC40_4 -2.39 0.00 -2.39 0.085 0.000 44.39 
PC34_1_PS36_5 -2.39 0.01 -2.39 0.085 0.001 44.22 
PE34_4_PS40_2 -0.06 0.05 -0.11 0.006 0.005 43.68 
PC34_1_PA34_2 -2.39 0.16 -2.55 0.085 0.034 42.76 
PC36_2_PE36_5 -6.76 2.06 -8.82 0.267 0.271 42.62 
PC36_2_PI34_2 -6.76 1.58 -8.34 0.267 0.231 42.07 
PC36_2_PI36_3 -6.76 0.07 -6.83 0.267 0.021 42.04 
PE36_2_PI36_3 -2.02 0.07 -2.09 0.086 0.021 41.82 
PC36_2_PE40_2 -6.76 0.07 -6.83 0.267 0.010 41.06 
PC36_2_PI36_5 -6.76 0.11 -6.87 0.267 0.013 41.03 
PC34_1_PA36_5 -2.39 0.10 -2.48 0.085 0.028 41.00 
PE36_2_PE40_2 -2.02 0.07 -2.09 0.086 0.010 40.81 
PC36_2_PS34_2 -6.76 0.07 -6.83 0.267 0.006 40.76 
PC36_2_PC38_3 -6.76 0.05 -6.81 0.267 0.006 40.74 
PE36_2_PI36_5 -2.02 0.11 -2.13 0.086 0.013 40.67 
PC36_2_PC38_5 -6.76 0.04 -6.80 0.267 0.005 40.53 
PC36_2_PS38_3 -6.76 0.02 -6.78 0.267 0.004 40.48 
PC36_2_PS40_2 -6.76 0.05 -6.81 0.267 0.005 40.45 
PC36_2_LysoPE18_2 -6.76 0.03 -6.79 0.267 0.004 40.38 
PC36_2_PS42_2 -6.76 0.05 -6.81 0.267 0.009 40.38 
PC36_2_LysoPE16_0 -6.76 0.02 -6.78 0.267 0.002 40.36 
PC36_2_PS36_3 -6.76 0.02 -6.78 0.267 0.005 40.30 
PC36_2_PS38_2 -6.76 0.01 -6.77 0.267 0.002 40.30 
PC36_2_PE38_5 -6.76 0.02 -6.78 0.267 0.004 40.29 
PC36_2_LysoPC18_2 -6.76 0.02 -6.78 0.267 0.002 40.28 
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PC36_2_LysoPC18_3 -6.76 0.01 -6.77 0.267 0.002 40.24 
PC36_2_PC40_4 -6.76 0.00 -6.76 0.267 0.000 40.13 
PC36_2_PS44_2 -6.76 0.00 -6.77 0.267 0.001 40.09 
PC36_2_PS36_5 -6.76 0.01 -6.77 0.267 0.001 40.09 
PC36_2_PA36_5 -6.76 0.10 -6.86 0.267 0.028 40.04 
PC36_2_PA34_2 -6.76 0.16 -6.93 0.267 0.034 40.01 
PC36_2_PE34_2 -6.76 3.88 -10.65 0.267 0.402 39.93 
PC36_2_PC36_6 -6.76 1.51 -8.27 0.267 0.268 39.80 
PE34_4_PC38_5 -0.06 0.04 -0.10 0.006 0.005 39.76 
PE36_2_PS34_2 -2.02 0.07 -2.09 0.086 0.006 39.04 
PE36_2_PC38_5 -2.02 0.04 -2.07 0.086 0.005 38.78 
PE36_2_PC38_3 -2.02 0.05 -2.07 0.086 0.006 38.77 
PE36_2_PS42_2 -2.02 0.05 -2.07 0.086 0.009 38.55 
PE36_2_PS38_3 -2.02 0.02 -2.04 0.086 0.004 38.51 
PE36_2_LysoPE18_2 -2.02 0.03 -2.05 0.086 0.004 38.42 
PE36_2_PS40_2 -2.02 0.05 -2.07 0.086 0.005 38.36 
PE36_2_LysoPE16_0 -2.02 0.02 -2.04 0.086 0.002 38.08 
PE36_2_PS38_2 -2.02 0.01 -2.03 0.086 0.002 37.99 
PE36_2_LysoPC18_2 -2.02 0.02 -2.04 0.086 0.002 37.90 
PE36_2_PS36_3 -2.02 0.02 -2.05 0.086 0.005 37.90 
PE36_2_PE38_5 -2.02 0.02 -2.04 0.086 0.004 37.89 
PE36_2_LysoPC18_3 -2.02 0.01 -2.03 0.086 0.002 37.63 
PE36_2_PS36_5 -2.02 0.01 -2.03 0.086 0.001 37.33 
PE36_2_PC40_4 -2.02 0.00 -2.02 0.086 0.000 37.32 
PC36_2_PC34_3 -6.76 1.63 -8.39 0.267 0.307 37.27 
PE36_2_PS44_2 -2.02 0.00 -2.03 0.086 0.001 37.25 
PS42_1_LysoPE16_0 -0.05 0.02 -0.06 0.003 0.002 35.67 
PE36_2_PA34_2 -2.02 0.16 -2.19 0.086 0.034 35.60 
PE36_2_PA36_5 -2.02 0.10 -2.12 0.086 0.028 35.59 
PC36_2_PE34_3 -6.76 1.28 -8.04 0.267 0.322 35.48 
PC34_1_PC34_2 -2.39 3.02 -5.41 0.085 0.292 34.87 
PC38_2_PC38_3 -0.08 0.05 -0.13 0.007 0.006 34.72 
PI34_1_PS34_2 -1.38 0.07 -1.45 0.068 0.006 34.34 
PS42_1_PC40_4 -0.05 0.00 -0.05 0.003 0.000 34.27 
PC38_2_PS34_2 -0.08 0.07 -0.15 0.007 0.006 34.11 
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PC36_4_PE34_3 -1.49 1.76 -3.25 0.375 0.326 45.37 
PE36_4_PE36_5 -1.48 1.22 -2.70 0.250 0.275 42.95 
PC36_4_PC34_3 -1.49 1.29 -2.78 0.375 0.314 39.90 
PE36_4_PE34_3 -1.48 1.76 -3.24 0.250 0.326 33.99 
PC36_4_PC36_6 -1.49 1.26 -2.76 0.375 0.276 32.60 
PC36_4_PE36_5 -1.49 1.22 -2.71 0.375 0.275 32.13 
PE36_4_PC36_6 -1.48 1.26 -2.74 0.250 0.276 31.88 
PE36_4_PC34_3 -1.48 1.29 -2.76 0.250 0.314 28.32 
PC36_4_PC36_5 -1.49 1.84 -3.33 0.375 0.533 28.02 
PE36_4_PE36_6 -1.48 0.66 -2.14 0.250 0.102 20.76 
PE36_4_PC36_5 -1.48 1.84 -3.32 0.250 0.533 16.03 
PS38_2_PC38_5 -0.01 0.03 -0.04 0.003 0.005 14.97 
PS38_2_PE38_5 -0.01 0.02 -0.03 0.003 0.004 14.67 
PS38_2_PE40_3 -0.01 0.03 -0.04 0.003 0.004 14.20 
PS38_2_PE42_4 -0.01 0.01 -0.03 0.003 0.002 13.33 
PS34_2_PS34_3 -0.04 0.04 -0.08 0.010 0.010 13.17 
PS38_2_PS38_3 -0.01 0.02 -0.04 0.003 0.004 12.67 
PS34_2_PC38_5 -0.04 0.03 -0.06 0.010 0.005 12.54 
PS38_2_PC38_4 -0.01 0.02 -0.04 0.003 0.006 12.44 
PS38_2_LysoPE16_0 -0.01 0.01 -0.02 0.003 0.002 12.41 
PS34_2_PS36_3 -0.04 0.02 -0.06 0.010 0.006 12.28 
PS38_2_PS42_4 -0.01 0.01 -0.02 0.003 0.002 12.25 
PS36_2_PC38_5 -0.01 0.03 -0.04 0.003 0.005 12.23 
PC36_4_PE36_6 -1.49 0.66 -2.16 0.375 0.102 12.21 
PS38_2_LysoPE18_3 -0.01 0.01 -0.02 0.003 0.003 12.07 
PS36_2_PE38_5 -0.01 0.02 -0.03 0.003 0.004 12.02 
PS36_2_PE40_3 -0.01 0.03 -0.04 0.003 0.004 11.82 
PS34_2_PS40_3 -0.04 0.03 -0.07 0.010 0.006 11.72 
PS34_2_PE40_3 -0.04 0.03 -0.06 0.010 0.004 11.69 
PS38_2_PC38_6 -0.01 0.01 -0.02 0.003 0.002 11.68 
MGDG36_5_PE36_6 -0.34 0.66 -1.00 0.102 0.102 11.63 
PS34_2_PC38_4 -0.04 0.02 -0.06 0.010 0.006 11.61 
1d 2d 1 2d d− 1sp 2sp
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PS34_2_PE36_6 -0.04 0.66 -0.70 0.010 0.102 11.27 
PS36_2_PS38_3 -0.01 0.02 -0.04 0.003 0.004 11.15 
PS36_2_PE42_4 -0.01 0.01 -0.02 0.003 0.002 10.98 
PS36_2_LysoPE16_0 -0.01 0.01 -0.02 0.003 0.002 10.90 
PS34_2_PE38_5 -0.04 0.02 -0.06 0.010 0.004 10.60 
PS38_2_PS40_3 -0.01 0.03 -0.04 0.003 0.006 10.59 
PS38_2_PE36_6 -0.01 0.66 -0.68 0.003 0.102 10.57 
PS36_2_PE36_6 -0.01 0.66 -0.68 0.003 0.102 10.50 
PE36_4_PI36_3 -1.48 0.06 -1.54 0.250 0.020 10.40 
PS36_2_PC38_4 -0.01 0.02 -0.03 0.003 0.006 10.39 
PS36_2_PE34_4 -0.01 0.02 -0.03 0.003 0.005 10.20 
PS34_2_PS38_3 -0.04 0.02 -0.06 0.010 0.004 10.15 
PS38_2_PS36_3 -0.01 0.02 -0.04 0.003 0.006 10.04 
PS36_2_PS42_4 -0.01 0.01 -0.02 0.003 0.002 10.03 
PE36_4_PS34_3 -1.48 0.04 -1.52 0.250 0.010 9.95 
PS38_2_PE34_4 -0.01 0.02 -0.04 0.003 0.005 9.93 
MGDG36_5_PE34_3 -0.34 1.76 -2.09 0.102 0.326 9.82 
PE36_4_PS40_3 -1.48 0.03 -1.51 0.250 0.006 9.74 
PE36_4_PC38_5 -1.48 0.03 -1.51 0.250 0.005 9.68 
PE36_4_PE40_3 -1.48 0.03 -1.50 0.250 0.004 9.66 
PE36_4_PC38_4 -1.48 0.02 -1.50 0.250 0.006 9.66 
PE36_4_PE34_4 -1.48 0.02 -1.50 0.250 0.005 9.64 
PE36_4_PS38_3 -1.48 0.02 -1.50 0.250 0.004 9.63 
PS36_2_PC38_6 -0.01 0.01 -0.02 0.003 0.002 9.62 
PE36_4_PS36_3 -1.48 0.02 -1.50 0.250 0.006 9.60 
PE36_4_PE38_5 -1.48 0.02 -1.50 0.250 0.004 9.60 
PS38_2_PS34_3 -0.01 0.04 -0.06 0.003 0.010 9.49 
PE36_4_PE42_4 -1.48 0.01 -1.49 0.250 0.002 9.48 
PE36_4_LysoPE16_0 -1.48 0.01 -1.49 0.250 0.002 9.47 
PE36_4_PC38_6 -1.48 0.01 -1.49 0.250 0.002 9.47 
PE36_4_LysoPE18_3 -1.48 0.01 -1.49 0.250 0.003 9.47 
PE36_4_PS42_4 -1.48 0.01 -1.49 0.250 0.002 9.44 
PE36_4_DGDG36_3 -1.48 0.11 -1.59 0.250 0.032 9.38 
PS36_2_PS40_3 -0.01 0.03 -0.04 0.003 0.006 9.36 
PE36_4_PS36_6 -1.48 0.00 -1.48 0.250 0.001 9.36 
PE36_4_PA36_6 -1.48 0.04 -1.52 0.250 0.013 9.35 
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PG34_3_PG34_4 -4.13 9.79 -13.92 0.371 0.648 35.59 
PG34_3_PG34_2 -4.13 0.83 -4.96 0.371 0.176 32.90 
PG32_0_PG34_4 -0.31 9.79 -10.10 0.064 0.648 25.91 
PG34_0_PG34_4 -0.09 9.79 -9.89 0.028 0.648 24.35 
PG34_3_PG32_1 -4.13 0.65 -4.79 0.371 0.083 21.39 
PG32_0_PG32_1 -0.31 0.65 -0.96 0.064 0.083 19.32 
PG34_3_lysoPG18_3 -4.13 0.04 -4.17 0.371 0.003 17.80 
PG34_0_PG32_1 -0.09 0.65 -0.75 0.028 0.083 14.26 
PG32_0_PG34_2 -0.31 0.83 -1.14 0.064 0.176 11.62 
 














DGDG34_3_DGDG36_6 -9.79 8.27 -18.06 0.953 0.799 34.41 
MGDG36_6_DGDG36_6 -21.58 8.27 -29.85 1.492 0.799 33.37 
MGDG36_6_MGDG34_6 -21.58 66.50 -88.08 1.492 4.598 30.16 
DGDG36_3_DGDG34_6 -0.32 2.22 -2.54 0.047 0.144 30.14 
MGDG38_4_DGDG34_6 -0.29 2.22 -2.52 0.059 0.144 28.02 
MGDG34_3_MGDG34_6 -17.52 66.50 -84.03 1.675 4.598 27.15 
DGDG34_3_MGDG34_6 -9.79 66.50 -76.29 0.953 4.598 26.50 
MGDG36_6_DGDG34_6 -21.58 2.22 -23.80 1.492 0.144 25.40 
DGDG36_3_DGDG34_1 -0.32 0.32 -0.63 0.047 0.047 25.07 
MGDG36_6_MGDG34_4 -21.58 1.90 -23.48 1.492 0.238 24.97 
LysoPC16_0_DGDG34_6 0.00 2.22 -2.23 0.001 0.144 24.50 
MGDG36_6_DGDG34_2 -21.58 0.93 -22.51 1.492 0.094 23.98 
MGDG36_6_MGDG36_4 -21.58 0.72 -22.30 1.492 0.136 23.70 
DGDG36_3_DGDG34_2 -0.32 0.93 -1.25 0.047 0.094 23.67 
MGDG36_6_MGDG34_2 -21.58 0.59 -22.17 1.492 0.096 23.60 
MGDG36_6_DGDG36_4 -21.58 0.29 -21.86 1.492 0.063 23.46 
MGDG36_6_DGDG34_1 -21.58 0.32 -21.89 1.492 0.047 23.32 
1d 2d 1 2d d− 1sp 2sp
1d 2d 1 2d d− 1sp 2sp
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MGDG38_4_MGDG34_6 -0.29 66.50 -66.79 0.059 4.598 23.07 
DGDG36_3_MGDG34_6 -0.32 66.50 -66.82 0.047 4.598 23.05 
MGDG36_6_PC34_4 -21.58 0.08 -21.66 1.492 0.014 22.91 
MGDG36_6_DGDG34_5 -21.58 0.11 -21.69 1.492 0.029 22.91 
MGDG36_6_PE34_4 -21.58 0.03 -21.61 1.492 0.005 22.88 
LysoPC16_0_MGDG34_6 0.00 66.50 -66.50 0.001 4.598 22.87 
MGDG38_4_DGDG34_2 -0.29 0.93 -1.23 0.059 0.094 20.84 
MGDG34_3_DGDG36_6 -17.52 8.27 -25.80 1.675 0.799 20.43 
DGDG34_3_DGDG34_6 -9.79 2.22 -12.01 0.953 0.144 20.14 
DGDG34_3_MGDG34_4 -9.79 1.90 -11.69 0.953 0.238 19.72 
MGDG38_4_DGDG36_4 -0.29 0.29 -0.58 0.059 0.063 19.38 
MGDG34_3_DGDG34_6 -17.52 2.22 -19.75 1.675 0.144 18.56 
MGDG34_3_MGDG34_4 -17.52 1.90 -19.43 1.675 0.238 18.50 
DGDG34_3_MGDG36_4 -9.79 0.72 -10.51 0.953 0.136 18.37 
DGDG34_3_DGDG34_2 -9.79 0.93 -10.72 0.953 0.094 18.07 
MGDG34_3_DGDG34_2 -17.52 0.93 -18.46 1.675 0.094 17.41 
MGDG38_4_DGDG36_6 -0.29 8.27 -8.57 0.059 0.799 17.25 
DGDG34_3_MGDG34_2 -9.79 0.59 -10.38 0.953 0.096 17.06 
MGDG34_3_MGDG34_2 -17.52 0.59 -18.11 1.675 0.096 17.05 
MGDG34_3_MGDG36_4 -17.52 0.72 -18.24 1.675 0.136 16.98 
MGDG34_3_DGDG36_4 -17.52 0.29 -17.81 1.675 0.063 16.87 
DGDG36_3_DGDG36_6 -0.32 8.27 -8.59 0.047 0.799 16.67 
 













MGDG36_4_DGDG34_6 -2.39 2.22 -4.62 0.181 0.144 52.78 
PG34_2_PG34_3 -9.15 1.79 -10.94 0.392 0.228 49.18 
PG34_2_PG34_4 -9.15 9.48 -18.62 0.392 0.649 45.41 
PG34_2_DGDG34_6 -9.15 2.22 -11.37 0.392 0.144 41.98 
MGDG34_2_PG34_4 -16.35 9.48 -25.82 0.774 0.649 39.74 
DGDG36_4_DGDG34_6 -3.28 2.22 -5.50 0.154 0.144 38.72 
PG34_2_PC38_5 -9.15 0.02 -9.17 0.392 0.005 37.21 
MGDG34_2_DGDG34_6 -16.35 2.22 -18.57 0.774 0.144 37.16 
PG34_2_lysoPG18_3 -9.15 0.04 -9.19 0.392 0.003 37.12 
1d 2d 1 2d d− 1sp 2sp
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PG34_2_PE38_5 -9.15 0.01 -9.16 0.392 0.004 37.09 
PG34_2_DGDG36_3 -9.15 0.18 -9.32 0.392 0.026 37.08 
PG34_2_PE40_3 -9.15 0.02 -9.16 0.392 0.004 37.08 
PG34_2_DGDG34_5 -9.15 0.11 -9.26 0.392 0.029 37.00 
MGDG34_2_PG34_3 -16.35 1.79 -18.14 0.774 0.228 35.53 
DGDG36_4_DGDG34_5 -3.28 0.11 -3.39 0.154 0.029 35.40 
DGDG36_4_DGDG36_3 -3.28 0.18 -3.45 0.154 0.026 34.66 
DGDG36_4_lysoPG18_3 -3.28 0.04 -3.32 0.154 0.003 34.01 
DGDG36_4_PC38_5 -3.28 0.02 -3.30 0.154 0.005 33.97 
DGDG36_4_PE38_5 -3.28 0.01 -3.29 0.154 0.004 33.91 
DGDG36_4_PE40_3 -3.28 0.02 -3.29 0.154 0.004 33.79 
MGDG34_2_DGDG36_3 -16.35 0.18 -16.52 0.774 0.026 33.70 
MGDG34_2_DGDG34_5 -16.35 0.11 -16.46 0.774 0.029 33.50 
MGDG34_2_lysoPG18_3 -16.35 0.04 -16.39 0.774 0.003 33.46 
MGDG34_2_PC38_5 -16.35 0.02 -16.37 0.774 0.005 33.41 
MGDG34_2_PE40_3 -16.35 0.02 -16.36 0.774 0.004 33.38 
MGDG34_2_PE38_5 -16.35 0.01 -16.36 0.774 0.004 33.38 
DGDG34_1_DGDG34_6 -0.79 2.22 -3.01 0.083 0.144 32.40 
DGDG36_4_PG34_3 -3.28 1.79 -5.07 0.154 0.228 30.50 
DGDG36_4_PG34_4 -3.28 9.48 -12.75 0.154 0.649 29.78 
PG34_2_DGDG34_3 -9.15 1.23 -10.38 0.392 0.369 28.96 
MGDG34_2_MGDG34_6 -16.35 66.54 -82.89 0.774 4.598 28.46 
MGDG36_2_DGDG34_6 -0.21 2.22 -2.43 0.027 0.144 27.90 
MGDG36_4_PG34_4 -2.39 9.48 -11.87 0.181 0.649 27.22 
DGDG36_2_DGDG34_6 -0.25 2.22 -2.47 0.022 0.144 26.83 
PG34_1_PG34_4 -1.36 9.48 -10.84 0.242 0.649 26.75 
MGDG34_2_DGDG34_3 -16.35 1.23 -17.58 0.774 0.369 26.59 
PC36_3_PG34_4 -0.45 9.48 -9.93 0.147 0.649 26.48 
PC34_4_PC38_5 -0.24 0.02 -0.27 0.019 0.005 26.47 
MGDG34_3_DGDG34_6 -2.48 2.22 -4.71 0.232 0.144 26.38 
PE34_4_PC38_5 -0.07 0.02 -0.09 0.007 0.005 26.29 
PC34_4_DGDG34_6 -0.24 2.22 -2.46 0.019 0.144 26.22 
PC36_3_PG34_3 -0.45 1.79 -2.24 0.147 0.228 25.93 
MGDG34_3_PG34_4 -2.48 9.48 -11.96 0.232 0.649 25.76 
PC34_4_PE40_3 -0.24 0.02 -0.26 0.019 0.004 25.72 
PG34_2_MGDG34_6 -9.15 66.54 -75.69 0.392 4.598 25.20 
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lysoPG18_1_DGDG34_6 -0.04 2.22 -2.27 0.003 0.144 24.94 
PE34_1_DGDG34_6 -0.05 2.22 -2.27 0.008 0.144 24.85 
DGDG34_1_PG34_4 -0.79 9.48 -10.27 0.083 0.649 24.76 
PE34_4_DGDG34_6 -0.07 2.22 -2.29 0.007 0.144 24.75 
PC34_1_PG34_4 -0.25 9.48 -9.73 0.056 0.649 24.66 
PE34_4_PE40_3 -0.07 0.02 -0.08 0.007 0.004 24.66 
 














DGDG36_5_MGDG36_6 -5.91 6.48 -12.39 0.273 0.481 47.94 
DGDG36_5_DGDG34_6 -5.91 1.50 -7.41 0.273 0.195 38.12 
DGDG36_5_DGDG34_3 -5.91 2.10 -8.01 0.273 0.292 37.03 
DGDG36_5_DGDG36_3 -5.91 0.15 -6.06 0.273 0.039 36.76 
DGDG36_5_lysoPG18_3 -5.91 0.01 -5.92 0.273 0.004 34.26 
MGDG34_5_MGDG36_6 -20.98 6.48 -27.47 1.293 0.481 32.46 
DGDG34_2_DGDG34_6 -1.29 1.50 -2.78 0.207 0.195 32.04 
MGDG34_5_DGDG36_6 -20.98 5.81 -26.79 1.293 0.794 30.99 
MGDG34_5_DGDG34_3 -20.98 2.10 -23.08 1.293 0.292 30.13 
MGDG34_5_DGDG34_6 -20.98 1.50 -22.48 1.293 0.195 28.24 
DGDG34_2_DGDG34_3 -1.29 2.10 -3.39 0.207 0.292 28.19 
MGDG34_5_PG34_4 -20.98 3.10 -24.08 1.293 0.680 28.12 
DGDG36_4_MGDG36_6 -1.78 6.48 -8.27 0.139 0.481 27.92 
DGDG34_5_DGDG34_6 -1.60 1.50 -3.10 0.183 0.195 26.69 
DGDG34_2_MGDG36_6 -1.29 6.48 -7.77 0.207 0.481 25.95 
MGDG34_5_DGDG36_3 -20.98 0.15 -21.13 1.293 0.039 25.76 
MGDG34_5_lysoPG18_3 -20.98 0.01 -21.00 1.293 0.004 25.70 
DGDG36_5_DGDG36_6 -5.91 5.81 -11.72 0.273 0.794 24.77 
DGDG34_5_MGDG36_6 -1.60 6.48 -8.08 0.183 0.481 24.42 
MGDG36_5_MGDG36_6 -3.30 6.48 -9.79 0.314 0.481 24.05 
DGDG34_4_MGDG36_6 -0.65 6.48 -7.14 0.105 0.481 23.76 
PG34_3_MGDG36_6 -1.18 6.48 -7.66 0.267 0.481 23.61 
DGDG34_5_DGDG34_3 -1.60 2.10 -3.70 0.183 0.292 23.51 
DGDG36_4_DGDG34_3 -1.78 2.10 -3.88 0.139 0.292 23.46 
DGDG36_4_DGDG34_6 -1.78 1.50 -3.28 0.139 0.195 23.41 
1d 2d 1 2d d− 1sp 2sp
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MGDG34_4_MGDG36_6 -9.07 6.48 -15.55 1.230 0.481 22.59 
MGDG34_5_MGDG34_6 -20.98 46.68 -67.66 1.293 4.957 22.51 
MGDG36_3_MGDG36_6 -0.23 6.48 -6.71 0.075 0.481 21.82 
PC34_4_MGDG36_6 -0.07 6.48 -6.55 0.014 0.481 21.39 
PE34_4_MGDG36_6 -0.03 6.48 -6.51 0.006 0.481 21.35 
LysoPC18_2_MGDG36_6 -0.02 6.48 -6.50 0.003 0.481 21.35 
LysoPE18_2_MGDG36_6 -0.02 6.48 -6.50 0.004 0.481 21.33 
lysoPG18_2_MGDG36_6 -0.01 6.48 -6.49 0.002 0.481 21.32 
LysoPC18_1_MGDG36_6 0.00 6.48 -6.49 0.001 0.481 21.30 
DGDG36_4_lysoPG18_3 -1.78 0.01 -1.80 0.139 0.004 20.76 
 














MGDG36_6_MGDG34_6 -19.70 30.94 -50.64 2.745 3.189 27.10 
DGDG36_6_MGDG34_6 -7.45 30.94 -38.39 2.099 3.189 25.98 
PE34_1_MGDG34_2 -0.28 0.28 -0.55 0.061 0.057 20.98 
PI34_1_DGDG34_2 -0.10 0.64 -0.74 0.016 0.071 17.68 
PE34_1_DGDG34_2 -0.28 0.64 -0.92 0.061 0.071 17.22 
PC36_2_MGDG34_6 -0.58 30.94 -31.52 0.181 3.189 16.07 
PC34_1_MGDG34_6 -0.50 30.94 -31.44 0.161 3.189 16.03 
PE34_1_MGDG34_6 -0.28 30.94 -31.21 0.061 3.189 15.58 
PI34_1_MGDG34_6 -0.10 30.94 -31.04 0.016 3.189 15.43 
PE36_1_MGDG34_6 -0.02 30.94 -30.95 0.004 3.189 15.35 
PA34_1_MGDG34_6 -0.03 30.94 -30.97 0.010 3.189 15.35 
PA34_1_DGDG34_2 -0.03 0.64 -0.68 0.010 0.071 14.95 
PE36_1_DGDG34_2 -0.02 0.64 -0.66 0.004 0.071 14.77 
MGDG36_6_DGDG34_6 -19.70 1.90 -21.60 2.745 0.318 12.94 
PI34_1_MGDG34_2 -0.10 0.28 -0.38 0.016 0.057 12.14 
PC34_1_DGDG34_6 -0.50 1.90 -2.40 0.161 0.318 12.06 
MGDG36_6_MGDG34_4 -19.70 0.97 -20.67 2.745 0.172 11.94 
MGDG36_6_DGDG34_2 -19.70 0.64 -20.35 2.745 0.071 11.78 
MGDG36_6_MGDG34_2 -19.70 0.28 -19.98 2.745 0.057 11.68 
PC36_2_DGDG34_6 -0.58 1.90 -2.48 0.181 0.318 11.52 
MGDG36_6_DGDG34_1 -19.70 0.20 -19.90 2.745 0.046 11.49 
1d 2d 1 2d d− 1sp 2sp
 70
 














MGDG36_6_MGDG34_6 -27.97 80.75 -108.73 4.665 8.648 21.02 
MGDG34_3_MGDG34_6 -3.64 80.75 -84.40 0.786 8.648 15.44 
PG34_1_MGDG34_6 -0.75 80.75 -81.50 0.242 8.648 15.03 
PE36_3_MGDG34_6 -0.83 80.75 -81.58 0.264 8.648 15.02 
PE36_2_MGDG34_6 -0.73 80.75 -81.48 0.234 8.648 14.98 
MGDG34_5_MGDG34_6 -0.63 80.75 -81.38 0.197 8.648 14.86 
PG34_0_MGDG34_6 -0.38 80.75 -81.14 0.092 8.648 14.84 
PI36_3_MGDG34_6 -0.16 80.75 -80.91 0.045 8.648 14.81 
PE40_3_MGDG34_6 -0.06 80.75 -80.81 0.018 8.648 14.79 
PE38_3_MGDG34_6 -0.05 80.75 -80.80 0.014 8.648 14.78 
PE38_5_MGDG34_6 -0.02 80.75 -80.77 0.006 8.648 14.77 
PG34_0_PG32_1 -0.38 0.33 -0.71 0.092 0.090 13.42 
PG34_1_DGDG34_6 -0.75 2.16 -2.90 0.242 0.399 12.57 
PG34_1_DGDG34_2 -0.75 1.19 -1.93 0.242 0.230 12.16 
PE36_3_DGDG34_6 -0.83 2.16 -2.99 0.264 0.399 11.55 
PE36_2_DGDG34_6 -0.73 2.16 -2.89 0.234 0.399 11.26 
MGDG34_3_DGDG34_6 -3.64 2.16 -5.80 0.786 0.399 10.85 
MGDG36_6_DGDG34_6 -27.97 2.16 -30.13 4.665 0.399 10.59 
PI36_3_DGDG34_1 -0.16 0.17 -0.34 0.045 0.051 10.52 
PG34_0_DGDG34_2 -0.38 1.19 -1.57 0.092 0.230 10.05 
MGDG36_6_DGDG34_2 -27.97 1.19 -29.16 4.665 0.230 10.05 
PG34_0_DGDG34_6 -0.38 2.16 -2.54 0.092 0.399 10.00 
PE36_2_DGDG34_2 -0.73 1.19 -1.91 0.234 0.230 9.88 
PE36_3_DGDG34_2 -0.83 1.19 -2.01 0.264 0.230 9.87 
MGDG34_5_DGDG34_6 -0.63 2.16 -2.79 0.197 0.399 9.75 
PG34_1_PG32_1 -0.75 0.33 -1.08 0.242 0.090 9.74 
MGDG36_6_PG32_1 -27.97 0.33 -28.30 4.665 0.090 9.71 
MGDG36_6_DGDG34_1 -27.97 0.17 -28.15 4.665 0.051 9.58 
MGDG34_5_DGDG34_2 -0.63 1.19 -1.82 0.197 0.230 9.49 
PI36_3_DGDG34_6 -0.16 2.16 -2.32 0.045 0.399 9.44 
MGDG34_3_DGDG34_2 -3.64 1.19 -4.83 0.786 0.230 9.39 
1d 2d 1 2d d− 1sp 2sp
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PI36_3_DGDG34_2 -0.16 1.19 -1.35 0.045 0.230 9.33 
PG34_0_DGDG34_1 -0.38 0.17 -0.56 0.092 0.051 9.06 
PE40_3_DGDG34_6 -0.06 2.16 -2.21 0.018 0.399 8.96 
PE38_3_DGDG34_6 -0.05 2.16 -2.21 0.014 0.399 8.90 
PE40_3_DGDG34_2 -0.06 1.19 -1.24 0.018 0.230 8.72 
PE38_5_DGDG34_6 -0.02 2.16 -2.18 0.006 0.399 8.70 
PE38_3_DGDG34_2 -0.05 1.19 -1.24 0.014 0.230 8.68 
 














MGDG34_2_PA36_6 -18.29 0.04 -18.33 0.350 0.008 83.15 
MGDG34_2_lysoPG18_3 -18.29 0.05 -18.34 0.350 0.004 82.92 
MGDG34_2_PG32_1 -18.29 0.18 -18.48 0.350 0.056 82.92 
MGDG34_2_PC38_5 -18.29 0.01 -18.30 0.350 0.001 82.77 
MGDG34_2_LysoPC18_3 -18.29 0.01 -18.30 0.350 0.003 82.63 
MGDG34_2_PC38_6 -18.29 0.00 -18.30 0.350 0.001 82.62 
MGDG34_2_PG34_3 -18.29 1.01 -19.30 0.350 0.096 82.02 
MGDG34_2_PE36_6 -18.29 0.36 -18.66 0.350 0.098 81.86 
MGDG34_2_PC36_6 -18.29 1.02 -19.31 0.350 0.190 77.14 
MGDG34_2_DGDG34_6 -18.29 2.64 -20.93 0.350 0.299 73.11 
MGDG34_2_PG34_4 -18.29 8.04 -26.34 0.350 0.500 67.54 
PG34_2_PG34_3 -10.98 1.01 -11.99 0.291 0.096 65.13 
PG34_2_LysoPC18_3 -10.98 0.01 -10.99 0.291 0.003 60.05 
PG34_2_lysoPG18_3 -10.98 0.05 -11.03 0.291 0.004 59.99 
PG34_2_PC38_5 -10.98 0.01 -10.99 0.291 0.001 59.80 
PG34_2_PA36_6 -10.98 0.04 -11.02 0.291 0.008 59.74 
PG34_2_PC38_6 -10.98 0.00 -10.99 0.291 0.001 59.72 
PG34_2_PE36_6 -10.98 0.36 -11.35 0.291 0.098 59.58 
PG34_2_PG32_1 -10.98 0.18 -11.17 0.291 0.056 59.14 
PG34_2_PG34_4 -10.98 8.04 -19.03 0.291 0.500 58.13 
PG34_2_PC36_6 -10.98 1.02 -12.00 0.291 0.190 56.34 
PE34_2_PG34_4 -0.92 8.04 -8.96 0.263 0.500 50.04 
PG34_2_DGDG34_6 -10.98 2.64 -13.62 0.291 0.299 49.57 
MGDG34_2_MGDG34_6 -18.29 56.99 -75.28 0.350 2.761 42.83 
1d 2d 1 2d d− 1sp 2sp
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PC36_4_PG34_4 -1.07 8.04 -9.11 0.207 0.500 40.44 
PE36_4_PG34_4 -1.18 8.04 -9.22 0.161 0.500 39.63 
PG34_2_MGDG34_6 -10.98 56.99 -67.98 0.291 2.761 39.58 
DGDG36_4_PG34_3 -2.86 1.01 -3.87 0.135 0.096 38.63 
MGDG36_6_MGDG34_6 -4.15 56.99 -61.14 0.528 2.761 38.33 
PC34_2_PG34_4 -0.63 8.04 -8.67 0.182 0.500 37.16 
DGDG36_4_PG34_4 -2.86 8.04 -10.91 0.135 0.500 36.59 
DGDG36_4_PE36_6 -2.86 0.36 -3.22 0.135 0.098 35.92 
PE34_2_MGDG34_6 -0.92 56.99 -57.91 0.263 2.761 35.25 
MGDG36_4_MGDG34_6 -3.19 56.99 -60.18 0.252 2.761 34.73 
PC36_4_MGDG34_6 -1.07 56.99 -58.06 0.207 2.761 34.65 
DGDG36_4_MGDG34_6 -2.86 56.99 -59.85 0.135 2.761 34.62 
PE36_4_MGDG34_6 -1.18 56.99 -58.17 0.161 2.761 34.61 
DGDG36_4_PA36_6 -2.86 0.04 -2.90 0.135 0.008 34.58 
MGDG34_3_MGDG34_6 -2.27 56.99 -59.26 0.236 2.761 34.55 
MGDG36_4_PG34_4 -3.19 8.04 -11.24 0.252 0.500 34.33 
PE36_4_PC36_6 -1.18 1.02 -2.19 0.161 0.190 34.27 
DGDG36_4_lysoPG18_3 -2.86 0.05 -2.91 0.135 0.004 34.16 
PC34_2_MGDG34_6 -0.63 56.99 -57.62 0.182 2.761 34.13 
PG34_1_MGDG34_6 -1.38 56.99 -58.38 0.137 2.761 34.09 
PC36_3_MGDG34_6 -0.85 56.99 -57.84 0.114 2.761 34.00 
DGDG36_4_LysoPC18_3 -2.86 0.01 -2.87 0.135 0.003 33.82 
DGDG36_4_PC38_5 -2.86 0.01 -2.87 0.135 0.001 33.74 
DGDG36_4_PC38_6 -2.86 0.00 -2.86 0.135 0.001 33.56 
DGDG34_1_MGDG34_6 -1.42 56.99 -58.41 0.209 2.761 33.51 
DGDG34_2_MGDG34_6 -0.54 56.99 -57.53 0.126 2.761 33.28 
PE36_3_MGDG34_6 -0.29 56.99 -57.28 0.057 2.761 33.23 
PC36_2_MGDG34_6 -0.42 56.99 -57.41 0.051 2.761 33.16 
PC34_1_MGDG34_6 -0.27 56.99 -57.27 0.043 2.761 33.10 
MGDG34_3_PG34_4 -2.27 8.04 -10.31 0.236 0.500 33.00 
PG34_1_PG34_4 -1.38 8.04 -9.43 0.137 0.500 32.96 
DGDG34_4_MGDG34_6 -0.26 56.99 -57.25 0.074 2.761 32.93 
PE36_2_MGDG34_6 -0.18 56.99 -57.17 0.023 2.761 32.87 
MGDG36_2_MGDG34_6 -0.19 56.99 -57.18 0.058 2.761 32.85 
PC34_4_MGDG34_6 -0.22 56.99 -57.22 0.019 2.761 32.83 
PC36_3_PG34_4 -0.85 8.04 -8.89 0.114 0.500 32.78 
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PI36_4_MGDG34_6 -0.06 56.99 -57.05 0.016 2.761 32.77 
PE42_2_MGDG34_6 -0.07 56.99 -57.06 0.009 2.761 32.73 
PE34_4_MGDG34_6 -0.08 56.99 -57.07 0.008 2.761 32.73 
PE38_2_MGDG34_6 -0.03 56.99 -57.02 0.008 2.761 32.73 
PE38_3_MGDG34_6 -0.02 56.99 -57.01 0.006 2.761 32.71 
PI36_2_MGDG34_6 -0.06 56.99 -57.05 0.016 2.761 32.71 
PE40_2_MGDG34_6 -0.05 56.99 -57.04 0.007 2.761 32.71 
lysoPG18_1_MGDG34_6 -0.07 56.99 -57.07 0.006 2.761 32.69 
PC38_3_MGDG34_6 -0.05 56.99 -57.04 0.004 2.761 32.69 
PE38_4_MGDG34_6 -0.02 56.99 -57.01 0.004 2.761 32.68 
PS42_2_MGDG34_6 -0.03 56.99 -57.02 0.007 2.761 32.68 
PC38_2_MGDG34_6 -0.02 56.99 -57.01 0.004 2.761 32.68 
PI34_4_MGDG34_6 -0.03 56.99 -57.02 0.005 2.761 32.67 
PI36_3_MGDG34_6 -0.05 56.99 -57.04 0.010 2.761 32.67 




Appendix C - R Programs used in the study 
To make these codes work well, you need to change the file path first. For the 
convenience of the reader and the possible user, I write all the codes as briefly as I could. All you 
need to do is just change the file list.  
 
C.1 Calculation of the statistic needed by this method 
setwd("C:\\lixia document\\My R Files\\ms report\\test"); 
 
##the original dataset should be saved as a "*.csv" file. 
##if the filename is "fad2.csv", then the the tablename should be "fad2". 
 
tablename <- c("FAD2"); 
 
##the sample size for the control group 
nc<-5;  
 
##the sample size for the treat group 
nt<-5;  
 
############# nothing needs to be changed below ####################### 
 
Pval3.rand<-function(data){ 
#This function does a randomization test for two sample microarray data 
#and will be called in the following step 






m <- 2^N 
v <- 1:m 
mat <- matrix(rep(v - 1, rep(N, m)) %/% 2^(0:(N - 1)) %% 2, ncol = m) 
test <- apply(mat, 2, sum) 







































return("done, results in pval") 
} 
 
## This part call the function Pval3.rand to calculate 


















write.csv(r,file=filename2,row.names=TRUE,append = FALSE); 
 
## arrange the dataset to a format easily for calculation; 
## the data was set in the formation of the reactant_product pairs 
## the first five columns are the reactant in the wildtype 
## the second five columns are the reatant in the mutant group 
## the third five columns are the product in the wildtype 
## the forth five columns are the product in the mutant group 
## rrx and rry was calculated by the program: pval3rand.r and pval3rand_head.r 
## rrx is the randomeration p_values for reactant in wildtype and mutant group 






for (n1 in 1:141) { 
 lipid1 <- lipidname[n1]; 
 x <- dat[n1,]; 
 rrx <- rrdat[n1,2]; 
 for (n2 in 1:141) { 
  lipid2 <- lipidname[n2]; 
  y <- dat[n2,]; 
  rry <- rrdat[n2,2]; 
  if (n1 != n2) { 
   lipid12<-paste(lipid1,"_",lipid2,sep=""); 
   cresult<-cbind(x,y,lipid1,lipid2,rrx,rry); 
   rownames(cresult)<-lipid12; 
   result<-rbind(result,cresult); 





## calculate the tscore; 
## x1 is calculated based on the reactant data from the wildtype 
## y1 is calculated based on the reactant data from the mutant group 
## x2 is calculated based on the product data from the wildtype 
## y2 is calculated based on the product data from the mutant group 
## x1bar is the mean for the reactant from wildtype 
## y1bar is the mean for the reactant from the mutant group 
## x2bar is the mean for the product from wildtypd 








dat$d1bar<-dat$x1bar - dat$y1bar; 







for (i in 1:nc) { 












           sqrt((dat$sx1)/nc+(dat$sy1)/nt+(dat$sx2)/nc+(dat$sy2)/nt-2*covx1-2*covy1); 
 
sp1 <- sqrt(((dat$sx1)*(nc-1) + (dat$sy1)*(nt-1))/(nc+nt-2)); 
sp2 <- sqrt(((dat$sx2)*(nc-1) + (dat$sy2)*(nt-1))/(nc+nt-2)); 
 
a<-dat[,-c(1:(nc+nt+nc+nt))]; 











C.2 Getting the most possible reactions by optimizing cut-off values 
setwd("C:\\lixia document\\My R Files\\ms report\\test"); 
 
/*rank for t-scroe. take NA out of consideration and choose a number 450*/ 












x3<-x2[x2[,"d1bar"]<(-3) * x2[,"sp1"],] 
x4<-x3[x3[,"d1bar_d2bar"]<0,] 
x5<-x4[x4[,"tscore"]>=cut_tscore,] 
x6<-x5[x5[,"d2bar"]>3 * x5[,"sp2"],] 
m<-x6[order(x6[,"tscore"],decreasing = TRUE),] 
write.csv(file=filename2,m,append=F,row.names=T); 
 
C.3 Calculate the number of times a lipid appearing as a reactant in each 
experiment  
setwd("C:\\lixia document\\My R Files\\ms report"); 


























 if (i==1) { 
  tmp_reactant <- reactant 
  tmp_product <- product 
 }  
 else { 
  tmp_reactant <- cbind(tmp_reactant,reactant) 










C.4 Permutation test 
#permutation test  by Gary 
#remove zeros, use prob from chisq 
 
setwd("C:\\lixia document\\My R Files\\ms report"); 
 





















for(i in 1:(J-1)){ 
 for(j in (i+1):J){ 
 
  y1<-x2[,i] 
 83
  y2<-x2[,j] 
 
  y<-cbind(y1,y2) 
  
  tt<-apply(y,1,sum) 
 
  o1<-y[tt>0,] 
  pval<-fisher.test(o1,workspace=2000000)$p.value 
 
  p1[i,j]<-pval 
  
  C<-apply(o1,1,sum) 
  n<-apply(o1,2,sum) 
  N<-sum(n) 
  E<-C%*%t(n)/N 
 
  t1<-(o1-E)^2/E 
 
  r1<-length(n) 
  c1<-length(C) 
  test<-sum(t1) 
 
  result[i,j]<-test 
  df<-dim(o1)[1]-1 
  pchi[i,j]<-pchisq(test,df) 
  d[i,j]<-df 
 } 
} 
 
 
